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GENERAL INTRODUCTION AND 
OUTLINE OF THIS THESIS
General introduction
The interpretation of various indirect param eters of systemic blood flow, such as 
blood pressure, heart rate, and urine output is the most used method to evaluate the 
hemodynamic status of a critically ill newborn infant. It has however been shown in 
adults and larger children that this clinical assessm ent of cardiac output is inaccurate. 
It is hypothesized that objective cardiac output m easurem ent can be used to guide 
hemodynamic management in order to reduce mortality and morbidity secondary to 
circulatory failure. In newborn infants, low cardiac output has been associated with an 
increased risk of intracranial hemorrhage (1-4), reduced diuresis with hyperkalemia 
(5), compromised electroencephalographic activity (6), impaired neurodevelopmental 
outcome and mortality (7, 8). Although many methods of cardiac output measurem ent 
are available, their application remains rather complex in neonates. This is due to 
technical and size restraints, potential toxicity of used indicators, risk of fluid overload, 
difficulty of vascular access and the high prevalence of intracardiac and extracardiac 
shunts (transitional circulation, congenital heart defects).
Objective monitoring of systemic blood flow can provide the pediatrician with essential 
information on which a rational hemodynamic treatm ent strategy can be based. The 
choice of treatm ent is better founded and the response to the initiated intervention can 
be monitored and evaluated. This may prevent over- and /or under-treatm ent with the 
subsequent risk of iatrogenic injury.
Outline of the thesis
The general aim of this thesis is to evaluate different available methods of cardiac 
output monitoring that are potentially feasible in critically ill newborns. Three 
technologies have been validated in an experimental animal model with special interest 
in the accuracy, precision, safety and applicability of each technique.
The thesis is divided in 4 sections. In the first section, chapter 2 gives an overview of 
the predictive value of the m ost used clinical indicators of neonatal circulatory failure, 
which are blood pressure, heart rate, urine output, capillary refill time, serum lactate 
concentration, central peripheral tem perature difference, pH, base excess, central 
venous oxygen saturation and color. In chapter 3 the literature is reviewed about 
basic principles of various techniques of cardiac output monitoring with the respective 
advantages and limitations of each method.
In the second section we present the evaluation of the modified carbon dioxide Fick 
method for m easurem ent of cardiac output in a lamb model. Chapter 4 reports the 
validation study in which we assessed the agreem ent between cardiac output measured 
with the modified carbon dioxide Fick method and invasively measured pulmonary 
blood flow. The influence of a significant left-to-right shunt on the modified carbon 
dioxide Fick method is described in chapter 5.
The ultrasound dilution technology is discussed in the third section. The validation 
study of the ultrasound dilution method is presented in chapter 6, where the agreement
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is assessed with invasively measured pulmonary blood flow in a piglet model. Ultrasound 
dilution cardiac output m easurem ent requires the insertion of an extracorporeal circuit 
between an indwelling arterial and central venous catheter with interm ittent blood 
flow through this loop and fast intravenous injections of isotonic saline. We analyzed 
the cerebral and systemic hemodynamic consequences of ultrasound dilution cardiac 
output measurements and the results are reported in chapter 7.
A third method of cardiac output measurement, transpulmonary thermodilution, is 
validated in section 4. Cardiac output monitoring using transpulmonary thermodilution 
is compared with invasively measured blood flow through the main pulmonary artery 
in a lamb model in chapter 8.
The most im portant findings are summarized in chapter 9 and conclusions are 
presented with suggestions for future translational and clinical research.
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INTRODUCTION
There is an increased interest in methods of objective cardiac output measurement, since it is assumed that knowledge of systemic blood flow will improve the treatm ent of critically ill patients. Monitoring cardiac performance 
can provide the clinician with essential information for the indication and choice of 
treatm ent strategy in patients with circulatory failure and the response to the initiated 
intervention can be monitored and evaluated. This may prevent iatrogenic damage due 
to both under- and overtreatment. However, it still has to be proven that goal-directed 
therapy using cardiac output monitoring improves the outcome on the shorter and 
longer term.
Many different techniques of cardiac output m easurem ent in children are available, 
although this remains complex in newborns. This is related to the specific cardiovascular 
physiologic changes that occur in the transition from fetal to neonatal life. The presence 
of intra- and /or extracardiac shunts ('fetal channels’) can distort the accuracy of many 
methods of cardiac output monitoring. Apart from that, several techniques are not 
applicable in neonates due to size restraints and the use of potential toxic indicators.
The hemodynamic status of newborns is usually estimated by the interpretation of 
indirect param eters of systemic blood flow, like blood pressure, heart rate and urine 
output. A survey questionnaire, sent to all directors of Dutch neonatal intensive care 
units, revealed that blood pressure, heart rate, urine output, capillary refill time and 
serum lactate concentration are the m ost often used hemodynamic variables to diagnose 
circulatory failure (1,2) and cardiac output m easurem ent is not even mentioned. This is 
not different from practice in other countries (3, 4).
An overview is provided of the predictive value of the clinical indicators of circulatory 
failure m ost often used in newborn infants, which are blood pressure (BP), heart rate 
(HR), urine output, capillary refill time (CRT), serum lactate concentration, central- 
peripheral tem perature difference (CPTd), blood gas analysis (BGA), central venous 
oxygen saturation (Sv02) and color.
BLOOD PRESSURE
Measurement of blood pressure is the most frequently used m ethod for assessment 
of the hemodynamic status in a neonatal intensive care unit (4, 5). The incidence of 
hypotension in critically ill newborn infants is reported to be approximately 40-50%, 
but it depends on the used criteria for hypotension, the method of blood pressure 
measurement, the population studied and postnatal age (6-8). Factors, associated with 
neonatal hypotension, are: high mean airway pressure, low birth weight (BW), low 
gestational age (GA), large ductal diameter and lack of antenatal corticosteroids (9-17). 
About 50% of critically ill preterm  neonates receive some cardiovascular support, such 
as volume suppletion, vasopressors and /o r inotropes (18). NICU’s differ widely in their 
use of cardiovascular support in extremely preterm  infants, varying between 29% and 
98% (19).
Blood pressure is measured non-invasively (indirect), in general with the oscillometric 
method, or invasively (direct) via an intra-arterial catheter. For an accurate noninvasive 
blood pressure m easurem ent it is essential to use an appropriate cuff size, which
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width should be between 0.45 and 0.70 times the circumference of the arm or calf. 
It is advised to average three consecutive measurements. The mean blood pressure 
[MBP] is the best value for trend monitoring, since artifacts least hinder this parameter. 
Many professionals prefer noninvasive blood pressure m easurem ent (NIBP), because 
of potential complications of invasive measurement. However, one should be cautious 
about interpreting the obtained NIBP values in low birth weight infants, since 
oscillometric measurements may not be reliable, especially in the lower blood pressure 
range (20, 21)! There is a difference in accuracy between noninvasive oscillometric 
blood pressure devices (21-24). The agreement between noninvasive blood pressure 
m easurem ent with a cuff positioned around the upper and lower extremities is good 
(24).
Bloodpressure canbem easuredinvasivelyinnew bornsw ithacatheter in the umbilical, 
the radial or posterior tibial artery. Butt and Whyte showed a good correlation between 
peripheral arterial blood pressure measurements and umbilical arterial blood pressure 
in 11 newborn infants (GA 26-39 weeks; BW 740-3200 g) (25). The more peripheral 
the site of m easurem ent from the proximal aorta, the higher and smaller the arterial 
pressure waveform will be, leading to a higher value of systolic arterial blood pressure 
(SABP) with practically unchanged mean and diastolic arterial blood pressure values. 
The invasive measured values of blood pressure are considered valid when a dicrotic 
notch can be detected in the arterial pressure waveform. An intra-arterial catheter with 
a too small lumen will decrease the values of blood pressure, especially the SABP. Air 
bubbles in the pressure transducer artifactual decrease SABP and increase DAB P.
Definitions of neonatal hypotension vary widely, which makes it complex to 
compare studies concerning management and outcome. Around 25% of the Canadian 
neonatologists rely solely on absolute blood pressure values to define hypotension, as 
the remainder combines blood pressure values with clinical signs of circulatory failure, 
like CRT, color and urine output (3).
Three different definitions of neonatal hypotension are in widespread use (3). The 
first definition is a blood pressure below the tenth (or fifth) percentile of normative 
blood pressure values derived from a reference population with regard to gestational 
age, birth weight and postnatal age (26). Many normative reference ranges for neonatal 
blood pressure have been published (26-36). The reference values vary a lot due to 
differences in statistic methodology, heterogeneity in study population, used exclusion 
criteria, postnatal age, and applied technology of blood pressure measurement.
The second and probably m ost used definition of hypotension in the newborn infant 
is that the lower border of normal mean arterial blood pressure (MABP) equals the 
numeric value of gestational age in whole weeks, provided no additional signs exist 
of hypoperfusion of endorgans, like hyperlactatemia or oliguria (37). This definition is 
only valid during the first 3 to 5 days of life, since MABP increases during the first three 
days oflife in am agnitude of 2 to 10 mmHg (15,20,26, 38, 39).
A third definition of neonatal hypotension is based on the assumption that cerebral 
blood flow becomes pressure dependent at a MABP around 30 mmHg and lower levels 
will lead to increased cerebral injury (10,26,40-42). According to this theory the value 
of mean blood pressure should be kept above the lower limit for cerebral autoregulation 
(approximately 30 mmHg) in order to preserve adequate cerebral blood flow. Published 
data are conflicting concerning the presence of an adequate cerebral autoregulation 
system in both critically ill and relatively stable preterm  infants (41-50).
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The major argument to treat low blood pressure in newborn infants is the aim to 
preserve or restore adequate organ perfusion, with special emphasis on cerebral blood 
flow. This is based on the observed association between systemic hypotension and 
neuromorbidity, like intracranial hemorrhage (10,18,26,38,40,47,51-53), white m atter 
injury (40,47, 54), hearing loss (55, 56) and impaired neurologic development (51, 55, 
57, 58). Both hypertension (59, 60) and fluctuating blood pressure (10, 38, 61, 62) are 
also identified as im portant factors in the pathophysiology of cerebral injury. A normal 
blood pressure however does not automatically imply an adequate cerebral blood flow, 
since the vascular bed of the cerebral cortex might act as a low priority vasculature and 
vasoconstrict in a state of shock (14, 63, 64). There is a strong association between low 
systemic and cerebral blood flow and adverse neurologic outcome (14, 62, 65-72). On 
the other hand, systemic hypotension does not automatically imply low cerebral blood 
flow (73).
Relation between blood pressure and systemic blood flow
Gill and Weindling examined myocardial performance with echocardiography in 
preterm  VLBW infants at a postnatal age less than 24 hours (6). Cardiac function was 
compared between two groups of infants, i.e. a shock group with systemic hypotension 
(MABP less than 10,h centile for birth weight and postnatal age) and /o r metabolic 
acidosis (arterial pH < 7.25 and base deficit > 6 mmol/L) and a control group, who 
had neither of these two problems. Measurement of cardiac output (left ventricular 
output, LVO) and shortening fraction was performed at a median postnatal age (PNA) of 
3 hours. Between the shock group and the control group only the ejection fraction was 
significantly different (median 38 percent versus 34 percent; p = 0.001); cardiac output 
was similar in both groups (218 m L/kg/m in versus 219 mL/kg/min). This implies that 
there is no direct relation between MABP and LVO. Noteworthy however is the fact 
that in all the infants a patent ducts arteriosus was observed with a left-to-right shunt 
in 50%, a bidirectional shunt in 45% and right-to-left shunt in 5% of the population. 
The authors stated that the ductal flow was never considered to be hemodynamically 
significant, because ductal flow only occurred in diastole, with low velocity and there 
was no left atrial or ventricular enlargement. Despite the fact that the authors mentioned 
that the degree of ductal shunting did not alter the results, part of the similarity in 
cardiac output levels between the shock and control group can probably be explained 
by an increased left ventricular output secondary to ductal shunting.
In a prospective, observational study Kluckow and Evans examined the contribution 
of cardiac output in determining the blood pressure of 67 ventilated preterm  VLBW 
infants (median gestational age 28 weeks; median birth weight 1015 grams) (11). 
Echocardiographic measurements of LVO and right ventricular output (RVO) were 
performed at a median postnatal age of 19 hours (range: 7 - 3 1  hours) and related 
to simultaneous obtained MABP. No correlation was observed between MABP and 
LVO (r = 0.14). However, a weak, but significant positive correlation was observed 
(r = 0.38; p = 0.01), when only infants with a non-significant or closed ductus arteriosus 
were included. Calculating the diagnostic accuracy of hypotension (MABP <30 mmHg) 
from their data for the prediction of a low LVO (< 150  m L/kg/m in) for all patients 
(PDA included) results in a sensitivity (Se) of 42%, specificity (Sp) of 79%, positive 
predictive value (PPV) 44%, and negative predictive value (NPV) 78%. For patients with 
a hemodynamically insignificant or closed ductus arteriosus a 38% sensitivity, 93%
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specificity, 75% PPV and 73% NPV is found.
Wardle et al. performed a prospective, observational cohort study in 30 ventilated 
preterm  infants (median gestational age 27 weeks; median birth weight 976 grams) 
and measured peripheral hemoglobin flow with near infrared spectroscopy (74). They 
observed a weak, but significant correlation between hemoglobin flow, measured in 
the forearm, and MABP (r = 0.40; p = 0.03) in this study population. 15 Infants were 
classified as hypotensive (< 10,h centile for birth weight and postnatal age). The 
hypotensive infants had significantly lower median hemoglobin flow in comparison 
with the normotensive group (10.2 um ol/100 mL/min versus 20.2 um ol/100 mL/min; 
p = 0.0006). There was no relationship observed between Hb-flow and MABP in both 
subgroups (hypotensive group: r = 0.04; p = 0.89 and normotensive group: r = -0.05; 
p = 0.87).
Pladys et al. assessed the contribution of left ventricular output in the determination 
of systemic hypotension in 34 preterm  infants (median gestational age 28.7 weeks; 
median birth weight 1180 grams) at a postnatal age less than 24 hours (75). None of 
the patients had been treated with inotropes, sedatives or volume expansion at the time 
of initial echocardiographic m easurements (median age 9 hours). MABP was measured 
non-invasively with an oscillometric method or invasively through an arterial catheter 
(umbilical or radial). A group of 17 infants were classified as hypotensive, defined as 
a MABP < 3 0  mmHg, and compared with a control group (n = 17) with normal blood 
pressure. No statistically significant differences were observed between the hypotensive 
and control group, except for the hematocrit (respectively 42.5% and 49.4%; p < 0.01). 
This difference could potentially have an influence on the results, as it is known that the 
hematocrit is one of the determ inants of vascular resistance. Calculating the diagnostic 
accuracy of MABP < 30 mmHg for the prediction of low LVO, that was defined as a LVO 
< 10,h centile (i.e. 185 m L/kg/m in) from their data results in a sensitivity of 57%, a 
specificity of 50%, a positive predictive value of 24% and a negative predictive value 
of 81%. When low LVO is defined as LVO < 150 mL/kg/min, like the study of Kluckow 
(11), the sensitivity increases to 100% with a specificity of 54%, a PPV of only 18% and 
a NPV of 100%. In 76.5% of the infants with a MABP < 30 mmHg the authors observed 
a normal or high LVO, m ost probably related to a PDA in the majority (92%) of the 
patients. In these cases the LVO overestimates the systemic blood flow, because the 
m easured LVO equals systemic blood flow plus ductal left-to-right flow.
In a prospective, observational study Kluckow and Evans analyzed the course of 
superior vena cava (SVC) flow in 126 preterm  infants (mean gestational age 27 weeks; 
mean birth weight 991 grams) at a postnatal age as close as possible to 5,12, 24, and 
48 hours (14). A weak correlation (r < 0.25) was observed between mean arterial blood 
pressure and SVC flow, that was significant for the measurements at a PNA of 5, 12 
and 24 hours (p < 0.04), but not significant at an age of 48 hours (p = 0.45). A clear, 
inverse relation was seen between the vascular resistance in the upper body (UBVR 
= MABP /  SVC flow) and SVC flow (r = 0.94; p < 0.0001) at a PNA of 5 hours. With the 
reconstruction of a 2x2 table from their data it is possible to calculate the diagnostic 
accuracy of hypotension (MBP < 30 mmHg) for the prediction of low SVC flow (< 30 mL/ 
kg/min) at a postnatal age of 5 hours. This results in a Se 80%, Sp 60%, PPV 17% and 
NPV 97% for these criteria. An interesting finding in this study was that an SVC flow < 
30 m L/kg/m in predicted late cerebral pathology (late IVH, extending early IVH, or PVL) 
with 80% sensitivity and 90% specificity.
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Osborn e t al. stud ied  the accuracy of blood pressure  for the detection of low  upper 
body flow in a two centre, prospective cohort study of 1 2 8  p re term  infants a t a postnatal 
age less than  1 2  hours (7 6 ). Mean gestational age was 2 6 . 8  weeks w ith a m ean b irth  
w eight of 9 8 6  grams. Patients, who w ere trea ted  w ith inotropes or indom ethacin before 
3 hours after birth , w ere excluded. Blood p ressure  was m easured  w ith an umbilical 
or peripheral a rteria l catheter. SVC flow was assessed a t a postnatal age of 3 , 5 -1 0 , 
and  2 4  hours. Low system ic blood flow (SBF) was defined as SVC flow < 4 1  m L /kg / 
min. A p a ten t ductus arteriosus was classified as hem odynam ic significant w hen the 
ductal diam eter exceeded 1 .6  mm. Low system ic blood flow was trea ted  w ith volume 
expansion and  inotropes. In the  first 2 4  hours of life a weak, bu t significant relationship 
was observed betw een SVC flow and both  m ean arterial blood pressure  (r = 0 .2 3 , p <
0 .0 0 1 ) and  systolic arteria l blood pressure  (r = 0 .2 6 ; p < 0 .0 0 1 ). Sensitivity, specificity, 
positive predictive value (PPV), and negative predictive value (NPV) are sum m arized in 
Table 1 . for the  two different lim its of m ean arteria l blood pressure  for the prediction 
of low  system ic blood flow (SVC flow < 4 1  m L /kg/m in). The prevalence of low  systemic 
blood flow was 1 8 % ( 5 4  ou t of 3 0 5 ).
Table 1. Diagnostic accuracy of mean arterial blood pressure (MABP) for the prediction of low 
systemic blood flow (SVC flow <41 mL/kg/min]
MABP < 30  m m H g MABP < GA (wks) m m H g
PNA 3 hrs PNA 10 hrs all PNA 3 hrs PNA 10 hrs all
Sensitivity, % 62(57-71)
62 
(53 - 71)
59
(5 4 -6 5 )
38 
(29 - 48)
27 
(19 - 35)
30 
(25 - 35)
Specificity, %
58 
(49 - 68)
82 
(74 - 89)
77 
(72 - 82)
76 
(68 - 85)
92 
(86 - 97)
88 
(84 - 91)
PPV, % 19(1 1 -2 6 )
64 
(55 - 73)
36 
(30 - 41)
20 
(12 -28)
63 
(53 - 72)
71 
(62 - 79)
NPV,% 91 (85 - 97)
81 
(73 - 88)
90 
(86 - 93)
89 
(83 - 95)
71 
(62 - 79)
85 
(81 89)
Modified from Osborn e ta l (76)
Adjusting the diagnostic criterion to MABP < 3 0  mmHg a n d /o r  a central capillary 
refill tim e (CRT) > 3 seconds im proves sensitivity from  5 9 % to 7 8 %, how ever still a t 
cost of specificity (6 3 %) and PPV (3 1 %).
In a prospective, cross-sectional observational study Groves e t al. evaluated the 
correlation betw een invasive m easured  blood pressure  and echocardiographic assessed 
left ventricular ou tpu t (LVO), righ t ventricular ou tpu t (RVO), superior vena cava (SVC) 
flow, and  descending aortic (DAo) flow in 3 4  p re te rm  infants (m edian gestational age 2 7 
weeks; m edian b irth  w eight 8 8 5  gram s) a t a postnatal age as close to 5 , 1 2 , 2 4 , and 4 8  
hours (4 ). No correlation was observed betw een  m ean arterial blood p ressu re  (MABP) 
and  LVO, RVO, and DAo flow. Only a t a postnatal age of approxim ately 5 hours there  
was a statistically significant, w eak inverse correlation betw een  SVC flow and  MABP 
(r2 = 0 .1 4 1 ; p = 0 .0 4 ), w hich persisted  after correction for b irth  weight, gestational age, 
and  use of inotropes. At a postnatal age of 1 2  hours there  was still a w eak association 
betw een SVC-flow and MABP, although no t statistically significant (r2 = 0 .1 1 3 ; p = 0 .0 6 ); 
excluding patien ts trea ted  w ith ino tropes leaded to a significant relation (r2 = 0.1 8 0 ;
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p = 0 .0 3 ). In summary, no positive relation  was observed betw een MABP and LVO, 
RVO, and  DAo flow in this category of p re te rm  infants. A weak, b u t rem arkable inverse 
correlation was seen betw een MABP and SVC flow in the first 1 2  hours of postnatal life. 
There was a weak, non-significant inverse correlation observed betw een  LVO or RVO 
and diastolic arterial blood p ressu re  (DABP) a t a postnatal age of 4 8  hours. This was 
m ost probably caused by patien ts w ith a hem odynam ic significant ductal a n d /o r  atrial 
shun t w ith respectively an increased LVO and  RVO in com bination w ith a decreased 
blood pressure.
In a prospective, observational study El-Khuffash e t al. assessed  the relationship 
betw een m ean arterial blood p ressu re  (MABP) and left ventricular ou tp u t (LVO), right 
ventricular ou tpu t (RVO), and  celiac arte ry  blood flow (CABF) in 3 0  p re term  infants 
(< 3 2  weeks gestation; < 1 5 0 0  gram s) (7 7 ). The m edian gestational age of the  study 
population was 2 7 . 4  weeks w ith a m edian w eight of 1 0 1 4  grams. Echocardiography 
was perform ed a t a postnatal age of 1 2 - 1 5  hours and 4 8  hours. No correlation was 
observed betw een  MABP, left or righ t ventricular output, and CABF, except for RVO and 
MABP a t an age of 1 2  hours after b irth  (r = 0 .4 9 ; p = 0 .0 1 ).
Kissack and W eindling exam ined the correlation betw een m ean arteria l blood 
p ressu re  and peripheral blood flow in a prospective, observational study in 2 4  sick, 
ventilated  p re te rm  VLBW infants (m edian gestational age: 2 6  weeks; m edian b irth  
weight: 8 9 2  gram s) a t a postnatal age less than  1 2  hours (7 8 ). Peripheral blood flow 
(PeBF) was m easured  by near infrared spectroscopy (calculated from peripheral 
hem oglobin flow) and was significantly correlated  w ith echocardiographic fractional 
shortening (r = 0 .5 6 ; p = 0 .0 0 5 ). There was no significant relationship betw een blood 
p ressu re  and  PBF (r = -0 .3 0 ; p = NS). Peripheral fractional oxygen extraction, defined 
as the ratio  betw een  oxygen consum ption and oxygen delivery, was also no t correlated  
w ith MABP (r = 0 .0 6 ; p = NS).
Miletin e t al. assessed  the correlation betw een  several ind irect param eters of systemic 
blood flow in a prospective, observational cohort study of 4 0  VLBW infants w ith a m ean 
gestational age of 2 8  weeks and  a m ean b irth  w eight of 1 .0 8  kg (7 9 ). Echocardiographic 
exam ination was perform ed a t a m ean postnatal age of 1 9 .1  hours. A low  SVC flow ( < 4 0  
m L /kg /m in) was found in 2 1 % op the  infants. Mean blood pressure, m easured  both 
invasively and  non-invasively, correlated  poorly w ith SVC flow (r = 0 .2 4 8 ; p = 0 .1 2 ).
Data about correlation betw een  blood p ressure  and  system ic blood flow are 
sum m arized in Table 2 . It is obvious th a t th ere  is an inconsistency in the observed 
relationship betw een SBF and  BP, w hich is m ost probably due to differences in study 
population (gestational age, postnatal age) and clinical m anagem ent. A part from th a t 
it  is know n th a t system ic blood flow m easurem ent using Doppler echocardiography is 
subject to variable accuracy, precision and repeatability  (8 0 -8 3 ).
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Table 2. Correlation between blood pressure and systemic blood flow
Reference Q Postnatal age Correlation
Kluckow, 1 9 9 6  (1 1 ) 
median GA 28 wks 
median B W 1015 g
LVO
1 9  hrs r  = 0 .1 4
1 9  h rs (no PDA) r  = 0 .3 8  (p = 0 .0 1 )
W ar die, 1 9 9 9  (7 4 ) 
median GA 27  wks 
median B W  976 g
PBF
< 2 4  h (all patients) r  = 0 .4 0  (n = 3 0 ; p = 0 .0 3 )
< 2 4  h (low BP) r = 0 . 0 4  (n = 1 5 ; p = 0 .8 9 )
< 2 4  h (norm al BP) r  = - 0 .0 5  (n = 1 5 ; p = 0 .8 7 )
Kluckow, 2 0 0 0  (1 4 ) 
mean GA 27  wks 
mean B W  991 g
SVC
5 h r  = 0 .2 1  (p = 0 .0 2 3 )
< 2 4  h r  <0 .2 5  (p = 0 .0 4 )
4 8  h r  <0 .2 5  (p = 0 .4 5 )
Osborn, 2 0 0 4  (7 6 ) 
mean GA 27  wks 
mean BW  986 g
SVC < 2 4  h r  = 0 .2 3  (p <0 .0 0 1 )
Groves, 2 0 0 8  (4 ) 
median GA 27  wks 
median B W 8 8 5 g
SVC
5 h r 2= 0 . 1 4 1  (p = 0 .0 4 )
12 h r 2= 0 . 1 1 3  (p = 0 .0 6 )
12 h (no inotropes) r 2 = 0 . 1 8 0  (p = 0 .0 3 )
2 4  h No correlation (p = 0 .4 6 )
4 8  h No correlation (p = 0 .2 2 )
LVO
5 h No correlation (p = 0 .2 7 )
12 h No correlation (p = 0 .1 2 )
2 4  h No correlation (p = 0 .7 5 )
4 8  h No correlation (p = 0 .2 3 )
RVO
5 h No correlation (p = 0 .1 5 )
12 h No correlation (p = 0 .2 2 )
2 4  h No correlation (p = 0 .4 7 )
4 8  h No correlation (p = 0 .0 8 )
DAo
5 h No correlation (p = 0 .2 3 )
12 h No correlation (p = 0 .2 1 )
2 4  h No correlation (p = 0 .8 2 )
4 8  h No correlation (p = 0 .5 9 )
BW: birth weight; DAo: descending aorta flow; GA: gestational age; LVO: left ventricular output; NS: not significant; PeBF: 
peripheral blood flow; RVO: right ventricular output; SVC: superior vena cava flow
2 0
Reference Q Postnatal age Correlation
El Khuffash, 2 0 0 8  
(7 7 )
mean GA 27  wks 
mean B W 1014 g
LVO
12 h r = 0 .1 9  (p = 0 .3 4 )
2 4  h r  = -0 .0 6  (p = 0 .7 6 )
RVO
12 h r = 0 .4 9  (p = 0 .0 1 )
2 4  h r  = -0 . 1 4  (p = 0 .5 0 )
CAF
12 h r = 0 .1 3  (p = 0 .5 1 )
2 4  h r  = 0 .1 2  (p = 0 .5 8 )
Kissack, 2 0 0 9  (7 8 ) 
median GA 26 wks 
median B W 892 g
PeBF <12 h r = -0 .3 0  (p = NS)
Miletin, 2 0 0 9  (7 9 ) 
mean GA 28 wks 
mean BW  1.08 kg
SVC < 2 4  h r  = 0 . 2 4 8  (p = 0 .1 2 )
BW: birth weight; DAo: descending aorta flow; GA: gestational age; LVO: left ventricular output; NS: not significant; PeBF: 
peripheral blood flow; RVO: right ventricular output; SVC: superior vena cava flow
Reported or reconstructed  statistical data abou t predictive values of hypotension for 
low  system ic blood flow are sum m arized in Table 3 . These data  have a w ide spread  due 
to variable definitions of low  blood p ressu re  and  low  blood flow.
Table 3. Predictive value o f hypotension fo r  the detection o f  low systemic blood flow.
Reference Criteria Se Sp PPV NPV
(% ) (% ) (% ) (% )
Kluckow, 1 9 9 6  (1 1 ) 
median GA 28 wks 
median B W  1015g
All patients, PDA included (n=67) 
MABP < 3 0  mmHg 
LVO < 1 5 0  m L /kg /m in
4 2 7 9 4 4 7 8
PDA closed or insignificant (n=4 5 ) 
MABP < 3 0  mmHg 
LVO < 1 5 0  m L /kg /m in
3 8 9 3 7 5 7 3
Pladys, 1 9 9 9  (7 5 ) 
median GA 29 wks 
median B W  1180g
MABP < 3 0  mmHg 
LVO < 1 0 th  percentile
5 7 5 0 2 4 8 1
MABP < 3 0  mmHg 
LVO < 1 5 0  m L /kg /m in
100 5 4 1 8 100
Kluckow, 2 0 0 0  (1 4 ) 
mean GA 27  wks 
mean B W  991 g
MABP < 3 0  mmHg
SVC flow < 3 0  m l/k g /m in  (PNA 5 h)
8 0 6 0 1 7 9 7
BW: birth weight; GA: gestational age; LVO: left ventricular output; MABP: mean arterial blood pressure; NPV: negative pre­
dictive value; PDA: patent ductus arteriosus; Se: sensitivity; Sp: specificity; PNA: postnatal age; PPV: positive predictive value; 
SVC: superior vena cava
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Reference Criteria Se
(% )
Sp
(% )
PPV
(% )
NPV
(% )
Osborn, 2 0 0 4  (7 6 ) 
mean GA 27 wks 
mean BW 986 g
Data PNA 3 hrs
MABP < 3 0  mmHg
SVC flow < 4 1  m L /kg/m in
6 2 5 8 1 9 9 1
Data PNA 3 hrs
MABP < GA (wks) mmHg
SVC flow < 4 1  m L /kg/m in
3 8 7 6 20 8 9
Data PNA 1 0  hrs 
MABP < 3 0  mmHg 
SVC flow < 4 1  m L /kg/m in
6 2 8 2 6 4 8 1
Data PNA 1 0  hrs 
MABP < GA (wks) mmHg 
SVC flow < 4 1  m L /kg/m in
2 7 9 2 6 3 7 1
All data  (PNA 3 & 1 0  hrs) 
MABP < 3 0  mmHg 
SVC flow < 4 1  m L /kg/m in
5 9 7 7 3 6 9 0
All data  (PNA 3 & 1 0  hrs) 
MABP < GA (wks) mmHg 
SVC flow < 4 1  m L /kg/m in
3 0 88 7 1 8 5
BW: birth weight; GA: gestational age; LVO: left ventricular output; MABP: mean arterial blood pressure; NPV: negative pre­
dictive value; PDA: patent ductus arteriosus; Se: sensitivity; Sp: specificity; PNA: postnatal age; PPV: positive predictive value; 
SVC: superior vena cava
From these  num bers it  is clear th a t only a small p roportion  of patien ts w ith low 
system ic blood flow will be identified w hen a low  blood p ressu re  is used as an indicator 
(low sensitivity) and a relatively high percentage of patien ts w ith norm al or high 
system ic blood flow will be falsely classified as shock (low specificity). The results from 
the study by Osborn and co-w orkers m ean, for example, th a t using a MABP less than 
the gestational age (in weeks) as the  clinical p aram eter to diagnose low  system ic blood 
flow will identify only 3 0 % of the p re term  infants in shock and  1 2 % of the patien ts w ith 
a norm al or high SVC flow will be classified as shock (7 6 ). Only 7 1 % of the pre term  
neonates w ith a MAPB less than  the gestational age will also have a low  systemic 
blood flow. Changing the definition of hypotension to a MABP less than  3 0  mmHg will 
resu lt in an increase of sensitivity from 3 0 % to 5 9 %, although this is accom panied by a 
decrease in specificity from 88%  to 7 7 %. This m eans th a tm o re  patien ts in shock will be 
recognized, bu t still a substantial percentage is m issed (4 1 %). A part from this, a quite 
large num ber of infants th a t is identified as in shock has a norm al or high system ic blood 
flow (6 4 %)! The observed values of NPV for both  definitions of hypotension implies 
th a t infants w ith a MABP > 3 0  mmHg or > GA (in w eeks) mmHg have a chance of low 
system ic blood flow of respectively 1 0 % and 1 5 %.
The consequence of using only blood p ressu re  to diagnose low  system ic blood flow 
will be th a t too m any patien ts will potentially be u n d ertrea ted  or overtreated, both  w ith 
substantial risk  of adverse effects and  iatrogenic damage.
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Treatment of neonatal hypotension is not without risk
Treatm ent of neonatal hypotension is associated w ith a w orse outcom e in com parison 
w ith hypotensive p re te rm  infants th a t have n o t been trea ted  (1 8 , 2 6 , 3 8 , 4 0 , 5 3 , 5 5 - 
5 8 , 8 4 -8 6 ). This m ight be due to the  underlying cause of hypotension (8 5 , 8 7 ), the  low 
blood p ressu re  itself (4 0 , 5 0 , 5 7 , 88) or the therapy  for hypotension (5 3 , 8 4 , 8 5 , 8 9 - 
9 2 ). T reatm ent for neonatal hypotension is potentially  dangerous and harmful. Various 
trea tm en t strategies have been published (3 , 9 3 -9 6 ) from  which the m ainstays are: 
volum e expansion, inotropes, vasopressors and corticosteroids. The potential side 
effects of the different therapeutic  m odalities are described below.
Volume expansion
Hypovolemia is seldom  the cause of hypotension or shock in new born  infants (3 3 , 
9 7 -1 0 1 ) and  prophylactic early volum e expansion in p re term s is no t associated w ith 
im proved outcom e (1 0 2 ). Moreover, excessive infusion of fluid boluses a n d /o r  fluid 
overload has been associated w ith adverse neurologic outcome, increased prevalence of 
chronic lung disease, and increased m ortality  (8 4 , 8 9 , 1 0 3 -1 0 6 ). Volume adm inistration 
increases global blood flow (9 9 , 1 0 7 , 1 0 8 ), b u t n o t necessarily  accom panied by a 
subsequen t increase in cerebral blood flow (1 0 7 ).
Inotropes/vasopressors
Blood p ressure  is m ore effectively increased w ith adm inistration  of dopam ine in 
com parison to dobutam ine (1 0 9 ), b u t the question still rem ains w hether it will also 
im prove outcome. This effect on blood p ressu re  can also be achieved w ith epinephrine 
(1 1 0 ). Dopamine increases blood p ressure  by vasoconstriction, bu t in general a t the 
expense of a decrease in system ic blood flow (9 1 , 1 0 7 , 1 0 8 , 1 1 1 , 1 1 2 ). Several reports 
show  th a t dopam ine causes suppression of p itu itary  and  thyroid function (1 1 3 -1 1 6 ). 
Increased blood pressure  after dopam ine adm inistration  is n o t autom atically associated 
w ith increased cerebral blood flow (1 0 7 , 1 1 7 ), although NIRS studies did show  b etter 
cerebral circulation and oxygenation (4 1 , 1 1 0 ).
Corticosteroids
Hydrocortisone increases blood p ressu re  and  m akes it  possible to w ean inotropic 
sup p o rt (1 1 8 -1 2 1 ). This effect is, however, n o t accom panied by a change in systemic 
and cerebral flow (1 1 9 ). Concern exists about an increase in spontaneous intestinal 
perforation  in patien ts trea ted  w ith hydrocortisone (122).
Hypotension without clinical shock - Permissive hypoten­
sion
Recently the policy of 'perm issive hypotension’ has been in troduced  in which 
cardiovascular sup p o rt of ELBW infants is restric ted  to patien ts w ith a MABP less than 
gestational age (in com pleted w eeks) in com bination w ith clinical signs of im paired 
tissue perfusion (heart rate, color, CRT, urine ou tp u t and  m etabolic acidosis) (8 , 1 2 3 ).
In 2 0 0 7  Batton and  co-w orkers published the results of a retrospective analysis of 
blood p ressure  ranges in the first postnatal w eek in 1 4 2  extrem ely p re term  infants 
(5 6 ). Sixty-one p ercen t of this study population did no t receive specific trea tm en t 
for hypotension, w hen there  w ere no clinical signs of hypoperfusion. Despite the 
occurrence of blood pressure  values below  the 'norm al' limit, these  u n trea ted  infants 
show ed no w orse sh o rt te rm  outcome. On the contrary, trea tm en t of hypotension was
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associated w ith increased m ortality  (8 5 % versus 4 3 %; p < 0 .0 0 1 ) and m ajor m orbidity  
(5 3 % versus 2 9 %; p = 0 .0 1 3 ).
In a retrospective cohort study of 1 1 8  ELBW infants Dempsey e t al. analyzed the 
so-called 'perm issive hypotension’ approach (8). H ypotension was diagnosed in 5 2 % 
of the patients. Only w hen the  hypotension was associated w ith alarm ing clinical signs 
of circulatory failure, trea tm en t was sta rted  w ith a fluid bolus a n d /o r  epinephrine 
infusion. Only 3 9 % of the hypotensive patien ts requ ired  cardiovascular support. This 
subgroup of patien ts was m ore im m ature than  the perm issive hypotensive patients, had  
higher illness severity scores and  was slightly low er in weight. The trea ted  hypotensive 
group had  significantly low er MABP a t different hours of postnatal age in com parison 
w ith the norm otensive or perm issive hypotensive patients. Interestingly, the sh o rt­
te rm  outcom e of the norm otensive and perm issive hypotensive patien ts was sim ilar 
(mortality, NEC stage >2 , spontaneous in testinal perforation, severe intracranial 
hem orrhage and  cystic PVL).
A potential risk  to perm issive hypotension was m entioned  by B arrington (9 2 ). 
Hypotension m ight be accom panied by maximal cerebral vasodilation, w hich could 
imply th a t any inevitable fluctuation in blood pressure  can cause m ajor changes in the 
cerebral circulation w ith potentially increased risk  of cerebral injury.
Summary
Blood pressu re  is no t simply related  to system ic blood flow, w hich is no t unexpected, 
since blood p ressu re  is no t only determ ined  by cardiac output, b u t also by systemic 
vascular resistance. The initiation of trea tm en t of circulatory failure, solely based  
on blood pressure  m easurem ent, is potentially harm ful and should be avoided. The 
concept of perm issive hypotension looks prom ising, although it  still has to be proven 
th a t cardiovascular support, w hether indicated  on hypotension or low  blood flow, is 
beneficial for the outcom e of critically ill new borns (9 1 , 9 2 , 1 2 4 ).
»  HEART RATE
Ventricular ou tpu t is determ ined  by stroke volum e (SV) and h ea rt ra te  (HR). It is 
assum ed th a t new born  infants cannot increase the ir stroke volum e and  th a t cardiac 
ou tp u t is mainly altered  by changes in h ea rt rate. Stroke volum e is considered to be 
a t a fixed level w ithou t m uch variation. This is based  on anim al and hum an studies, in 
which it was concluded th a t the fetal and  neonatal h ea rt cannot change stroke volume, 
due to the fact th a t it  already operates a t or near its peak  capacity (1 2 5 -1 2 7 ). This was 
supposed  to be caused by a low er m yocardial com pliance and  contractile reserve in 
com parison w ith the m ature  h ea rt (1 2 8 -1 3 1 ). Supposing th a t cardiac ou tp u t is alm ost 
entirely  dependen t on h ea rt frequency the circulatory sta tus is often evaluated by 
in terp re ta tion  of the h ea rt rate. Low system ic blood flow is wrongfully considered 
w hen a tachycardia is p resen t, w hereas a stable h ea rt ra te  is regarded  as a sign of stable 
hem odynam ics.
An increase in h ea rt ra te  for com pensation of shock can only be effective w hen end- 
diastolic volum e is m aintained. In addition, w hen the h ea rt ra te  is too high, diastolic 
coronary blood flow can be im peded due to insufficient filling time, w hich m ight resu lt 
in a decrease in contractility and  hence cardiac output.
The alm ost to tal dependency of cardiac ou tp u t on h ea rt ra te  has been questioned in
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animal and human studies (132-137).
Relation between heart rate and systemic blood flow
Winberg et al. studied prospectively the left ventricular output during circulatory 
adaptation in 16 healthy full term  infants (138). LVO was assessed with Doppler 
echocardiography at a postnatal age of <15 minutes, 30 minutes, 2 hours, 5 hours, 
24 hours and 72 hours. All infants were born by elective caesarean section at a 
mean gestational age of 38.5 weeks with a mean birth weight of 3370 grams. Heart 
rate decreased with increasing postnatal age and was significantly lower at 2 hours 
of age than at birth (p < 0.01), probably reflecting hormonal and metabolic changes. 
In this time period LVO remained unchanged, because the decline in heart rate was 
compensated by an increase in stroke volume. This may be partially related to ductal 
left-to-right shunting, although no data are available about the incidence of PDA in these 
infants. Between a postnatal age of 2 and 24 hours a decrease in stroke volume was 
observed, while heart rate remained nearly constant and LVO decreased.
Lindner and co-workers studied the intra-individual changes of SV, HR and LVO in 21 
preterm  infants with RDS and symptomatic PDA before and after surgical ligation of the 
ductus arteriosus (139). The median gestational age of the infants was 28 weeks with 
a median weight of 870 grams. All infants were mechanically ventilated and sedated 
with phenobarbital. A PDA was considered significant when there was a respiratory 
deterioration, a decrease in urine output, or a gastrointestinal problem, that could not 
be related to other conditions than PDA. Seven of the studied infants (33%) received 
cardiovascular medications (dopamine, 2-4 ug/kg/m in and dobutamine, 5-10 ug/kg/ 
min) before and after surgical ligation. The HR in this subgroup did not differ from 
the whole study group. Comparing the pre- and postoperative hemodynamic data in 
patients with a symptomatic PDA showed a significant decrease in LVO (median 419 
m L/kg/m in versus 246 mL/kg/min; p < 0.001) and SV (median 2.69 mL/kg versus 1.63 
mL/kg; p < 0.001), while HR remained unchanged. This means that the increased LVO 
in ventilated, preterm  infants with RDS and symptomatic PDA is caused by an increased 
SV and not by an altered heart rate.
Agata et al. measured left ventricular output (LVO), stroke volume (SV), heart rate 
(HR), left ventricular end-diastolic dimension (LVEDD), left ventricular end-systolic 
dimension (LVESD), and left ventricular percent fractional shortening (%FS) with 
Doppler echocardiography in 34 normal, full term  infants 12 to 24 hours before birth 
and thereafter at a postnatal age of 1, 24, and 48 hours (127). After birth a twofold 
increase in LVO was observed (170 ± 46 m L/kg/m in versus 327 ± 66 mL/kg/min; p < 
0.01). This was related to a significant increase in SV (1.21 ± 0.33 mL/kg versus 2.25 
± 0.37 mL/kg; p < 0.01), %FS (34.3 ± 5.8 % versus 37.7 ± 5.4%; p < 0.05), and LVEDD 
(15.4 ± 1.1 mm versus 17.7 ± 1.4 mm; p < 0.01). The heart rate remained unchanged 
(140 ± 8 bpm versus 145 ± 13 bpm; NS). During the first three days of life LVO decreased 
significantly to a stable level of 245 ± 56 m L/kg/m in (p < 0.01), that was reached at a 
postnatal age of 24 hours. This decline in LVO was associated with a decrease in SV 
(2.02 ± 0.42 mL/kg; p < 0.01), LVEDD (17.0 ± 1.1 mm; p < 0.05), and heart rate (121 
± 11 bpm; p < 0.01). The %FS was not altered in this period. Reduced ductal shunting 
m ost likely caused the decrease in LVO 24 hours after birth. The authors stated that the 
heart rate accounted for half of the total decline in LVO, the remainder being caused by 
the decrease in SV.
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In a prospective, observational study Winberg et al. evaluated the relationship 
between heart rate, cardiac output, and stroke volume in preterm  infants less than 34 
weeks (140). The study population consisted of 18 preterm  infants (mean gestational 
age 29.6 weeks and mean birth weight 1363 grams), all with normal blood gas analysis 
and no cardiovascular support. Left ventricular output (LVO) was measured with 
Doppler echocardiography at a mean postnatal age of 10.3 hours (range: 1-21 hours). 
A selection was made of all m easurements of LVO, SV and HR to obtain one value of LVO 
and SV for every HR in each patient. The highest LVO was chosen, when more than one 
LVO determinations were obtained for a given HR. This resulted in 5-14 combinations 
of HR, LVO and SV per patient. The variation in the num ber of determinations in each 
infant was dependent on the fluctuation of the HR. Four (22%) infants had a moderate 
PDA (flow disturbance in a larger part of the pulmonary artery; LA-/Ao-ratio < 1.25 and 
no diastolic reversal of flow in the descending aorta). None had a large ductal shunt 
(LA-/Ao-ratio > 1.25; diastolic reversal of flow in the descending aorta). No infant was 
treated for a PDA (medication and /o r ligation). There was a poor relation between 
mean LVO and mean heart rate for each infant (r2 = 0.17). The association between mean 
stroke volume and mean LVO was much stronger. In only 4 (22%) infants a significant 
correlation between HR and LVO was observed. In m ost patients substantial changes 
in stroke volume were observed, which in 13 infants (72%) exceeded a percentage of 
25. Variations in SV were closely related to LVO. For each infant the maximum change 
in HR was calculated, which ranged from 9 bpm (7%) to 84 bpm (127%). In 15 of the 
18 children (83%) the maximum HR change was inversely related to the change in SV 
and in 12 of 18 infants (66%) directly related to change in LVO. This direct relationship 
between HR and LVO could only be found with larger changes in HR. It was observed 
that the group average of the maximum increase in HR, 24 bpm (18%), corresponded to 
an increase in LVO of 22.7 m L/kg/m in (9%; p < 0.05) and a decrease in SV of 0.15 mL/ 
kg (9%; p < 0.05). This study indicates that stroke volume is a major determ inant of LVO 
in the neonatal period. These results are in agreement with the opinion that HR does 
not predict ventricular output. A rather large change in heart rate however may suggest 
a relevant change in cardiac output.
Simma et al. performed a prospective, observational study to determine whether 
cardiac output changes after volume replacement is related to an altered stroke volume 
or heart rate in 12 newborns with systemic hypotension (141). Hypotension was defined 
as an invasively measured blood pressure less than the 10,h centile related to age and 
weight. Median gestational age was 38 weeks (range: 35-41 weeks) with a median birth 
weight of 2690 grams (range: 1980-3850 grams). Several hemodynamic param eters 
(such as HR, MABP, and cardiac output) were measured before and after volume 
expansion with 20 mL/kg Ringer’s lactate or 5% plasma protein within 60 minutes. 
Cardiac output (left ventricular output) was m easured with Doppler echocardiography. 
The diagnoses in the patients were gastroschisis (n=4), asphyxia (n=3), sepsis (n=2), 
congenital diaphragmatic hernia (n=2) and omphalocele (n=l). Three patients 
participated twice in the study. Cardiac output changed significantly (267 ± 69 m L/kg/ 
min versus 302 ± 55 mL/kg/min; p < 0.01) mainly because of an altered stroke volume 
(5.2 ± 1.7 mL/kg versus 5.8 ± 1.7 mL/kg; p < 0.05) with an unchanged heart rate (140 ± 
12 bpm versus 142 ±20  bpm; NS). LVO is predominantly determ ined by stroke volume 
and not heart rate in newborns with hypovolemic or cardiogenic shock.
Gullberg and co-workers evaluated prospectively the relationship between stroke
26
volume and cardiac output in response to altered mean airway pressure (MAP) in 14 
ventilated newborns and infants (142). Two study groups were formed, group I (n=8) 
with a decrease in MAP by switching the ventilation mode from pressure controlled 
ventilation (PCV) to pressure support ventilation (PSV), and group II (n=6) with an 
increase in MAP by applying a higher positive end-expiratory pressure (PEEP). LVO, SV 
and HR were m easured with Doppler echocardiography. A decrease in MAP (2 cmH20) 
caused a significant increase in LVO (+16 ± 2%; p < 0.01) and SV (+17 ± 2%; p < 0.02), 
w ithout a significant change in HR. Vice versa, an increased MAP (6 cmH20) resulted in a 
decline in LVO (-13 ± 4%; p < 0.02) and SV (-14 ± 5%; p < 0.01) with an unaltered HR. In 
both groups these changes in LVO were not associated with a significant change in blood 
pressure (non-invasively measured). These results show that neonates and infants can 
change cardiac output by modulating stroke volume without a changing heart rate in 
response to altered mean airway pressure.
In a prospective, observational study Kluckow and Evans analyzed the incidence, 
timing, degree, and associations of systemic hypoperfusion in 126 preterm  infants 
(mean gestational age 2 7 weeks; mean birth weight 991 grams) (14). Superior vena cava 
(SVC) flow was assessed with Doppler echocardiography at a postnatal age as close as 
possible to 5,12,24, and 48 hours. Low SVC flow was defined as less than 30,34,42, and 
46 m L/kg/m in at 5,12, 24 and 48 hours of age respectively. No statistically significant 
relationship was observed between low SVC flow and heart rate at any postnatal age. 
Comparison of the heart rate between the two groups with a low and normal SVC flow 
showed no statistically significant difference at a PNA of 5 hours (median 142 bpm 
versus 144 bpm; p = 0.9), 12 hours (median 148 bpm versus 144 bpm; p = 0.28), and 
24 hours (median 144 bpm versus 144 bpm; p = 0.8). Only at 48 hours a significant 
difference was noted (median 159 bpm versus 148 bpm; p = 0.03).
Many studies have been published in which term  and preterm  infants with low 
systemic blood flow and /o r hypotension are compared with a control group without 
shock and /o r low blood pressure (6,14, 75). A consistent observation in these studies 
is that there was no significant difference in heart rate when the shocked patient group 
was compared to the group with a normal systemic blood flow.
Summary
The value of absolute heart rate and /o r the changes in heart rate in the prediction 
of neonatal circulatory failure and /or shock have not been validated. Systemic blood 
flow is determ ined by heart rate and stroke volume. Stroke volume can change in the 
neonatal period, which excludes a simple linear relation between systemic blood flow 
and heart rate. Heart rate can be influenced by many factors, such as body temperature, 
stress, pain, medication etcetera. This means that a single heart rate value poorly 
reflects systemic perfusion, but that large changes in heart rate may indicate relevant 
changes in cardiac output.
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»  URINE OUTPUT
Normal urine production in neonates
In 1955 Sherry and Kramer published data concerning the first passage of urine in 
500 healthy term  born infants (birth weight >2500 grams) (143). This was followed in 
1957 with a report on the timing of the first void in 200 healthy preterm  infants with a 
birth weight < 2500 grams (144). Data from these studies are shown in Table 4.
Clark evaluated in 1976 the influence of gestational age, maternal premedication 
and mode of delivery on the timing of first urine production in 500 newborn infants 
(145). Eighty infants were born at a gestational age less than 37 weeks. All infants 
produced urine within 24 hours. Preterm infants tended to pass urine earlier than full 
term  infants. At a postnatal age of 1-8 hours 83.7% of the prem ature neonates had 
voided in comparison to 38.0% in the full term  newborns. Mode of delivery, maternal 
premedication or birth weight (small for gestational age) did not change the timing of 
urine passage. The author mentioned in the discussion that 'failure of any newborn 
to void by 24 hours should prom pt the physician to check the infant’s hematocrit and 
blood pressure’.
One hundred and eleven VLBWinfants (birth weight < 1500 grams) were prospectively 
observed to study the time of first urination by Wang and Huang (146). 97.3% had their 
first void within 24 hours after birth. Only 3 patients had a delayed urine passage, i.e. 
a t a postnatal age more than 24 hours. These patients passed their urine at a postnatal 
age of 25, 25, and 45 hours of postnatal age respectively. No significant factors could be 
noted between the groups of delayed and normal first urine passage.
In a retrospective study Metaj et al. compared the time to first stool and urine passage 
in breast- and formula-fed newborn infants with a gestational age > 34 weeks, that 
were admitted and discharged from the normal newborn nursery (147). A total of 979 
neonates were included and 74% respectively 97.9% had passed urine at a postnatal 
age of 12 hours and 24 hours.
The results from the above mentioned observational studies are summarized in Table 4.
Table 4. Timing of first passage of urine in newborn infants (in cumulative %)
PNA (hrs)
Reference Population DR 0-12 12-24 24-48
Sherry, 1955 (143) 500 healthy full term  
(BW > 2500 g) 21.5% 64.5% 90.5% 100%
Kramer, 1957 (144) 200 healthy preterm  
(BW < 2500 g) 17.0% 67.6% 92.4% 99.4%
Clark, 1977 (145) 420 full term  
(GA > 37 wks) 12.9% 91.1%* 100% 100%
80 preterm  
(GA < 37 wks) 21.2% 98.7%* 100% 100%
* Postnatal age 0-16 hrs; DR: delivery room; BW: birth weight; GA: gestational age; PNA: postnatal age; VLBW: very low birth 
weight
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PNA (hrs)
Reference Population DR 0-12 12-24 24-48
Wang, 1994 (146) 111 VLBW (<1500 g)
mean BW  1267g 
mean GA 30 wks
2.7% 82.7% 97.3% 100%
Metaj, 2003 (147) 979 near/full term  
(GA >34 wks) NA 74.0% 97.9% 100%
* Postnatal age 0-16 hrs; DR: delivery room; BW: birth weight; GA: gestational age; PNA: postnatal age; VLBW: very low birth 
weight
The urine production directly after birth is closely associated with the total volume 
of body water, blood volume, renal perfusion, and the continuity of the urinary tract. 
Delayed voiding is associated with a stressful birth and prolonged labor (148). The 
voiding pattern of newborn infants can be influenced by many factors, like stress, 
illness, or maternal and neonatal drug therapy. Five independent risk factors have been 
identified for the development of impaired renal function in preterm  infants: maternal 
consumption of non-steroidal anti-inflammatory drugs during pregnancy, intubation 
at birth, respiratory distress syndrome, low Apgar score and neonatal treatm ent with 
ibuprofen (149).
The initial postnatal increase in serum creatinine is higher in newborns with a lower 
gestational age, with subsequent a more gradual decrease. This is probably caused by a 
slower progression of glomerular function and a greater creatinine back-flow across the 
immature tubular and vascular structures (150-152). Glomerular function progresses 
proportional to the postnatal age, also in newborns with a very low gestational age. This 
improvement is caused by a progressive increase in systemic blood pressure, reduction 
in renal vascular resistance, maturational changes in renal perfusion, increase in 
hydraulic permeability, increase in glomerular filtering areas, and an increased number 
of nephrons (152,153). Fractional sodium excretion (FeNa), an indirect param eter of 
renal tubular function, is inversely correlated to gestational age and postnatal age. This 
means that FeNa is high immediately after birth and subsequently decreases with time 
(152,154-159). Possible mechanisms are: tubular immaturity, low density of sodium- 
transporting sites in the tubular epithelium, and reduced renal response to aldosterone 
(160-162). It has also been postulated that the high FeNa is a physiologic phenomenon 
secondary to redistribution of extracellular fluid after birth (155). Kidneys have a 
limited capacity to concentrate the urine in the neonatal phase (163).
After a short period of decreased diuresis, preterm  infants increase their urine 
production during the second and third day of life independent of enhanced fluid 
intake, after which urine output varies in response to the changes in fluid intake. This 
pattern of an initial low urine production that is followed by an increased micturition 
is described in preterm  infants with respiratory distress syndrome (164,165), and has 
been related to changes in hormonal levels, like aldosterone, arginine vasopressin, and 
atrial natriuretic factor (148, 164, 166, 167). Oliguria during the first day of life can 
also be caused by a transient low systemic blood flow secondary to the inability of the 
immature myocardium to respond to an increased systemic vascular resistance related 
to the cessation of the placental circulation. Likewise, positive pressure ventilation 
with high mean airway pressure can impede venous return. Another possible causative
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factor is ductal left-to-right shunting with decreased blood flow to the end organs, like 
the kidneys.
Bidiwala and co-workers performed a prospective, observational study in 22 preterm  
infants and described the three postnatal phases of fluid homeostasis (165). The mean 
(±SD) gestational age of the study group was 30.0 ± 2.1 weeks with a mean birth weight 
of 1350 ± 300 grams. Polyuria was defined as a ratio of urine output to fluid intake > 1 
and a urine output > 3 mL/kg/hr. In 17 out of 22 patients a period of polyuria occurred 
(77%), which started in the majority during the first 48 hours after birth. Mean (±SD) 
urine production was 1.5 ± 0,7 m L/kg/hr during the first oliguric phase, 4.4 ±1.1 m L/kg/ 
hr in the polyuric phase, and 3.6 ± 0,7 m L/kg/hr in the normalized phase. The increase 
in urine output occurred without a significant change in fluid intake. The secondary 
decrease in urine production was seen despite a significant increase in fluid intake.
Relation between urine output and systemic blood flow
Kluckow and Evans prospectively examined the relationship between low systemic 
blood flow, renal function and early changes in blood potassium in the first 48 hours of 
life of preterm  infants (168). Serial Doppler echocardiographic studies were performed 
in 119 infants with a gestational age less than 30 weeks (mean gestational age 27 
weeks; mean birth weight 984 grams) at a postnatal age of 5, 12, 24 and 48 hours to 
quantify SVC flow. Serial arterial blood potassium measurements were taken and urine 
production was determ ined by regular weighing of diapers. All patients were treated 
according the same fluid management protocol. In the first 24 hours the mean urine 
production was 28 ± 2.2 m L/kg/day (1.2 ± 0.1 m L/kg/h), which increased to 99 ± 4.4 
m L/kg/day (4.1 ± 0.2 m L/kg/h) in the second 24 hours of life. On the first day of life 
a significant relationship was observed between lower urinary output and lowest SVC 
flow (r = 0.25; p = 0.02). This relationship was not longer seen on the second day of 
life. The chronology of the events appeared to be first a reduced systemic blood flow 
(and glomerular filtration rate) with subsequently within several hours an increase in 
blood potassium, which was associated with a decreased urine production. An other 
observation was that rise in blood potassium > 0.12 m m ol/L /h in the first 12 hours of 
life had a positive predictive value of 93% for the presence of low SVC flow at a postnatal 
age of 12 hours. The sensitivity, however, appeared to be only 35%. The authors stated 
that 'the rate of rise of blood potassium concentration could act as a form of screening 
for subsequent low flow, with a rapid rate of rise of potassium suggesting the need for 
an assessm ent of flow, even if the blood pressure is in the normal range’.
In a prospective cohort observational study Miletin et al. assessed the relationship 
between clinical and biochemical param eters of systemic perfusion and superior vena 
cava (SVC) flow in 38 VLBW infants on their first day of postnatal life (79). The mean 
(± SD) birth weight was 1.08 (± 0.28) kg and the mean gestational age was 27.8 (± 2.1) 
weeks. The urine output was calculated from birth to the time of echocardiographic 
measurements at a mean postnatal age of 19.1 (± 4.9) hrs. They found a poor correlation 
between urine production and SVC flow (r = 0.189; p = 0.28). Urine output was only 
slightly lower in the group with low SVC-flow (< 40 m L/kg/m in) in comparison to the 
normal SVC-flow group (median 2.6 m L/kg/h versus 3.1 m L/kg/h; p = 0.50). This may 
be related to the fact that echocardiography was performed within 12 hours of postnatal 
age and that the micturition in the delivery room was not included.
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Summary
Under normal conditions the neonatal urine output changes during the first days of 
life with a initial phase of low urine production (first 24 hours), followed by a period 
of transient polyuria (second and third day of life), after which diuresis stabilizes 
and depends on fluid intake. These physiologic changes in urine output are difficult 
to differentiate from oliguria due to impaired renal perfusion. Urine output is a poor 
m arker of low output state in the absence of a direct relationship with systemic blood 
flow. Persistent oliguria after the second day of life or anuria indicates poor renal 
perfusion after exclusion of congenital malformations and provided that no nephrotoxic 
drugs are used. In case of renal tubular immaturity urine production may even be in the 
normal range, despite a compromised renal perfusion.
»  CAPILLARY REFILL TIME (CRT)
The capillary refill time is a clinical test that is frequently used to diagnose circulatory 
failure, because it is easily applicable, noninvasive, quick, and inexpensive. Beecher et al. 
introduced capillary refill time in 1947 to assess the hemodynamic status in wounded 
soldiers (169) and the first normal values in children were reported by Schriger et al. in 
1988 (170). CRT is defined as the time that is required for the return of normal color of 
the skin after application of blanching pressure to a distal capillary bed (171). Minimal 
pressure is applied on a part of the body, until the skin is blanched. Sites that have been 
recommended are: finger pulp, nail bed, fore head, lip mucosa, chest wall, sternum, toe 
and heel. Time is recorded from the release of pressure until the return of skin color 
to baseline. Blood flow in the skin is determ ined by many factors, like cardiac output, 
tem perature (ambient, core, skin) and circulatory needs of the tissues. It is interesting 
that despite the fact that CRT m easurem ent is seen as a valuable noninvasive tool in the 
assessm ent of circulatory status, there is no consensus about the way CRT should be 
performed and interpreted. There is a great inconsistency in the way CRT is obtained 
among healthcare providers (172). Variation of pressure time between 3 and 7 seconds 
does not influence the resultant CRT (173). At least two measurements should be 
made and averaged to obtain a reliable result. CRT can be measured central (forehead 
or midsternal) or peripheral (extremities). An extremity should be lifted just above 
the level of the heart to prevent coloring of the skin by inflow of venous blood (174). 
CRT on lower extremities is longer in comparison with upper extremities (174). The 
m ost representative results in newborns are obtained with pressure on the forehead 
or midsternal (173,175), although Osborn and co-workers did not find a difference in 
sensitivity and specificity between central and peripheral CRT (76). One should be aware 
of many confounding variables that potentially influence the interpretation of CRT, such 
as body temperature, ambient tem perature and the use ofvasoactive medications (170, 
171, 176-178). It is best to assess CRT in a well-lit room with a comfortable ambient 
temperature.
Normal values of capillary refill time in newborn infants
In a prospective, descriptive study 203 term  and 266 preterm  infants were evaluated 
at an age of 1 to 7 days after birth (175). Only healthy newborns with a normal body 
tem perature were included. CRT was m easured in 4 body areas (midpoint of sternum;
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midpoint of forehead; palm of the hand; plantar surface of the heel) with the babies in a 
well-lit room with a stable, ambient tem perature of 23°C ± 1°C. Pressure was applied for 
5 seconds after which CRT was recorded with a stopwatch. The patients were in a supine 
position. Only the distribution curves of CRT determined on the chest and forehead 
showed a Gaussian curve, reason why only these CRT’s were analyzed. CRT never 
exceeded 3 seconds, irrespective of the subgroups (with or without phototherapy, type 
of nursery container, sex, gestational age and size for gestational age, and observers). 
Mean CRT was 1.73 (upper limit: 2.47) seconds on the head and 1.90 (upper limit: 2.66) 
seconds on the chest.
In a subsequent study Strozik et al. analyzed the duration of pressure time, 
the best area for m easurem ent and the normal value of CRT in 280 healthy, full-term 
newborns with an appropriate weight for gestational age (173). In each of the seven 
subgroups a different time period of pressure was applied on the head, chest and heel, 
varying from 1-7 seconds. A stopwatch was used to measure the time till the skin color 
returned to baseline. All patients had a normal axillary body tem perature (36-37 °C); 
none was treated with phototherapy. Measurements were carried out in a well-lit room 
with a controlled ambient tem perature of 23°C ± 1°C. The results of the former study of 
this group were confirmed, as the upper limit of normal CRT never exceeded 3 seconds. 
Varying pressing times between 3 and 7 seconds for the head and chest did not show 
any difference in CRT values. CRT measured on the heel was longer and less consistent 
in comparison to m easurem ent on the head and chest. Mean CRT for the chest and head 
was 1.83 ± 0.35 and 1.82 ± 0.39 respectively.
In another prospective, descriptive study CRT was evaluated in 137 healthy newborns 
with a gestational age of 36-42 weeks atapostna ta l age of 1-120 hours (178). Moderate 
pressure was applied for 5 seconds to the dorsum of the right hand and right foot. CRT 
was significantly related to the environmental temperature, axillary temperature, and 
tem perature of the extremities. With each successive m easurem ent CRT decreased 
significantly, which was related to an increasing temperature. The mean CRT was 4.23 
± 1.47 seconds on the hand and 4.64 ± 1.41 seconds on the foot.
Raichur et al. analyzed CRT in 155 healthy full-term neonates (49% LBW) in four 
different body sites (forehead, chest, palm, and heel) at a mean age of 50.7 hours (179). 
Two observers measured CRT with at least 30 minutes in between the two assessments. 
Blanching pressure was applied for 5 seconds. Inter-observer difference was high 
and statistically significant for m easurem ent of CRT on forehead, palm and heel. Only 
the assessment of CRT on the chest showed some inter-observer agreement (r = 0.40; 
p<0.001).
The relation between CRT and circulatory status (heart rate and non-invasive blood 
pressure) was analyzed in a prospective, cross-sectional study under 42 healthy, full- 
term  newborns (appropriate for gestational age) at a mean age of 2.4 hours (180). The 
infants were examined in a therm oneutral environment and CRT was measured on the 
finger, heel and sternum. In this study extended blanching pressure (3 to 4 seconds) 
resulted in a statistically significant longer duration of CRT in comparison with brief 
period of pressure (1 to 2 seconds). The relation between heart rate and CRT was not 
significant. A remarkable, although moderate, direct relationship was observed between 
blood pressure and CRT for all sites of CRT measurement, which was not consistent 
with the presumed hypothesis that a decreased blood pressure would be associated 
with a longer CRT. It was suggested that this unexpected direct relationship between
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blood pressure and CRT might be secondary to increased systemic vascular resistance 
due to circulating vasoactive substances in the direct postnatal period, such as arginine 
vasopressin, catecholamines, and endothelin.
Relation between capillary refill time and systemic blood flow
Wodey et al. reported a prospective, descriptive study of 100 newborns in a neonatal 
intensive care unit in which they evaluated the correlation between CRT, clinical 
parameters, and hemodynamic param eters obtained by echocardiography (181). 
CRT was m easured at the hand and the heel with the patient in a controlled ambient 
temperature. Blanching pressure (80-100 mmHg) was applied for 5 seconds on a 
standard surface of 1 cm2. CRT was defined as the average of 4 subsequent measurements 
at the extremities. Cardiac index (Cl) was calculated by multiplying the aortic sectional 
area with the mean aortic flow velocity, indexed to body weight in kg. In this way cardiac 
index represents left ventricular output (LVO). No correlation was found between CRT 
and shortening fraction, mean airway pressure, body weight, left atrial diam eter/ 
aortic diameter ratio, blood pressure, and heart rate. In a subgroup of patients with 
an obliterated ductus arteriosus a significant correlation was found between CRT and 
cardiac index (r2 = 0.54; p<0.01). The correlation was weaker in the subgroup with a 
PDA with or without retrograde flow in the subdiaphragmatic aorta (r2 = 0.41; p<0.001 
and r2 = 0.31; p<0.001 respectively). This is probably caused by the fact that in the 
presence of a PDA the measured cardiac index equals LVO and left-to-right shunt flow 
and therefore Cl overestimates systemic blood flow to the postductal regions.
Osborn et al. evaluated the accuracy of CRT for detecting low superior vena cava (SVC) 
flow in preterm  infants during the first 12 hours of life in a two centre, prospective 
cohort study (76). The study population consisted of patients born at a gestational 
age less than 30 weeks and without treatm ent with inotropes or indomethacin before 
three hours after birth. Central tem perature was maintained at > 36.5°C in a humidified 
incubator (>80% humidity). In 128 infants CRT was measured on the chest (central) 
and on the palm of the hand (peripheral) by applying a blanching pressure during 5 
seconds. CRT was considered representative when two consecutive reproducible results 
were obtained. A significant correlation was found between low SVC flow (defined as < 
41 m L/kg/m in) and both central and peripheral CRT (r = 0.42; p < 0.001 and 0.38; p < 
0.001 respectively). A CRT > 3 seconds had a sensitivity of 55% and specificity of 80% 
for low SVC flow. With a pretest probability of 15% of low SVC flow a positive predictive 
value of 33% [95%-CI: 29%-38%] was found and a negative predictive value of 91% 
[95%-CI: 88%-94%] of a central CRT > 3 seconds. Defining a positive test as a central 
CRT > 4 seconds resulted in a specificity of 96% at the cost of a reduced sensitivity 
(29%) with a PPV of 55% (95%-CI: 50%-60%] and a NPV of 88% [85%-91%], These 
results mean that a central CRT > 3 seconds will detect 55% of the preterm  infants with 
a low SVC-flow, but only 33% of the patients with a CRT > 3 seconds will truly have a SVC 
flow < 41 mL/kg/min. Adapting the limit of a pathologic CRT to > 4 seconds will reveal 
only 29% of patients in shock. This study proves that CRT m easurem ent alone is not a 
reliable clinical indicator of shock in preterm  infants. The sensitivity of a central CRT >
3 seconds increased to 78% in the population with a mean arterial blood pressure < 30 
mmHg. However, the corresponding PPV was only 31%.
In a prospective, observational cohort study Miletin and Dempsey examined the 
relationship between SVC flow and adverse outcome in 45 VLBW (mean GA 27.8 ± 2.1
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weeks; mean BW 1.08 ± 0.28 g) on the first day of life (72). Low SVC flow, defined as less 
than 40 mL/kg/min, predicted adverse outcome (early neonatal death or severe IVH) 
with 66.7% sensitivity and 87.5% specificity. When the clinical assessm ent of CRT was 
added the predictive value increased significantly. Low SVC flow (< 40 m L/kg/m in) in 
combination with a CRT > 4 seconds in the big toe resulted in a positive predictive value 
of 100% for adverse outcome with a sensitivity of 66.7% and a specificity of 100%. CRT 
did not appear to be a good individual param eter to evaluate the hemodynamic status, 
as the CRT was similar in the group with low and normal SVC flow (respectively median 
2.25 sec versus 2.5 sec on forehead, 2.9 sec versus 2.7 seconds on sternum  and 3.4 sec 
versus 3.1 sec on big toe).
In a prospective cohort observational study in 38 VLBW infants (mean gestational 
age 27.8 ± 2.1 weeks; mean birth weight 1.08 ± 0.28 kg; mean postnatal age 19.1 ± 
4.9 hours) the correlation was assessed between several clinical and biochemical 
param eters of perfusion and SVC flow (79). CRT was measured in three sites (forehead, 
mid sternum, and big toe) with a blanching pressure applied for 5 seconds in thermally 
stable preterms. Pretest probability of low SVC flow (< 40 m L/kg/m in) was 21%. 
Median CRT was comparable in patients with low and normal SVC flow. Correlation 
between CRT and SVC flow was poor, when m easured in the forehead (r = 0.008; p = 
0.96), sternum  (r = 0.11; p = 0.52), and foot (r = -0.101; p = 0.54). No data concerning 
sensitivity, specificity, PPV or NPV were reported for the generally used cut-off point of 
a CRT > 3 seconds. Combining a CRT > 4 seconds with a serum lactate concentration of >
4 mmol/L resulted in a sensitivity of 50%, a specificity of 97%, a PPV of 80% and a NPV 
of 88% for a SVC flow less than 40 mL/kg/min.
Summary
CRT should be measured on the forehead or midsternal and normally last less than 
3 seconds in newborn infants. CRT remains a rather subjective measurement, which 
should not solely be relied on and at it best it will increase the predictive value of other 
clinical variables, such as blood pressure, when used in combination.
»  LACTATE
Lactate metabolism
The discovery of lactate in m eat juices was described in 1807 by Berzelius (182). 
Lactate is the end product of glycolysis and formed from pyruvate by lactate 
dehydrogenase (LDH), as is shown in Figure 1.
There is an im portant difference between lactate and lactic acid. Lactic acid is a so- 
called strong ion, which dissociates into lactate and hydrogen ions at pH levels in the 
physiological range. According the Henderson-Hasselbalch equation the concentration 
of lactate is 3548-fold the concentration of lactic acid at a pH of 7.4 (182). Lactate itself 
does not act as an acid. Moreover, the conversion of pyruvate to lactate is not coupled 
with an increase in hydrogen ions, so an elevated blood concentration of lactate is 
not synonymous to lactic acidosis. The conversion of glucose to pyruvate produces
2 mol ATP and 2 mol H* ions per mol glucose, whereas the conversion of glucose to 
lactate produces also 2 mol ATP per mol glucose, but without the acidifying effect of H
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generation (Figure 2). 
Figure 1. Lactate metabolism
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Figure 2. Conversion of glucose in pyruvate and lactate
Glue + 2 ADP + 2 P i+ 2 NAD 2 pyruvate + 2 ATP + 2 NADH + 2 H+
Glue + 2 ADP + 2 P i+ 2 NAD -> 2 lactate + 2 A T P+ 2 NAD
Only when hydrogen ions, which are released with ATP hydrolysis, cannot be recycled 
in the mitochondria hyperlactatemia results in lactic acidosis. This can occur for example 
under anaerobic conditions. The absence of a significant correlation between arterial 
pH and arterial lactate concentration has been confirmed in adults and newborn infants 
(183,184).
The conversion of pyruvate to lactate instead of acetyl-CoA can be caused by several 
mechanisms, like a limited availability of oxygen, the absence of mitochondria (as in 
erythrocytes), a rapid increase in metabolic rate, or an increased glucose metabolism 
that exceeds the oxidative capacity of the mitochondria (inborn errors of metabolism 
or during the administration of catecholamines). An increased aerobic glycolysis can be 
caused by an elevated cellular uptake of glucose, m ediated by cytokines or by increased 
NA-K-ATPase activity, mediated by catecholamines. All types of cells are capable of 
the production of lactate, but mostly in tissues with a high metabolic rate, like brain,
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intestines, skin, muscles and erythrocytes. Not all tissues can metabolize lactate, which 
occurs mainly in the liver (50%), the kidneys (25-30%) and muscles.
Main etiologic factors for an increased lactate production in newborn infants are: 
anaerobic metabolism, increased glycogenolysis, glucose infusion, administration 
of sympathicomimetic drugs, catecholamine surge, alkalosis (buffer therapy, 
hyperventilation) and intrauterine growth retardation (185-187).
Accumulation of lactate will occur when production exceeds the clearance via liver and 
kidneys. There has to be a substantially increased lactate production before an increase 
in blood lactate concentration occurs because of an exceeded metabolic threshold of the 
liver and kidneys. Sepsis and respiratory alkalosis are associated with a reduced lactate 
clearance by the liver and other organs (188,189).
In order to differentiate between transient dysoxia and inborn errors of metabolism in 
newborn infants with persistent hyperlactatemia during the first two days of life one can 
measure serum alanine concentration. In a prospective observational study neonates 
with transient hyperlactatemia did not have an increased alanine concentration, 
whereas an increased serum alanine concentration turned out to be a sensitive marker 
in neonates with an inborn error of metabolism (190).
An elevated lactate concentration can be associated with acidosis, alkalosis and 
normal blood pH and can be found under conditions of normoxemia, hypoxemia and 
anoxemia. Under ischemic conditions lactate synthesis will only increase when a critical 
low level of oxygen delivery is reached and maximal oxygen extraction is insufficient for 
metabolic demand. This means that an increased blood lactate concentration is a rather 
late phenomenon in circulatory failure.
Normal values of lactate in newborn infants
The balance between lactate production and consumption determines blood lactate 
concentration. Many studies established normal values for lactate concentration in 
arterial, capillary and /o r (central) venous blood with the use of several different 
methods (191-196). Table 5 shows an overview of studies of normal blood lactate 
concentrations in newborn infants. Beyond the first six hours after birth the lactate 
concentration in arterial blood of healthy term  and preterm  infants is generally less 
than 2.5 mmol/L (191,192).
Table 5. Normal values of blood lactate concentrations in newborns
Reference Population Sample
site
PNA [lactate] 
in mmol/L
Yu, 1965 Healthy preterm Arterial Mean
(191) infants (n=31) Cord 
3 hrs 
48 hrs
3.6 (33 m g/100 mL) 
2.3 (21 m g/100 mL)
1.7 (15 m g/100 mL)
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Reference Population Sample
site
PNA [lactate] 
in mmol/L
Koch, 1968 
(192,193)
Healthy term  infants 
(n = 79)
Arterial
Birth 
5-10 min 
30 min 
60 min 
5 hrs 
24 hrs 
7 days
Mean (range)
2.7 (1.5-4.5)
3.8 (2.6-4.7)
2.2 (1.2-4.3) 
1.6 (0.9-2.7)
1.3 (0.9-2.0) 
1.0 (0.8-1.2) 
0.9 (0.5-1.4)
Hawdon, 1992 
(194)
Healthy term  
(>37 wks) neonates 
(n=165)
Capillary
Cord - vag 
Cord - cs 
2nd day 
3rd day 
4th day 
5 th day 
6th day
Mean (SEM)
3.45 (0.41) 
1.60 (0.17) 
1.48 (0.14)
1.46 (0.09) 
1.45 (0.16) 
1.32 (0.10) 
1.68 (0.16)
Healthy preterm  
(<36 wks) neonates 
(n=62)
Capillary
Cord 
2nd day 
3rd day 
4th day 
5 th day 
6th day
Mean (SEM) 
2.73 (0.44) 
1.49 (0.18) 
1.57 (0.31) 
1.43 (0.20) 
1.93 (0.38) 
1.46 (0.15)
Nielsen, 1994 
(195)
Healthy full term  
newborns (n = 114)
Capillary Range: 0.37 -  3.2
Yoxall, 1996 
(196)
Neonates receiving 
intensive care 
(n = 80)
Arterial
0-6 hrs 
6-12 hrs 
> 12 hrs
Median (p5-p95)  
1.74 (0.62 to 8.22) 
1.47 (0.66 to 7.86) 
1.21 (0.51 to 5.06)
In general, there is a good agreem ent between lactate concentration in arterial, 
venous and capillary blood (197-202). However, the difference between arterial and 
capillary lactate concentration is increased with the use of vasoactive medication and 
in sepsis (202).
Prognostic value of blood lactate concentration
Lactate concentrations have mainly been subject to studies in order to investigate the 
prognostic value of this param eter to predict mortality or major morbidity in newborns. 
The prognostic value is increased when serial measurements are done (184,193, 203- 
205).
In preterm  newborns with respiratory distress syndrome hyperlactatemia is 
associated with increased mortality (193, 206, 207). In the early 70’s Beca and Scopes 
m easured arterial lactate concentration every 4 hours in 21 newborn infants with
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respiratory distress syndrome (193). The mean (±SD) gestational age of the study 
population was 32.6 (±3.0) weeks with a mean birth weight of 1765 (±524) grams. 
Lactate concentration was higher in non-survivors. Only with serial m easurements a 
reliable prediction could be made. All infants with lactate concentration < 3.9 mmol/L 
survived. Infants with an initial high value of lactate concentration that decreased in 
time also had a good prognosis. Patients with a rising lactate concentration, even with 
a normal initial value, died.
Fitzgerald et al. showed that newborn infants (> 1200 g; appropriate for gestational 
age) with a proven sepsis had a significant higher arterial concentration of lactate in 
comparison to control subjects (p < 0.003) (2 08). They concluded that hyperlactatemia 
(> 2.0 mmol/L) could be used as an early m arker for sepsis in preterm  infants.
Several studies evaluated the usefulness of blood lactate concentration as an indication 
for blood transfusion with controversial results and conclusions (201, 209-211).
Cheung and co-workers evaluated retrospectively the predictive value of the arterial 
concentration of lactate for mortality in 2 8 term  newborn infants with severe hypoxemia, 
that were treated with extracorporeal membrane oxygenation (212). Arterial blood 
samples were taken on admission and with an interval of 12 hours thereafter. The 
mortality rate was 25% in the study population. Mean lactate levels (± SD) were 
significantly higher in the non-survivors compared to the survivors for both the initial 
value (10.0 ± 6.35 mmol/L versus 24.9 ± 9.90 mmol/L; p < 0.00001) and the peak level 
(13.7 ± 6.32 mmol/L versus 38.4 ± 9.20 mmol/L; p < 0.00001). In survivors the lactate 
level decreased significantly after the initiation of ECMO, whereas in the non-survivors 
no significant changes were noted after the start of ECMO. An initial arterial lactate 
concentration < 25 mmol/L predicted survival with a sensitivity of 100%, a specificity 
of 71.4%, a positive predictive value of 91.3% and a negative predictive value of 100%. 
In comparison, an arterial pH >7.10 had a Se of 95%, a Sp of 28.5% with a PPV of 80% 
and a NPV of 66.7%. Serum bicarbonate> 10 mmol/L resulted in a Se of 100%, a Sp of 
57.1%, a PPV of 87.5% and a NPV of 100%.
In a subsequent study Cheung et al. reported the predictive value of lactate 
concentration in relation to neurodevelopmental outcome in 17 newborn infants, 
treated with extracorporeal membrane oxygenation (213). The mean (± SD) gestational 
age of the study population was 40.5 (± 1.66) weeks with a mean birth weight of 3403 
(± 588.1) grams. An initial lactate concentration < 15 mmol/L on admission predicted 
a favorable developmental outcome (Mental Developmental Index and Psychomotor 
Developmental Index > 70 and no disability) with a sensitivity of 100%, a specificity of 
63%, a positive predictive value of 75% and a negative predictive value of 100%. The 
addition of a peak lactate concentration <15 mmol/L resulted in 100% sensitivity, 88% 
specificity, 90% positive predictive value and 100% negative predictive value.
Yoxall et al. (196) m easured lactate concentration in arterial blood samples in 80 
neonates on an intensive care unit in the first two days of life. A normal range was 
calculated for each 6 hours period in a total of 658 blood lactate measurements. In 
the first 6 hours median [5,h-95,h percentile] lactate concentration was 1.74 [0.62- 
8.22] mmol/1. This changed to 1.47 [0.66-7.86] mmol/L between 6 to 12 hours and
1.21 [0.51-5.06] mmol/L after a postnatal age of 12 hours. Hyperlactatemia, defined as 
an arterial blood lactate concentration >95,h percentile, predicted death or significant 
intraventricular hemorrhage with a positive predictive value of 75% and a negative 
predictive value of 90%.
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Deshpande and Ward Platt performed a prospective, observational study to evaluate 
the association between blood lactate, acid-base status (pH, base excess, bicarbonate 
concentration) and mortality in a cohort of 75 ventilated newborn infants with indwelling 
arterial catheters (184). The median gestational age of the study population was 29 
(range: 23-40) weeks with a median birth weight of 1340 (range: 550-4080) grams. 
A total of 278 simultaneous measurements of arterial pH, base excess, bicarbonate 
concentration and lactate concentration were obtained at a median postnatal age of 20 
(range: 1-68) hours. No correlation was found between pH, base excess, bicarbonate 
concentration and blood lactate concentration. Even within subjects no association 
was seen between pH or base excess and lactate concentration. A significant, but 
clinically irrelevant weakly positive, correlation was found between peak lactate 
concentration and concurrent pH (r = 0.279; p < 0.05) and no correlation between 
peak lactate concentration and base excess (r = 0.162; p > 0.2). Even when only infants 
were included, that did not receive bicarbonate infusion prior to blood gas analysis and 
lactate concentration measurement, there was no correlation between initial blood 
lactate concentration and pH (r = 0.269; p > 0.05), base excess (r = 0.169; p > 0.2), 
or bicarbonate concentration (r = -0.179; p > 0.2). 29% of the total study population 
had hyperlactatemia, defined as lactate > 2.5 mmol/L. Neither pH nor base excess were 
sensitive indicators of hyperlactatemia. Increased blood lactate concentration was 
associated with increased mortality, while lowest pH and w orst base excess were not. 
The mortality in the study population was 20%. A peak lactate concentration (PLC) <2.5 
mmol/L resulted in an inpatient mortality of 11%. Mortality increased to 2 7% and 57% 
with a PLC of 2.5-5.0 mmol/L and PLC > 5.0 mmol/L respectively. In 66 patients serial 
lactate measurements were available. The highest mortality was found in the subgroup 
with a persistently high or continuously rising lactate concentration. The decrease in 
lactate concentration in patients with a hyperlactatemia (> 2.5 mmol/L) was different 
in survivors and non-survivors. In survivors the subsequent median change was -44.7% 
(range: -32.2 to -65.1%) versus -7.2% (range: -17.5 to +0.9%) in the non-survivors (p 
= 0.008).
In a prospective, observational study da Silva et al. examined the predictive value of 
blood lactate measurements in 115 full term  newborns after intrapartum  asphyxia for 
moderate or severe neonatal encephalopathy (214). Lactate levels > 9 mmol/L was 
associated with adverse neurologic outcome with a sensitivity of 84%, a specificity of 
67%, a positive predictive value of 50% and a negative predictive value of 91%. The area 
under the ROC curve was 0.81. The calculated relative risk was 5.8 (95%-CI: 2.2-15.4).
Cheung et al. conducted a prospective cohort study to evaluate the predictive value of 
serial arterial lactate m easurements in 74 newborns treated with ECMO for mortality 
and neurodevelopmental outcome in early childhood (215). Mean (± SD) gestational age 
of the study population was 39 (± 2) weeks with a mean birth weight of 3200 (± 770) 
grams. A peak lactate concentration >25 mmol/L predicted mortality during the initial 
hospitalization with a Se 47%, Sp 100%, PPV100% and NPV 88%. Lactate concentration
> 15 mmol/L predicted adverse outcome with a Se 35%, Sp 91%, PPV 89% and NPV 
38%. Adverse outcome was defined as death or surviving with neurodevelopmental 
disability (cerebral palsy, blindness, hearing loss and /o r MDI < 55) or delay (MDI or 
PDI >2 SD below the mean for normative data). The predictive value increased when 
patients with congenital diaphragmatic hernia of lethal anomalies were excluded.
The positive and negative predictive value of arterial lactate concentration for
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adverse outcome, defined as death or adverse neurodevelopmental outcome, were 
estimated in 88 preterm  babies less than 3 hours of age by Groenendaal et al. (216). 
Adverse neurodevelopmental outcome was defined as cerebral palsy or psychomotor 
retardation (Griffiths’ developmental quotient < 85). The mean (±SD) gestational age 
was 29.8 ± 2.4 weeks and the mean weight at birth was 1225 ± 445 grams. Using a cutoff 
value of 5.7 mmol/L the PPV was 47% and the NPV was 92%. The area under the curve 
obtained with ROC analysis was 0.78.
Abubacker et al. evaluated retrospectively the prognostic value of peri-operative 
m easurem ent of blood lactate m easurem ent in newborns undergoing surgery for 
necrotizing enterocolitis (217). Preoperative lactate concentration was significant 
higher in non-survivors than in survivors (2.7 versus 0.9 mmol/L; p = 0.05). The positive 
predictive value for mortality of a preoperative lactate level > 1.6 mmol/L was 66.7% 
with a negative predictive value of 92.8%. Mortality was increased in the group with a 
lactate concentration > 1.6 mmol/L (OR 22; 95%CI 1.54 to 314.3, p = 0.04). Interestingly 
the postoperative lactate concentration in survivors was lower than in non-survivors, 
but just did not reach statistical significance (1.2 versus 4.7 mmol/L; p = 0.06).
Shah and co-workers conducted a retrospective observational study to determine 
the predictive value of blood gas param eters and arterial lactate concentration for the 
occurrence of moderate to severe hypoxic ischemic encephalopathy in 61 full term  
newborn infants with suspected intrapartum  asphyxia (218). Patients were included 
when there were signs of fetal distress, and depression at birth (Apgar score < 5 at 5 
minutes), and hemodynamic, respiratory or neurological abnormalities persisting 30 
minutes after birth, and umbilical arterial pH < 7.00. They dem onstrated a higher risk 
of neurologic and systemic complications in the presence of a concentration of lactate
> 7.5 mmol/L at a postnatal age of 1 hour. A lactate concentration > 7.5 mmol/L within 
the first hour of life predicted neonatal encephalopathy (Sarnat stage 2 or 3) with 94% 
Se, 67% Sp, 55% PPV and 97% NPV and systemic complications (renal and hepatic 
dysfunction, thrombocytopenia and cardiac ischemia) with 77% Se, 70% Sp, 68% PPV 
and 80% NPV
Kidokoro et al. performed a case control study to evaluate the usefulness of blood 
lactate concentration as a predictor for the development of periventricular leukomalacia 
(PVL) in preterm  infants (219). 13 preterm  newborns with cystic PVL (mean GA 29.2 
± 1.5 weeks; BW 1392 ± 311 grams) were matched with 26 control patients (mean GA 
29.7 ± 1.4 weeks; BW 1389 ± 315 grams). The mean serum lactate levels on admission 
did not differ significantly between the PVL and control group (2.95 ± 0.43 mmol/L 
versus 3.21 ± 0.29 mmol/L respectively). There were also no significant differences in 
subsequent lactate concentrations between the groups during the first 72 hours of age.
In a prospective observational study Murray et al. determined whether the initial 
capillary or arterial lactate concentration (< 3 0  minutes after birth) could predict 
the severity of the resultant EEG grade of encephalopathy and whether a persistent 
hyperlactatemia is indicative of a more severe cerebral injury (220). Time for lactate 
to normalize (TLN) was defined as the time from birth until lactate concentration was
< 4 mmol/L. The study population consisted of 50 term  newborn infants with a mean 
(±SD) gestational age of 40.3 (± 1.4) weeks and a mean birth weight of 3409 (± 600) 
grams. Lactate concentration directly after birth (<30 minutes) had no useful predictive 
value for the severity of the ensuing encephalopathy. A prolonged TLN however was 
associated with severe encephalopathy on EEG.
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Kalyanaraman and co-workers analyzed initial postoperative lactate levels, peak 
lactate levels and lactime (total time that lactate m easured > 2 mmol/L] in children 
after cardiopulmonary bypass surgery (204). Subgroup analysis of 22 neonates (< 1 
month of age) revealed that this group had an increased risk for having a lactime > 48 
hours (OR 8.3). Lactime correlated in this group with mortality (r = 0.46; p = 0.04) and 
the positive predictive value of mortality for lactime > 48 hours was 75%.
Relation between lactate and systemic blood flow
Only a few studies address the diagnostic value of blood lactate concentration to 
detect hemodynamic compromise.
In a prospective study Wardle et al. studied peripheral perfusion param eters in 15 
normotensive and 15 hypotensive preterm  infants (<1500 grams) (74). Hypotension was 
defined as a blood pressure below the 10,h percentile for birth weight and postnatal age. 
No significant difference in blood lactate concentration was found in the normotensive 
and hypotensive group respectively (median [IQR] 1.20 [0.97-1.97] mmol/L versus
1.22 [0.70-1.51] mmol/L; p = 0.44). Moreover, treatm ent of hypotension did not cause 
a change in blood lactate concentration (median [IQR]: 1.22 [0.70-1.51] mmol/L versus
1.22 [0.75-1.75] mmol/L; p = 0.94). Peripheral oxygen consumption (V02) and oxygen 
delivery (D02) was m easured with near infrared spectroscopy with venous occlusion 
in the forearm. There was no relationship between blood lactate concentration and 
peripheral V02 (r = -0.03; n = 27; p = 0.79) or D02 (r = 0.05; n = 27; p = 0.79). Even 
in circulatory failure the blood lactate concentration can be in the normal range as 
long as the diminished oxygen delivery is sufficient for the oxygen consumption. Next 
to that, regional low blood flow might result in local lactate accumulation that cannot 
be detected in the central circulation until the circulation has recovered and lactate is 
mobilized.
Hart et al. conducted a prospective observational study to evaluate the relation 
between inferior vena cava oxygen saturation, superior vena cava flow, fractional oxygen 
extraction and hemoglobin affinity in 17 neonates (221). A total of 56 measurements 
was made in the study population with a median gestational age of 26 weeks and 6 
days (range: 23 wk 3 d to 42 wk 4d) and a median birth weight 875 (range: 400-3425) 
grams. Hyperlactatemia was defined as a blood lactate concentration > 2.5 mmol/L. 
There was no significant difference in mean (±SD) SVC flow between the normolactemic 
and hyperlactemic subgroup (respectively 110 ± 83 m L/kg/m in versus 94 ± 69 mL/ 
kg/min). Also no significant difference was observed in mean lactate concentration 
between the low and normal SVC flow subgroup (3.4 ± 2.2 mmol/L versus 2.6 ± 1.6 
mmol/L respectively).
In a subsequent prospective cohort observational study in 38 VLBW infants (mean 
birth weight 1.08 ± 0.28 kg; mean gestational age 27.8 ± 2.1 weeks) Miletin et al. studied 
the relationship between superior vena cava (SVC) flow and several param eters of 
systemic perfusion (mean blood pressure, urine output, capillary refill time, and serum 
lactate concentration) (79). Serum lactate concentration was measured at the time 
of echocardiographic m easurem ent of SVC flow at a mean postnatal age of 19.1 ± 4.9 
hours from either an arterial or capillary blood sample. Low SVC flow was defined as
< 40 mL/kg/min. Median serum lactate concentration was significantly higher in the 
subgroup of infants with low SVC flow in comparison with neonates with a SVC flow >
41
CHAPTER 
CM
40 m L/kg/m in (3.5 mmol/L versus 2.7 mmol/L; p = 0.015). The correlation between 
SVC-flow and lactate concentration was only -0.28 (p = 0.15). In this study an optimum 
cut-off point for serum lactate concentration was 2.8 mmol/L with an area under the 
ROC curve of 0.80. This resulted in a sensitivity of 100% and a specificity of 60% for the 
detection of a low flow state, defined as a SVC-flow less than 40 mL/kg/min. Combining 
a capillary refill time of more than 4 seconds with a serum lactate concentration > 4 
mmol/L resulted in a PPV of 80% and a NPV of 88% for the prediction of alow  SVC flow.
According to the 2007 update of the 2002 American College of Critical Care Medicine 
Clinical Guidelines for Hemodynamic Support of Neonates and Children with Septic 
Shock the use of blood lactate concentration is not part of the recommendations for 
early recognition of pediatric and neonatal septic shock (95).
Summary
Blood lactate concentrations can identify neonates at risk for adverse outcome, 
especially when serial measurements are used. Blood lactate concentration is not 
increased during circulatory failure when lactate clearance is in balance with lactate 
production and when oxygen delivery meets the oxygen demand in the tissues by 
increased oxygen extraction. Moreover, lactate may accumulate locally and remain 
undetectable until perfusion improves and mobilizes lactate. The predictive value of 
lactate as an isolated indicator of circulatory failure is poor. When lactate is used in 
conjunction with other markers of poor systemic perfusion it may improve the accuracy 
of the identification of circulatory failure.
»  CENTRAL-PERIPHERAL TEMPERATURE 
DIFFERENCE
The central-peripheral tem perature difference (CPTd) has been used since 1967 in 
adults as an indicator of hypovolemic shock (222). Measurement of central-peripheral 
tem perature difference (CPTd) in children was first described by Aynsley-Green and 
Pickering in 1974 (223, 224). The assumption is that in a therm oneutral environment 
peripheral vasoconstriction, secondary to poor peripheral perfusion, will decrease 
skin tem perature and thus lead to an elevated CPTd. In this way CPTd can be used as a 
m arker of poor peripheral perfusion.
Normal central-peripheral temperature difference in neonates
Lyon et al. conducted a study to determine the ranges for skin tem peratures in preterm  
infants < 1000 grams in the first postnatal days (225). Both central tem perature (with 
probe on the abdominal skin over the liver) and peripheral tem perature (with probe 
on the sole of the foot) were continuously m easured in 83 newborns. The probes were 
covered to exclude the influence of direct heat. The humidity of the incubator was 
80% and the tem perature setting was servo-controlled. All infants were covered with 
a plastic sheet during the first week of life. The trend of mean central tem perature 
(mCT), mean peripheral tem perature (mPT) and mean central-peripheral tem perature 
difference (mCPTd) during the first postnatal days are shown in Figure 3.
There was no peripheral vasoconstriction during the first day in response to cold 
stress. The vasomotor response seems to develop over the first two or three postnatal
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days. The authors postulated that an elevated CPTd might be caused by poor peripheral 
perfusion secondary to hypovolemia, which was defined as an episode of rising heart 
rate and /o r falling blood pressure. In only 11.4% of the overall period of time a CPTd > 
2°C was associated with these indirect indicators of hypovolemia. The authors conclude 
that an elevated CPTd was more likely to reflect thermal stress than a compromised 
circulation. This conclusion m ust be disputed, because of the invalid definition of 
hypovolemia that might be present with or without tachycardia and /o r hypotension.
Figure 3. Mean central temperature (mCT), mean peripheral temperature (mPT) and mean central- 
peripheral temperature difference (mCPTd) in the first 5 postnatal days (after Lyon etal.(225]]
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Relation between central-peripheral temperature difference 
and systemic blood flow
Lambert et al. found a significant correlation between CPTd and plasma concentration 
of arginine vasopressin (AVP) in a study to examine the effect of intravascular volume 
expansion for the treatm ent of hypovolemia in 14 sick preterm  infants (226). Plasma 
AVP was used as a m arker of blood volume and blood pressure, because AVP is released 
in response to hypotension and hypovolemia. The changes in CPTd reflected changes in 
AVP before and after infusion of20m L /kg albumin in 20 minutes (R2 0.61 (p < 0.05) and 
0.45 (p < 0.05) respectively).
Tibby et al. evaluated the usefulness of central-peripheral tem perature difference 
(CPTd) as indicator of hemodynamic status in pediatric intensive care patients (174). 
Measurements were done in an ambient tem perature of 22°C with a rectal probe 
(CT) and skin probe on a distal limb, usually great toe (PT). The study population was 
divided into two groups, i.e. postcardiac surgery (n=27) and general (n=28; 86% septic 
shock). The median age was 30 and 41 months for the cardiac group and general 
group respectively. Hemodynamic param eters were measured with transpulmonary 
thermodilution (cardiac index, systemic vascular resistance index and stroke volume 
index). The correlation between CPTd and Cl, SVRI and SVI was very poor with 
correlation coefficients of respectively -0.12 (p = 0.44), 0.14 (p = 0.36) and -0.19 (p =
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0.22) in the cardiac group and -0.24 (p = 0.13), 0.29 (p = 0.08) and -0.29 (p = 0.07) in 
the non-cardiac patients.
In a prospective cohort study Osborn and co-workers evaluated the accuracy of blood 
pressure, capillary refill time and central-peripheral tem perature difference (CPTd) for 
detecting low superior vena cava (SVC) flow in preterm  infants during the first 12 hours 
of life (76). The study population consisted of patients born at a gestational age less 
than 30 weeks without treatm ent with inotropes or indomethacin before three hours 
after birth. Central tem perature was maintained at > 36.5°C in a humidified incubator 
(>80% humidity). In 46 patients CPTd was m easured before SVC flow measurement. 
Central tem perature was recorded with a sensor at the thorax/bed interface; the sensor 
for peripheral tem perature m easurem ent was placed on the sole of the foot. CPTd was 
recorder after a stabilization period of 15 minutes. Low systemic blood flow was defined 
as SVC-flow < 41 mL/kg/min. The prevalence of low flow was 19%. No correlation was 
found between CPTd and SVC flow (r = 0.02; p = 0.8). A CPTd of > 2°C had a sensitivity of 
40% and a specificity of 69%. The positive and negative predictive value of CPTd > 2°C 
was 23% and 83% respectively. The authors conclude that there is no clinical utility of 
CPTd in the first day after birth for the detection of low blood flow.
Kissack and Weindling evaluated the relationship between physiologic variables, 
under which peripheral temperature, and both peripheral blood flow (PeBF) and 
peripheral fractional oxygen extraction (pFOE) in 24 critically ill VLBW infants within 
12 h of birth (78). PeBF and pFOE were measured with NIRS on the upper part of the 
right forearm using complete venous occlusion technique. Peripheral tem perature was 
significantly related to PeBF (r = 0.52; p = 0.01), but not to pFOE (r = -0.18; p = NS).
Summary
The predictive value of central-peripheral tem perature difference is insufficient to 
be used in the assessment of the hemodynamic status of critically ill newborn infants.
»  ACID-BASE BALANCE
Traditionally, blood gas parameters, like pH and base excess (BE), are used as indirect 
indicators of tissue acidosis in critically ill patients. It is assumed that metabolic acidosis 
assessed by pH and BE reflects tissue hypoxia secondary to inadequate perfusion and/ 
or oxygenation. This is based on the classical Henderson-Hasselbalch approach to acid- 
base balance, where disturbances of this balance are classified as respiratory, when 
there is a change in total carbon dioxide concentration, or as metabolic with an abnormal 
concentration of bicarbonate. However, according Stewart’s theory, the concentration 
of the hydrogen ion (pH) in blood is determined by three independent factors that 
influence the dissociation of water (227). These factors are pC02, total concentration of 
weak acids (buffers, such as albumin and phosphate) and strong ion difference (SID). 
An increase in pC02 and total concentration of weak acids or a decrease in SID will lower 
the pH. The apparent SID (SIDa) can be calculated when blood concentration of sodium, 
potassium, calcium, magnesium and chloride are known.
Equation 1
SIDa = [Na+ ] + [K+ ] + [Ca2+ ] + [Mg2+ ] -  [CT ]
44
The effective SID (SIDe) is the sum of concentration of bicarbonate, phosphate and 
albumin in blood.
Equation 2
SIDe = [HCO~3 ]aLC + [phosphate\ALC + [albumin \ ALC 
Equation 3
R PC0,[nc°-1 =  2.46 X 10-8 X 2
3 aLC 10 - p H
pCO, in mmHg 
Equation 4
[phosphate~ ] = [phosphate~ ] x (pH  -  0.469)
[phosphate] in mmol/L
Equation 5
[ialbumin~\aLC = [a!bum in~]x[0.123xpH -0 .631 )
[albumin] in g/dL
The strong ion gap (SIG) is the difference between apparent SID and effective SID and 
SIG represents the total concentration of unm easured strong ions, including lactate. A 
positive SIG means that the concentration of unmeasured anions is higher than cations, 
which will have an acidic effect. A negative SIG, with a higher concentration unmeasured 
cations than anions, will have a basic effect.
Equation 6
SIG = SID a-SID e
As the calculations related to the Stewart approach (SID, SIG) are relatively complex, 
its use is limited in clinical practice. The anion gap can also be used to determine 
whether there is an excess of unm easured inorganic and organic anions, such as lactate. 
The anion gap (AG) is the measured difference between the major cations and anions 
in blood.
Equation 7
AG = {[Na+] + [K+]}-{[CI-] + [HCO;]}
However, this ‘uncorrected’ AG may be influenced by abnormal albumin, phosphate 
and lactate concentrations. This has led to an alternative equation for the calculation 
of the ‘corrected’ anion gap (AGC), in which the actual albumin, phosphate and lactate 
concentrations are incorporated (228).
Equation 8
AGC = {[iVa+ ] + [K+ ]} -  {[CI~ ] + [HCO~ ]} -  (2 x [Alb]} + (0.5 x [Phos]} -  [Lactate]
[Alb] in g/dL ; [Phos] in mg/dL; [Lactate] in mEq/L
The principles of the Stewart approach have been applied to the calculation of the 
standard base excess (SBE) that can be partitioned into three components. The SBE 
is the resultant of the albumin effect (BEalb), the sodium/chloride effect (BEN CI) and 
unm easured anion effect (BEUMA) (229-231). Unfortunately, different formulas have
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been used to partition the base excess (232). The Taylor method is probably the best to 
be used in critically ill children (230, 232, 233).
Equation 9
SBE = 0.9287 x {[HCO~3 ]aLC -  24.4 +14.83 x {pH -  7.4)}
Equation 10
BEalb = (42 -  [Alb]} x 0.24
[Alb] in g /L  
Equation 11
BENua = [Na~ ] -  [CL ] -  32 
Equation 12
BE = SBE-BE -BE
UMA ALB NaCl
Both the anion gap and SBE will underestimate the contribution of unmeasured 
anions, including lactate, to metabolic acidosis in the presence of hypoalbuminemia. It 
is already known for a long time that the SBE does not accurately reflect tissue hypoxia 
in children (185, 234).
Relation between parameters reflecting acid-base balance 
and systemic blood flow
There is an increasing interest in evaluation of acid-base balance with the Stewart 
approach in children (230-242). Only one abstract has been published to analyze acid- 
base balance in newborn infants using the Stewart approach (243).
Lee et al. performed a prospective cohort study and analyzed acid-base balance in 
26 extreme preterm infants using the Stewart approach (243). The median gestational 
age was 25*6 weeks (range: 23 -  32 weeks) with a median birth weight of 708 grams 
(range: 510-990  grams). A total of 104 blood samples were collected at a postnatal age 
of 0, 24, 48 and 72 hours. Next to standard base excess (SBE) and anion gap (AG), the 
albumin-corrected AG (AGC) and strong ion gap (SIG) were calculated. Tissue acidosis, 
defined as (SIG + [lactate] > 3 mEq/L), was found in 91.3% of the measurements. The 
incidence of hypoalbuminemia (< 25 g/L) in this study population was 100% with in 
50% a value <20 g/L. Tissue acidosis correlated best with AGC and AG with a coefficient 
of determination (r2) of 0.88 (p<0.001) and 0.90 (p<0.0001) respectively. The correlation 
between tissue acidosis and SBE was weak (r2 0.25, p<0.0001). The area under the ROC 
curve for prediction of tissue acidosis was 0.64 (95% Cl: 0.51 to 0.76) for SBE, 0.59 
(95% Cl: 0.47 to 0.70) for lactate, 0.84 (95% Cl: 0.75 to 0.94) for AG and 0.83 (95% Cl: 
0.74 to 0.93) for AGC (232).
Simma et al. performed a prospective, observational study to determine whether 
cardiac output changes after volume replacement is related to an altered stroke volume 
or heart rate in 12 newborns with systemic hypotension (141). Hypotension was 
defined as an invasively measured blood pressure less than the 10th centile related to age 
and weight. Median gestational age was 38 weeks (range: 35-41 weeks) with a median 
birth weight of 2690 grams (range: 1980-3850 grams). Next to several hemodynamic 
parameters, they also measured pH and SBE before and after volume expansion with 20
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mL/kg Ringer’s lactate or 5% plasma protein within 60 minutes. Both pH and SBE did 
not change after volume administration in hypotensive patients (pH 7.39, range: 7.20 
to 7.53 versus pH 7.40, range 7.22 to 7.50; SBE -2.9, range: -8.4 to +8.0 versus BE -2.7, 
range: -8.6 to +7.5).
In a prospective, observational study Deshpande and Ward Platt obtained serial 
arterial acid-base status and lactate concentrations in 75 critically ill newborn infants 
with a median gestational age of 29 (range: 23 to 40) weeks and a median birth weight 
of 1340 (range: 550 to 4080) grams (184). A total of 278 paired measurements were 
studied. No correlation was found between pH, base excess, bicarbonate concentrations 
and blood lactate concentrations. Neither the lowest pH nor the worst SBE is able to 
discriminate between survivors and non-survivors.
Kluckow and Evans examined the correlation between low superior vena cava flow, 
renal function and early changes in blood potassium concentration in 119 preterm 
infants with a gestational age less than 30 weeks in the first two days of life (168). The 
authors also looked at the relationship between SVC flow values and the averaged arterial 
pH and SBE in the six-hour period before and after echocardiographic assessment of 
SVC flow at a postnatal age of 5 and 24 hours. They observed no correlation between 
SVC flow and pH or SBE.
Summary
pH, SBE and anion gap are poor indicators of circulatory failure. Proper analysis 
of acid base balance disorders requires at least measurement of pH, pC02, albumin, 
sodium, chloride and lactate concentration. Moreover, hypoalbuminemia, which has a 
high prevalence in ELBW infants, will mask an existing tissue acidosis when SBE and/ 
or AG are not corrected for albumin.
»  CENTRAL VENOUS OXYGEN 
SATURATION
The delivery of oxygen to the tissues (D02) is determined by arterial oxygen 
concentration (Ca02) and cardiac output (Q).
Equation 13
DO = Q x CaO
2 2
DO, in mmol/min; Q in L/min; CaO, in mmol/L
The oxygen consumption or oxygen extraction (V02) can be calculated by multiplying 
the arterial-mixed venous oxygen concentration difference (C(a mv,02) with cardiac output 
(Q). Normal oxygen consumption in newborn infants is 5-8 mL/kg/min, while in adults 
it is 3-5 mL/kg/min.
Equation 14
VO = Q x (CaO - CmvO ) = Q x C  0
2 ^  \  2 2 /  ^  (f l-m v ) 2
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VO, in mmol/min; Q in L/min; CaO, in mmol/L; CmvO, in mmol/L
The total oxygen concentration in blood (tcO,) mainly depends on hemoglobin 
concentration (cHb) and oxygen saturation (sO) with just a minor contribution from 
dissolved oxygen (pO J.
Equation 15
tc0 2 = (s0 2 x c H b x 0 .9 8 ) + [p0 2 x 0 .0 0 0 4 ^
tcO, in mmol/L; sO, as gradient; cHb in mmol/L; pO, in kPa
When oxygen delivery and oxygen consumption are known, the fractional oxygen 
extraction (FOE) can be calculated.
Equation 16
VOt CaO -  CmvO.
FOE------L-------1----------2-
DO CaO
2 2
FOE as gradient; VO, in mmol/min; DO, in mmol/min; CaO, in m m ol/L; CmvO, in m mol/L
The functional oxygen reserve (FOR) is the amount of oxygen that is transported in 
the blood in excess of the actual need of oxygen in the tissues. This is also known as the 
oxygen excess factor, or omega (XI).
Equation 17
FOR = 1 -  FOE
FOR as gradient; FOE as gradient
Because the contribution of p 0 2 to the total oxygen concentration can be neglected 
V02 can also be calculated as:
Equation 18
V02 = Q x  cHb x 0 .9 8  x [sa 0 2 -  Smv0 2 j
VO, in mmol/min; Q in L/min; cHb in mmol/L; SaO, in gradient; SmvO, in gradient 
This means that mixed venous oxygen saturation can be expressed as:
Equation 19
VO,
SmvO = S a O ------- 1------ -------- r
Qx^cHbx 0 .9 8 ]
VO, in mmol/min; Q in L/min; cHb in mmol/L; SaO, in gradient; SmvO, in gradient
This equation shows that mixed venous oxygen saturation (Smv02) is related to 
arterial oxygen saturation (Sa02), oxygen consumption (V02), cardiac output (Q) and 
hemoglobin concentration (cHb). The mixed venous oxygen saturation is correlated 
to the mixed venous oxygen content, which accounts for about 50% of the total body 
oxygen content (244). There is no linear relationship between cardiac output and 
mixed venous oxygen saturation, which implies that a relative change in Smv02 is not 
equivalent to a similar change in cardiac output (245).
Mixed venous oxygen saturation reflects the adequacy of global tissue oxygenation, 
because itrepresents the oxygen reserve after tissue oxygen extraction (246). A decrease 
in mixed venous oxygen saturation indicates either an increase in oxygen consumption
48
or a decrease in cardiac output, provided that the arterial oxygen saturation and blood 
hemoglobin concentration remain constant. This change in venous oxygen saturation 
precedes an eventually increase in lactate.
An overview of possible cause of changes in venous oxygen concentration is shown 
in Table 6.
Table 6. Causes of changes in venous oxygen saturation
Decreased Sv02 Increased Sv02
Increased oxygen consumption Decreased oxygen consumption
- stress, pain, agitation - sedation, analgesia, anesthesia
- fever, shivering - muscle relaxation
- increased metabolic demand (sepsis) - hypothermia
- seizures - mechanical ventilation
Decreased oxygen delivery Increased oxygen delivery
- decreased cardiac output - blood transfusion
- anemia, hemorrhage - increased cardiac output
- hypoxia Decreased oxygen extraction
- respiratory failure - microcirculatory shunting (sepsis)
- right-to-left shunting - cell death
Mixed venous versus central venous oxygen saturation
The site of sampling, the presence of a left-to-right shunt and the level of arterial oxygen 
saturation influence the absolute value of venous oxygen saturation. The common 
pulmonary artery is in theory the m ost optimal site for mixed venous blood sampling, 
but this is not feasible in newborn infants. It is, however, fairly easy to sample central 
venous blood from the right atrium  at the conjunction with the inferior or superior vena 
cava. Right atrial blood originates from the inferior vena cava (IVC), superior vena cava 
(SVC) and coronary sinus (CS). Oxygen concentration in the right atrium  is a resultant 
of the oxygen delivery via the SVC, IVC and CS, which depends on blood flow through the 
respective vascular beds. Several studies addressed the question about the agreement 
between mixed venous and central venous oxygen saturation. In general, sITC0 2 > sSTC0 2 > 
scs0 2. There is no standard difference between mixed venous and central venous oxygen 
saturation, since this difference is inversely correlated with the level of cardiac output 
and oxygen delivery and influenced by redistribution phenomena.
Under normal physiologic circumstances inferior vena cava oxygen saturation (SITC0 2) 
is on average 6% higher than superior vena cava oxygen saturation (Ssvc0 2), because 
the inferior vena cava returns the blood mainly from the renal and hepatic vascular 
bed, which are high blood flow, low oxygen extraction organ systems (247). In healthy 
adults Ssvc0 2 is 2-3% lower than mixed venous oxygen saturation (247, 248). During 
shock there is a reversal of the relation between Ssvc0 2 and Smv02 with the latter being 
5-18% lower in adults (248, 249). In septic shock this is caused by increased intestinal 
oxygen consumption without compensatory increase in oxygen delivery. Redistributive 
phenomena in cardiogenic and hypovolemic shock will impede flow to mesenteric,
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renal and splanchnic vascular beds with a resultant increased oxygen extraction and 
subsequent decreased SITC0 2 (248,249). This means that during shock the mixed venous 
oxygen saturation is overestimated by Ssvc0 2 and underestim ated by SITC0 2 (250). The 
normal relationship between Smv02 and Ssvc0 2 is altered by general anesthesia. Due 
to a decrease in cerebral oxygen consumption and extraction Ssvc0 2 is equivalent to or 
slightly higher than Smv02 (247, 251). One should be cautious with the interpretation 
of the absolute values of central venous oxygen saturation in critically ill children. Trend 
monitoring of Scv02 is possibly more informative than individual absolute values, as has 
been proven in adult patients (252).
The relationship between mixed venous and central venous oxygen saturation 
is analyzed extensively in animal and adult studies (248, 252). There are only a few 
pediatric studies that examined the agreement between Smv02 and Scv02 (247, 251, 
253).
Whyte mentioned that in children and young adults, in absence of a left-to-right 
shunt, right atrial oxygen saturation is slightly higher than the oxygen saturation 
in the common pulmonary artery with a mean difference of 0.7% (95%-CI: -0.9% to 
-0.5%) (244). No significant difference was observed between the oxygen saturation 
in the superior vena cava or right ventricle and the common pulmonary artery with a 
mean difference of 0.2% (95%-CI: -0.1% to +0.5%) and 0.1% (95%-CI: -0.1% to +0.3%) 
respectively.
Thayssen et al. found a difference in relationship between Smv02 and Scv02 in children 
under general and local anesthesia (251). A significant correlation was observed 
between Smv02 and Ssvc0 2 (r = 0.90; p<0.001) and SITC0 2 (r = 0.57; p<0.005). Under 
general anesthesia the mean (±SD) Smv02, Ssvc0 2 and SITC0 2 was 83.0% (±4.0%), 87.2% 
(±3.9%) and 74.4% (±6.6%) respectively, while during local anesthesia these values 
were 75.9 (±3.5%), 73.8% (±4.1%) and 79.3% (5.7%) respectively. In children under 
general anesthesia the relation could be described as Smv02= -0.85 + 0.81 x Ssvc0 2 + 0.18 
xSITC0 2; for children during local anesthesia the formula was Smv02= 10.21 + 0.52 xSsvc0 2 
+ 0.34 x SIVC0 2.
The use of superior vena cava blood samples was evaluated in 15 children recovering 
from open heart surgery (247). Mean (±SD) age was 11 (±15) months with a mean 
weight of 6.2 (±3.4) kg. Simultaneous m easurements of Smv02 (via pulmonary artery 
catheter) and Ssvc0 2 were done in the PICU during the first 4 postoperative days, with the 
patients in a hemodynamic stable condition. The Smv02 and Ssvc0 2 changed significantly 
during the study period with the lowest values in the immediate postoperative phase. In 
the subsequent days Smv02 and Ssvc0 2 increased and stabilized within the normal range 
by the 3rd postoperative day. Smv02 exceeded Ssvc0 2 in 77% of the blood samples. The 
mean difference between Smv02 and Ssvc0 2 was highest immediately after the operation 
and decreased significantly during the following days (17.0 ± 12,9%, 6.6 ± 8.1%, 7.8 ± 
8.4%, 5.5 ± 8.4% and 2.7 ± 7.3% on day 0,1, 2, 3 and 4 postoperatively respectively). 
This large difference between Smv02 and Ssvc0 2 in the immediate postoperative 
phase could be caused by different mechanisms, like residual left-to-right shunts and 
decreased cerebral oxygen delivery secondary to low cardiac output state or cerebral 
vasoconstriction due to respiratory alkalosis.
Pérez et al. determ ined the agreem ent between venous oxygen saturation in the right 
atrium and in the pulmonary artery in 30 critically ill children with a mean (±SD) age of 
9.5 (±5.3) years (253). The median Scv02 was significantly higher than Smv02 in the total
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study population (83 versus 81%; p = 0.0003). Analysis of two subgroups with different 
diagnosis (shocked and postoperative patients) revealed only a significant difference 
in the shocked group (80.5% versus 77.5%; p = 0.0001) and not in the postoperative 
group. Bland and Altman analysis showed a mean bias of 2% with limits of agreement of 
-6.9% to 10.9%. It was found that changes in Scv02 reflected changes in Smv02, although 
different in magnitude. In 79% of the times the difference in Scv02 and Smv02 was in 
the range of ±l%-5%. As expected this difference was larger in the shocked patients in 
comparison with the postoperative patients (3% versus 0.5%).
Normal values of venous oxygen saturation in newborn infants
O’Connor and Hall measured oxygenation param eters in 18 critically ill, but 
hemodynamic stable newborn infants (246). The mean birth weight was 2.3 kg (range: 
0.6-3.8 kg). Blood was sampled simultaneously from an umbilical arterial catheter with 
the tip positioned at the level of 6,h -10,h thoracic vertebra and via a venous umbilical 
catheter with the tip positioned in the right atrium. A total of 100 paired arterial and 
venous blood samples were analyzed. In the right atrium a mean (±SD) venous oxygen 
saturation of 83.3(± 4.7)% was found. In this population the mean (±SD) arterial-venous 
oxygen concentration difference and mean (±SD) fractional oxygen extraction was 3.0 
(±1.2) mL/dL and 0.16 (±0.05) respectively. As expected, Sv02 correlated very poorly 
with Sa02 (r2 0.02). The relation between Sv02 and arterial-venous oxygen concentration 
difference or fractional oxygen extraction was good (r2 = 0.59 a n d r2 = 0.72 respectively).
Schulze et al measured the effect of two different target ranges of Sa02 (91%-94% 
versus 95%-98%) on several param eters of oxygenation in 20 preterm  infants with 
a mean (±SD) gestational age of 28.7 (±2.7) weeks with a mean birth weight of 1192 
(±396) grams (254). Central venous oxygen saturation was measured (ScvO;11) in a 
subgroup of 14 infants via an umbilical catheter with the tip positioned in the right 
atrium. Moreover, mixed venous oxygen saturation was also calculated (SmvO/1') 
from measured cardiac output by echocardiography, arterial oxygen content by co­
oximetry and oxygen consumption by indirect calorimetry. There was a 6% decrease in 
arterial oxygen content in the lower targeting Sp02 group (16.9 ± 2.51 mL/dL versus 
18.0 ± 2.56 mL/dL; p < 0.001). This did not lead to an increased cardiac output as a 
compensation mechanism (253 ± 44 m L/kg/m in versus 263 ± 52 m L/kg/m in) and the 
m easured oxygen consumption was also not changed (7.64 ± 1.2 m L/kg/m in versus 
7.59 ± 1.5 mL/kg/min). As a consequence there was a significant decrease in ScvO/""" 
(79.6 ± 7.5% versus 87.9 ± 4.8 %; p < 0.001) due to an increased oxygen extraction ratio 
(0.190 ± 0.060 versus 0.169 ± 0.055; p = 0.005). There was a mean difference of 8.2% 
±4.1% between ScvO/""" and SmvO;1'. This is explained by incomplete mixing in the 
right atrium  with less desaturated blood from the coronary sinus, leading to a higher 
value of Scv02meas.
Central venous oxygen saturation was measured in 10 preterm  infants breathing 
room air after the initial phase of respiratory distress syndrome via an umbilical venous 
catheter with the tip positioned in the right atrium  by van der Hoeven and co-workers 
(255). The mean gestational age was 27.0 (±1.3) weeks with a mean birth weight of 
938 (±246) grams. The mean Scv02 was 73.6 (±5.3)% with a range of 60.1% - 83.5% 
(lowest 5,h and highest 95,h percentile) with hemoglobin concentration >7.0  mmol/L 
and Sa02 > 86%. They also obtained values for fractional oxygen extraction (FOE) and 
shunt index. FOE was calculated as (Sa02-Scv02)/S a0 2 and a mean value of 0.21 (±0.04)
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was observed. A good relationship was found between Scv02 and FOE.
To avoid potentially dangerous cannulation of the right atrium or the influence of 
a potential left-to-right atrial shunt Plotz et al examined the feasibility of Scv02 
measurements in the inferior vena cava via an umbilical catheter in 22 newborn infants 
with a mean (±SEM) gestational age of 33 (±2) weeks and a mean birth weight of 2235 
(±195) grams (256). Fifty paired arterial and central venous blood samples were 
analyzed and oxygen content, arterial-venous oxygen content difference and oxygen 
extraction ratio were calculated. A poor correlation was found between Sa02 and C 0 2 
(r = -0.057) and Sa02 and OER (r = -0.139). The correlation between SITC0 2and C(av)0 2 and 
SITC0 2 and OER was better (r = -0.634 and -0.712 respectively). In this study population 
a mean (±SEM) SITC0 2 of 88.4% ± 0.8% was found with mean central venous oxygen 
content of 17.6 (±0.4) mL/dL.
Relation between venous oxygen saturation and systemic 
blood flow
Hart et al. performed a prospective cohort study in 17 newborn infants to determine 
whether Scv02, sampled from the inferior vena cava via an umbilical catheter, or lower 
body fractional oxygen extraction (FOE) could detect cardiac failure (221). Mean 
gestational age and birth weight (range) was 26*6 weeks (23 : -  42 1 weeks) and 875 
grams (400 -  3425 grams) respectively. Superior vena cava (SVC) flow was assessed at 
a postnatal age < 12,12-24 and > 24 hours. No correlation was found between SVC flow 
and Scv02 or between SVC flow and FOE. No significant difference was found in mean 
Scv02 between groups with normal SVC flow and low SVC flow (81.3±11.4% versus 
79.2±9.5%). The mean (±SD) values of Scv02 at a postnatal age of <12h, 12-24h and 
>24h were 84.9% (±5.0%), 77.6 (±9.2%) and 81.7 (±12.9%) respectively.
Implementation of the 2002 American College of Critical Care Medicine Clinical 
Guidelines for Hemodynamic Support of Neonates and Children with Septic Shock 
(ACCM/PALS) has been associated with an improved outcome (95,257-259). According 
to these guidelines intensive care unit hemodynamic support should aim at a central 
venous oxygen saturation >70% and a cardiac index 3.3-6.0 L /m in/m 2. de Oliveira et 
al. evaluated the contribution of the use of the endpoint of a Scv02 >70% as part of the 
ACCM/PALS guidelines and showed a significant and additive impact on the outcome of 
children and adolescents with septic shock (260).
Summary
Mixed venous oxygen saturation reflects the adequacy of global tissue oxygenation, 
as it represents the oxygen reserve after tissue oxygen extraction. The level of Smv02 
depends on arterial oxygen concentration, oxygen consumption, cardiac output and 
hemoglobin concentration. The common pulmonary artery is in theory the most 
optimal site for mixed venous blood sampling, but this is not feasible in newborn 
infants. However, it is fairly easy to sample central venous blood from the right atrium 
at the junction with the inferior or superior vena cava. Absolute values of central venous 
oxygen saturation and mixed venous oxygen saturation are not interchangeable and the 
difference between these two param eters is influenced by the sampling site of central 
venous blood, the presence of left-to-right shunts, incomplete mixing of venous blood, 
redistribution of blood flow through upper and lower body, level of consciousness
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(anesthesia) and myocardial oxygen consumption. During shock Sscv0 2 overestimates 
Smv02, while SIVC02 will give an underestimation. Changes in central venous oxygen 
saturation are more informative, since these parallel changes in mixed venous oxygen 
saturation. Venous oxygen saturation reflects global tissue oxygenation, so a normal 
value cannot exclude dysoxia in individual organs. Moreover, in the presence of multiple 
peripheral shunts the oxygen extraction will be decreased with relatively increased 
venous oxygen saturation as a result. Some evidence is available that implementation 
of goal directed therapy, under which aiming at a Scv02 >70%, improves outcome of 
pediatric septic shock.
»  COLOR
The adequacy of peripheral perfusion an d / or oxygenation is often evaluated by clinical 
assessm ent of the color of the patient. One should realize, however, that an infant’s 
color is influenced by many factors, such as oxygenation, hemoglobin concentration, 
skin tem perature, skin thickness, peripheral perfusion, race, gestational age, ambient 
tem perature and light. The determination of the color of newborn infants has been 
proven to be very subjective with large interobserver variability (261, 262). De Felice 
reported that objective skin colorimetry by dermatologists during the first 24 hours 
after birth can predict initial clinical severity and adverse outcome in white newborn 
infants, admitted to a third level NICU (mean GA 35.1 ± 4.0 weeks; mean BW 2 380 ±960 
g) (263). No data are available about a possible association between skin colorimetry 
and systemic blood flow or pressure.
»  COMBINATION OF DIFFERENT 
CLINICAL HEMODYNAMIC VARIABLES
Because an instantaneous interpretation of a single hemodynamic param eter has its 
shortcomings in the prediction of actual systemic blood flow, it will be plausible that a 
combination of different hemodynamic variables can improve the predictive value for 
the clinical detection of circulatory failure in the critically ill newborn.
Tibby et al. performed a prospective observational study to evaluate the clinician’s 
ability to estimate cardiac performance in critically ill children based on the 
interpretation of routine clinical and biochemical hemodynamic variables, such as heart 
rate, blood pressure, urine output, capillary refill time, blood lactate concentration, 
blood gas analysis et cetera (264). Cardiac output was measured by transpulm onary 
thermodilution (TPTD) in 36 patients with a median age of 34.5 months and median 
weight of 12.9 kg. Most patients had undergone cardiac surgery (73%). 27 Clinicians 
made a total of 112 estimates of cardiac index, both categorically (high, high-to-normal, 
normal, low-to-normal, low) and numerically. There was a very poor agreement 
between the clinician’s estimates and the TPTD cardiac index and this inaccuracy was 
-  surprisingly - not influenced by origin of pediatric discipline or level of seniority. Only 
26% of the patients with a true low cardiac output (Cl < 3.0 L /m in/m 2) were clinically 
categorized as such. Respectively 36% and 11% of these patients were classified as 
normal-to-high cardiac output (4.0-4.9 L /m in/m 2) and high cardiac output (> 5 L/m in/
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m ). This study was not designed to analyze the agreement between clinically assessed 
changes in cardiac index and objective changes in TPTD cardiac output.
A prospective, observational study was conducted to compare clinical assessment of 
cardiac output, volume status and systemic vascular resistance (SVR) with the actual 
values measured by transpulmonary thermodilution in 16 post cardiac surgery patients 
(265). The median age was 15 months with a median weight of 9 kg. The clinician was 
asked to estimate the exact value of cardiac index (Cl) and to categorize Cl, SVRI and 
intravascular volume as low, low-to-normal, normal-to-high and high with use of all 
routinely available clinical variables. The clinically estimated Cl underestim ated CITPTD 
with a mean bias of 0.71 L /m in/m 2 (95% Cl: 0.7 to 1.04) with limits of agreement 
of ± 2.7 L /m in/m 2. Also the agreem ent between invasively m easured SVRI and 
intravascular volume and their clinically assessed estimates was poor. In this study the 
clinicians detected only 45% of the patients in shock (Cl < 3 L /m in/m 2) and 13% of the 
hypovolemic patients.
No equivalent neonatal study has been published, but it seems reasonable to state 
that these findings can be extrapolated to critically ill newborns. One study evaluated 
the relation between global blood flow and individual clinical parameters, such as blood 
pressure, CRT and CPTd, in preterm  neonates and showed the limited accuracy of these 
subjective param eters (76).
It seems obvious that individual clinical assessed hemodynamic variables have a 
limited predictive value in the detection of circulatory failure in critically ill newborn 
infants. There are some studies that show an enhanced predictive value, when clinical 
param eters are used in combination (76, 79).
Nevertheless, clinical assessment of the hemodynamic status of critically ill newborns 
is very valuable, since it can guide professionals to earlier recognition and hence sooner 
initiation of treatm ent of circulatory failure. According to the 2007 update of the 2002 
American College of Critical Care Medicine Clinical Guidelines for Hemodynamic Support 
of Neonates and Children with Septic Shock emergency departm ent therapies should 
be directed towards restoring normal mental status, threshold heart rates, peripheral 
perfusion (CRT <2 sec), palpable distal pulses, and normal blood pressure for age 
(95). The combined interpretation of individual clinical param eters according to these 
ACCM-PALS guidelines and subsequent goal directed therapy has resulted in earlier 
recognition and treatm ent of circulatory failure and reduced mortality in newborns 
and children (257-259). A twofold increase in adjusted mortality odds ratio has been 
observed for every hour with persistent hypotension and a CRT longer than 3 seconds 
(258). The concept of permissive hypotension, in which hypotension is only treated 
when it is associated with clinical markers of circulatory failure seems promising, but 
requires further evaluation by randomized controlled studies. This concept stresses, 
however, the importance of evaluation of signs and symptoms of neonatal circulatory 
failure. Effort should be put into the development of a standardized neonatal clinical 
hemodynamic scoring system, in which ideally systemic blood flow m easurem ent is 
incorporated.
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»  CONCLUSIONS
The incidence of low blood pressure varies approximately around 50% in critically 
ill newborn infants and the timing of initiation of cardiovascular support is mainly 
determ ined by the development of hypotension. This implies that patients with 
compensated low systemic blood flow, and therefore normal blood pressure, will be 
missed with this pressure-based approach. Low systemic blood flow has been found 
in 35% of preterm  infants born before 30 weeks gestation (14, 76). Most clinical signs 
and symptoms of circulatory failure, like capillary refill time, urine output, central- 
peripheral tem perature difference and color, are rather subjective with a questionable 
reproducibility. The predictive values of individual indicators of compromised systemic 
perfusion are limited, as can be observed in Table 7, in which available and published 
data are summarized for blood pressure, renal function, capillary refill time, blood 
lactate concentration and central-peripheral tem perature difference. The disappointing 
predictive values of individual clinical markers mean that only a small portion of 
newborns with low systemic blood flow will be identified (sensitivity and positive 
predictive value), while a large percentage will falsely be classified as low cardiac output 
(specificity and negative predictive value). Despite concerns about its accuracy, clinical 
assessm ent is the most widely used m ethod of hemodynamic monitoring in critically 
ill newborn infants. Since systemic blood pressure, one of the inaccurate markers of 
tissue malperfusion, is generally the param eter to guide cardiovascular therapy, many 
neonates will be under- and overtreated. It should be realized that this consequently 
increases the risk of iatrogenic injury, because treatm ent of neonatal hypotension is 
potentially harmful.
The predictive value of clinical indicators of systemic blood flow may increase when 
they are used in combination or when they are interpreted as dynamic variables. 
The variation in time (trend monitoring) might possibly be more informative than 
individual, static values of clinical and biochemical param eters to evaluate the adequacy 
of neonatal hemodynamics.
There is evidence that clinical param eters can be used to stratify newborns in potential 
risk groups. Patients with low blood pressure in combination with signs of impaired end 
organ perfusion (prolonged CRT, decreased urine output, metabolic acidosis et cetera) 
are a t risk for adverse outcome in contrast to hypotensive newborns without symptoms 
who appear to have the same outcome as normotensive neonates (8, 56).
Scientific effort should be directed towards the development, validation and 
implementation of methods of systemic blood flow measurement, because this will 
provide the clinician with more objective information about oxygen delivery. Knowledge 
of the actual cardiac output likely improves the indication and choice of subsequent 
cardiovascular support. Moreover, the response to the therapeutic intervention can be 
monitored and evaluated. Cardiac output m easurem ent will only provide information 
on global blood flow and clinical signs and symptoms, such as urine output and blood 
lactate concentration, will provide invaluable additional information for the estimation 
of regional perfusion.
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Table 7. Oveiview o f predictive values o f different clinical hemodynamic variables.
% %cr a>
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INTRODUCTION
It  is well known that clinical assessm ent of cardiac output using indirect param eters of systemic blood flow is inaccurate, irrespective of the level of experience of the clinicians (1-3). Objective cardiac output monitoring may be beneficial for the 
patient and reduce morbidity and mortality. Low cardiac output is associated with an 
increased mortality in children (4) and any delay in the diagnostic process of pediatric- 
neonatal shock increases mortality (5). Low systemic blood flow in preterm  infants is 
associated with increased risk of periventricular/intraventricular hemorrhage (6-9), 
reduced urine output with subsequent hyperkalemia (10), compromised EEG activity 
(11), mortality and impaired neurodevelopmental outcome (12, 13). It is therefore 
plausible to prevent the risks of low systemic blood flow by monitoring cardiac output 
in critically ill neonates.
Several indications for cardiac output monitoring are suggested, like congenital 
and acquired heart defects, shock states, multiple organ failure, cardiorespiratory 
interactions, improved understanding of disease states, and assessm ent of novel 
therapies (14,15).
Shephard defined the ideal characteristics of any method of hemodynamic monitoring 
(16). These characteristics are: accurate, reproducible, rapid response, operator 
independent, easily applied use, non-invasive (no additional morbidity or mortality), 
continuous use, and cost effective.
Prior to clinical application all methods of cardiac output monitoring should be 
validated by comparison with a reference method, that is generally accepted as a 'gold 
standard’ reference technique, with respect to the intended population. Ideally these 
methods are primarily tested in an animal model equipped with ultrasonic transit time 
flow probes. Blood flow, measured with ultrasonic transit time flow probes, is considered 
to be the 'gold standard’ of cardiac output m easurem ent in animals (17,18). Pulmonary 
artery thermodilution is generally regarded as the clinical standard of cardiac output 
m easurem ent in adults, while in children the oxygen-Fick derived cardiac output 
m easurem ent is often used as standard reference technique, despite significant 
limitations of both methods (18-20). Recently, transpulm onary thermodilution has 
been proposed as the new clinical reference standard for cardiac output measurem ent 
in the pediatric population (21). The agreement between two methods of cardiac output 
m easurem ent should be assessed by Bland-Altman analysis in which the difference 
(bias) between the techniques is plotted against their mean (22, 23). The accuracy is 
expressed as mean bias, while the precision is defined as the limits of agreement (LOA= 
± 1.96 x SD). Critchley and Critchley stated that both accuracy and precision should 
be expressed as percentage instead of absolute values, unless the mean cardiac output 
approximates 5 L/min, which is always the case in newborn infants (23). Bias% is 
defined as mean bias divided by mean cardiac output multiplied by 100%, while error%  
is calculated as 100% x (1.96 x SD)/mean cardiac output. They recommended that an 
error%  up to 30% is clinically acceptable. In smaller patients, however, any method of 
cardiac output m easurem ent with even small absolute values of mean bias and precision 
will result in relatively large bias% and error%, due to the lower range of cardiac output 
in this population.
Many methods of cardiac output monitoring are available, but not all are feasible in
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newborn infants (17,18, 24-29). This limitation is due to technical and size restraints, 
potential toxicity of indicators (lithium, carbon dioxide), risk of fluid overload, difficulties 
in vascular access and the presence of shunts (transitional circulation, congenital heart 
defects). An overview is provided of available methods of cardiac output monitoring 
with special attention to the feasibility in critically ill newborns and their respective 
advantages and limitations.
»  FICK PRINCIPLE
Oxygen Fick (02-Fick)
In 1870 Adolf Eugen Fick stated that the volume of blood flow in a given period equals 
the amount of substance entering the blood stream in the same period divided by the 
difference in concentrations of the substrate upstream respectively downstream to the 
point of entry in the circulation (30).
If the substance is oxygen, it is assumed that during steady state the pulmonary oxygen 
uptake equals the oxygen consumption in the tissues. Cardiac output (pulmonary blood 
flow) can be calculated by dividing the pulmonary oxygen uptake by the arteriovenous 
oxygen concentration difference.
Equation 1
VOi
Q ----------- --------
(Ca02 - Cmv02)
Q= cardiac output (mL/min); V02 = pulmonary oxygen uptake (mL/min); Ca02 = arterial oxygen concentration 
(mL/mL); Cmv02 = mixed venous oxygen concentration (mL/mL)
Whole body oxygen uptake can be m easured with a Douglas bag, spirometry, mass 
spectrometry, or metabolic monitor (indirect calorimetry). The oxygen consumption 
can also be assumed with use of the Krovetz-Goldbloom formula (Equation 2) or 
LaFarge-Miettinen formula (Equation 3) (31, 32).
Equation 2
(1.39 x height + 0.84 x weight -  3.56)
2 ~ BSA
V02 = oxygen consumption (m L/m in/m 2); height in cm; weight in kg; BSA = body surface area (m2)
Equation 3
V02 = (138.1-17.04 xln(age) + 0.378 x HR) fo r  females  
70, = (138.1 -11.49 x ln(age) + 0.378 x HR) fo r  males
V02 = oxygen consumption (m L/m in/m 2); age in years; HR = heart rate (bpm)
However, the assumption instead of the m easurem ent of oxygen consumption will 
introduce considerable errors in the calculation of cardiac output, in a range of more 
than 50% (33-36). The magnitude of discrepancy between calculated and measured 
is dependent on temperature, ventilatory manipulation and use of inotropes and
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vasoactive drugs (36-38). Whole body oxygen consumption is not interchangeable with 
systemic oxygen consumption, since it also includes pulmonary oxygen consumption. 
Pulmonary oxygen consumption, which is part of whole body oxygen consumption, is 
increased in low birth weight infants with lung injury (39). This enhanced pulmonary 
oxygen consumption will result in an overestimation of cardiac output.
The oxygen concentration in arterial and venous blood can be calculated, when the 
hemoglobin concentration, oxygen saturation, and partial pressure of oxygen are known.
Equation 4
cO, ={cHb-sO, -0.98)+ (p0, -0.01)
c02 = oxygen concentration in blood (mmol/L); cHb = hemoglobin concentration (mmol/L); s03 = oxygen satu­
ration (gradient); 0.98 = oxygen binding capacity o f  hemoglobin (mmol 02/mmolHb); p0 2 = partial pressure o f  
oxygen (kPa); 0.01 = solubility coefficient o f  oxygen (mmol/L/kPa)
The Fick principle was used only in animal studies for m easurem ent of cardiac output 
until the 1930’s, because of the inability of mixed venous blood sampling in humans 
(40,41). In 1930 the first results were published of cardiac output m easurem ent in man 
by Klein (42). This had not been possible without the pioneering work of Forssman, 
who described a method of mixed venous blood sampling, that he had practiced on 
himself (43).
The direct oxygen Fick method is regarded the gold standard in cardiac output 
monitoring, despite several disadvantages. Many pediatric validation studies ofmethods 
of cardiac output monitoring have used the direct oxygen Fick method (44-48).
The advantages and limitations of the oxygen Fick method for cardiac output 
m easurem ent are summarized in Table 1.
Table 1 . Advantages and limitations of the O Fick method
Advantages
Accurate ('gold standard’), when performed correctly; most accurate in low flow 
state (larger substrate concentration difference)
Limitations
Technically challenging; only reliable during steady state; mixed venous blood 
sample required; withdrawal of blood necessary; co-oximetry needed for accurate 
calculation of oxygen content; accuracy limited by: presence of endotracheal tube 
leakage or pneumothorax, cardiopulmonary disease, FiO, >0.50 (unless mass spec­
trom etry is used) (49), high flow state (smaller substrate concentration difference); 
enhanced pulmonary oxygen consumption (for example in preterm  infants with 
chronic lung disease); affected by intra- and extracardiac shunts; not easily repeat- 
able; 'side-stream' capnography should be avoided; no continuous cardiac output 
monitoring
Carbon dioxide Fick (C02-Fick)
The Fick principle can also be applied to the balance between pulmonary carbon 
dioxide exchange and carbon dioxide production in the tissues. The advantage of using 
carbon dioxide as an indicator is that carbon dioxide exchange is easier to measure 
accurately than oxygen consumption. C02-Fick methods appear to be as accurate as 0 2- 
Fick methods (50-52). During steady state cardiac output can be calculated by dividing
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pulmonary carbon dioxide exchange by the veno-arterial carbon dioxide concentration 
difference.
Equation 5
vco,
Q --------------------CmvC02 -  CaC02
Q= cardiac output (mL/min); VC02 = pulmonary carbon dioxide exchange (mL/min); CmvC02 = mixed venous 
carbon dioxide concentration (mL/mL); CaC02 = arterial carbon dioxide concentration (mL/mL)
Pulmonary carbon dioxide exchange can be assessed with a Douglas bag, spirometer, 
metabolic monitor or integrated capnography and expiratory flow measurement.
Carbon dioxide re-breathing technology (C O ft)
A partial rebreathing technique has been introduced to eliminate the need to directly 
measure mixed venous carbon dioxide concentration, which is relatively difficult. With 
the carbon dioxide rebreathing technique, a change in carbon dioxide exchange and 
associated change in arterial carbon dioxide concentration in response to a change in 
ventilation (end-expiratory hold or addition of dead space) are used in the Fick equation 
(Equation 6-8) (53).
Equation 6
VCOn VCOr
Q =----------- ±-------- =------------±--------
CmvCOji-CaCOji CmvC02r-CaC 02r
Q= cardiac output; VCO = pulmonary carbon dioxide exchange; CmvC02 = mixed venous carbon dioxide concen­
tration; CaC02 = arterial carbon dioxide concentration; n = normal situation; r = rebreathing
During the m easurem ent period pulmonary blood flow is considered to be 
stable. It is assumed that CmvC02 does not change significantly throughout the 
period of rebreathing and non-rebreathing, because of the high diffusion capacity 
of carbon dioxide, the relatively large size of carbon dioxide body stores and slow 
time constants of the carbon dioxide stores relative to the time of rebreathing.
Equation 7
CmvCOji = CmvC02r
CmvC02 = mixed venous carbon dioxide concentration; n = normal situation; r = rebreathing 
Equation 8
VCOn-VCOr delta VCO,
Q = ----------------------- ---------- -------------------- = ------------- —
(iCmvC02n -  CaC02n) -  (CmvC02r  -  CaC02r ) deltaCaC02
Q= cardiac output; VC02 = pulmonary carbon dioxide exchange; CmvC02 = mixed venous carbon dioxide con­
centration; CaC02 = arterial carbon dioxide concentration; n = normal situation; r = rebreathing; delta VC02 = 
change in pulmonary carbon dioxide exchange; delta CaC02 = change in arterial carbon dioxide concentration
The m easured value of cardiac output is merely that part of pulmonary blood flow 
that participates in pulmonary gas exchange, which is the non-shunted blood flow or 
pulmonary capillary blood flow. To estimate true cardiac output a correction for shunt 
flow is made.
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Q = Q +Q
^  ^P C B F  ^  SHUNT
Q= cardiac output; <JpcBF = pulmonary capillary blood flow ; = intrapulmonary shunt flow
However, not ACaC02 is m easured in clinical practice, but ApC02 at the endotracheal 
tube, assuming equivalence between endotracheal ApC02, alveolar ApC02 and arterial 
CaC02. This may result in erroneous calculation of cardiac output, for example in children 
with large dead space ventilation and /o r acidosis (54).
Partial carbon dioxide rebreathing with the NICO1 system (Philips Respironics, Pitts­
burgh, Pennsylvania, USA) is not feasible in small children (<15 kg) due to the dead 
space of the rebreathing valve (32 mL) and an imposed tidal volume of at least 200 
mL. Another concern about the application of the rebreathing technology to calculate 
cardiac output in newborn, and especially preterm  infants, is the possible fluctuation 
in PaC02 during periods of measurement. It is known from studies about permissive 
hypercapnia that extreme high and low PaC02 values as well as large fluctuations in 
PaC02 are associated with an increased risk of neuromorbidity (intraventricular 
hemorrhage, impaired neurodevelopmental outcome) (55, 56). It is advised not to use 
the NICO system in patients who are susceptible to a change in PaC02 up to several 
mmHg, such as in children with severe hypercapnia, pulmonary hypertension, or raised 
intracranial pressure (57).
The advantages and limitations of the carbon dioxide rebreathing technique for car­
diac output m easurem ent are summarized in Table 2.
Table 2 . Advantages and limitations of the C02 rebreathing technology
Equation 9
Advantages
Easy to use; non-invasive; semi-continuous
Limitations
Not feasible in children < 15 kg; not accurate in children with BSA < 0.6 m 2 and 
tidal volume < 300 mL (58); only applicable in intubated patients; contraindicated 
in patients who are susceptible to injury due to fluctuating PaC02, such as preterm  
infants and patients after traumatic brain injury; accuracy influenced by increased 
carbon dioxide production, spontaneous ventilation, and high cardiac output state; 
affected by intrapulmonary shunt
Modified carbon dioxide Fick method (mC02F)
The modified carbon dioxide Fick (mC02F) method is based on the principle that in 
a steady state carbon dioxide production in tissue equals pulmonary carbon dioxide 
exchange. Pulmonary carbon dioxide exchange can be m easured in a ventilated patient 
using a computer-aided analysis of expiratory airflow (Qexp) and carbon dioxide fraction 
in expiratory air (FeCOJ.
Equation 10
T
VC02 ={$QEXp{t\F eC 02{ ty d t } x T ~ 1
0
VC02 = carbon dioxide exchange (L/min); <?Eip = expiratory airflow (L/min); FeC02 = carbon dioxide fraction in 
expiratory air (gradient); T = time (min)
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Carbon dioxide production is the product of cardiac output and the veno-arterial 
difference in carbon dioxide concentration.
Equation 11
C02P = Q-[CvC02-CaC02)
C02P = carbon dioxide production (mL/min); Q = cardiac output (L/min); CvC02 = venous carbon dioxide concen­
tration (mL/L); CaC02 = arterial carbon dioxide concentration (mL/L)
Carbon dioxide concentration in blood can be measured using several methods that 
differ in the calculation of carbon dioxide concentration in the erythrocyte. The Douglas 
equation is assumed to be the most accurate method:
Equation 12
™  r, (0-0289-cHb)c, CO, = c CO, •{ 1 ------------------------------- ------------- }
b 2 p 2 (3.352 -  0.456 • s02 )• (8.142 -  pH)
cbC02= total carbon dioxide concentration in blood (mL/100 mL); cC 02 = total carbon dioxide concentration in 
plasma (m L/100 mL); cHb = hemoglobin concentration (g/dL); s02 = oxygen saturation (gradient)
Total carbon dioxide concentration in plasma is calculated with the use of the 
Henderson-Hasselbalch equation:
Equation 13
c C 0 2 = 2.226 • s • pC02 ■ (1 + 10pH-pK')
cC 02 = total carbon dioxide concentration in plasma (mL/100 mL); 2.226 = conversion factor mEq to mL/100  
mL; s = solubility coefficient o f carbon dioxide in plasma (mEq/mmHg); pK’= apparent pK; pC02 = partial carbon 
dioxide pressure (mmHg)
Equation 14
s = 0.0307 + 0.00057 • (37-T ) - (37- T )2
s = solubility coefficient o f carbon dioxide in plasma (mEq/mmHg); T = temperature (°C)
Equation 15
pK ' = 6.086 + [0.042• (7.4 -  pH)] + {(38 - T ) - [0.0047 + 0.00139 • (7.4 -  pH)]}
For use in calculations C02P and VC02 need to be converted to 'Standard Temperature 
Pressure, Dry’ (STPD] conditions.
Equation 16
T rpBTPS -  pH 0 )
CO p STPD = CO P BTPS ■ ■ —______
2 2 J ,B T P S  p
0
C02Pstpd = carbon dioxide production under STPD conditions; C02Pbtps = carbon dioxide production under 
BTPS conditions; BTPS = Body Temperature Pressure, Saturated; Tg = standard temperature (273K); TBTPS = 
temperature under BTPS (K); PBTPS = pressure under BTPS conditions (kPa); pH20 = partial pressure o f water 
vapor a t TBTPS (kPa); Pg = standard pressure (101.4 kPa)
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T f PATPS- p H O }
VCOSTPD = VCOATPS ■ — • ------------- 2
2 2 J .A T P S  p
0
VC02stpd = pulmonary carbon dioxide exchange under STPD conditions; VC02 rps = pulmonary carbon dioxide 
exchange under ATPS conditions; ATPS = Ambient Temperature Pressure, Saturated; Tg = standard temperature 
(273K); T'TPS = ambient temperature (K); PiTPS = pressure under ATPS conditions (kPa); pH20 = partial pressure 
o f water vapor a t T'TPS (kPa); Pg = standard pressure (101.4 kPa)
Equation 17
Then, cardiac output can be calculated using the following equation.
Equation 18
{ V C O j TPD
Q — ------ ---------
(C CO )STPD(v-a) 2 J
Q = cardiac output (L/min); (VCOJSTPD = pulmonary carbon dioxide exchange under STPD conditions (mL/min); 
(C a)COJSTPD = veno-arterial difference in carbon dioxide concentration under STPD conditions (mL/L)
The advantages and limitations of the modified carbon dioxide Fick m ethod for 
cardiac output m easurem ent are summarized in Table 3.
Table 3. Advantages and limitations of the modified carbon dioxide Fick method
Advantages
No specific devices required; regular arterial and central venous catheters; reliable 
in the presence of significant left-to-right shunt
Limitations
Steady state required; blood loss due to frequent arterial and central venous blood 
sampling; no continuous cardiac output monitoring; inaccurate in the presence of 
large expiratory endotracheal tube leakage; interpretation of mCO F-derived out­
put in a shunt circulation depends on the position of the shunt in relation to the 
venous and arterial blood sample sites; inaccuracy due to error in the calculation of 
total CO, concentration in arterial and central venous blood
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Validation studies Fick-based cardiac output measurement
Statistical data (accuracy and precision) of cardiac output m easurem ent based on 
the Fick principle from animal (59-64) and human pediatric (57, 58, 65) studies are 
summarized in Tables 4, 5 and 6.
Table 4. Carbon dioxide Fick method; animal studies
Study Comparator Reference Mean bias Precision Error% CO, mean (range)
(L/min) (L/min) (L/min)
Haryadi, 2000 (61)
6 dogs [18.2-39.5 kg) 
246 measurements
C02r PATD -0.07 1.37 27% NA (0.60-8.87)
Maxwell, 2001 (62) 
11 pigs (35-45 kg) 
120 measurements
C02r PATD -0.01 1.35 39% 3.5
Bajorat, 2006 (63) 
6 pigs (26-32 kg) 
366 measurements
C°2r PATD
all data 0.19 1.77 54% 3.25(0.5-7.0)
< 4 L/min -0.51 1.36 55% 2.46 (0.5-4.0)
> 4 L/min 0.45 1.93 39% 4.92 (4.0 - 7.0)
Peyton, 2006 (64) 
6 sheep (35-45 kg)
c° 2f TTPPAAO
all data 0.25 1.84 53% 3.50(0.0-8.67)
stable TTFP“ 0 (5 min) -0.20 1.08 37% 2.94 (1.0-5.94)
de Boode, 2007 (59) 
7 lambs (2.9-64 kg) 
30 measurements
mC02F t t f pmpa -0.082 0.241 31% 0.79 (0.23-1.47)
de Boode, 2009 (60)
8 lambs (4.7-12.5 kg) 
31/30 measurements
mC02F t t f pmpa 0.081 0.531 55% 0.96(0.50-1.55)
CO = cardiac output; C02F= C02 Fick; CO2R = C02 rebreathing; DAo-flow = descending aorta flow; mCO 2F =modified C02 Fick; 
NA = not available; PATD = pulmonary artery thermodilution; T T F P = transit time flow probe ascending aorta; TTFPMPA = 
transit time flow probe main pulmonary artery
Table 5. Oxygen Fick method; pediatric study
Study Comparator Reference Mean bias 
(L/min)
Precision
(L/min)
Error% CO, mean (range) 
(L/min)
Wippermann, 1996 (65) 
N=25 (1 week-17years) 
Cardiac surgery
0 2-Fick,
continuous PATD -0.05 0.32 NA NA
CO = cardiac output; NA = not available; PATD = pulmonary artery thermodilution
Table 6. Carbon dioxide Fick method; pediatiicstudies
Study Comparator Reference Mean bias 
(L/min)
Precision
(L/min)
Error% CO, mean (range) 
(L/min)
Levy, 2004 (58)
N=37 (16 months-12 years; >8 
kg); Heart catheterization
C°2R PATD -0.27 1.49 NA NA
Botte, 2006 (57) 
N=21 (2.9-16.8 years; 
> 15 kg) PICU
C°2R TTE -0.61 1.84 45% 4.06(1.76-7.40)
CO = cardiac output; C02R = C02 rebreathing; NA = not available; PATD = pulmonary artery thermodilution; TTE = transtho- 
racic echocardiography
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Cardiac output m easurem ent based on the Fick principle has not been validated in 
newborn infants. The modified C02-Fick method may be interesting to use in neonates, 
because this method has been shown to be also reliable in the presence of a significant 
left-to-right shunt in a juvenile lamb model (59, 60). Major limitation of this method 
is however, that every m easurem ent requires sampling of arterial and central venous 
blood that will result in an unacceptable blood loss in this population.
»  INDICATOR DILUTION TECHNIQUES
In 1761 Haller reported the use of a colored dye in an attem pt to measure pulmonary 
circulation time in an animal model (66). Stewart adopted this principle of usage of an 
exogenous indicator for m easurem ent of cardiac output, which was further modified 
by Hamilton (67-70). Blood flow can be calculated if the change in concentration of a 
known quantity of injected indicator is measured in time distal to the point of injection, 
so an indicator dilution curve can be obtained.
Cardiac output can then be calculated with the use of the Stewart-Hamilton equation.
Equation 19
Q.  601
Q = blood flow  (L/min); i = injected quantity o f  indicator (mg]; C = concentration o f indicator (mg/L); t = time 
(sec].
The mean indicator concentration can be calculated by determining the area under 
the dilution curve. Cardiac output is inversely proportional to the area under the dilution 
curve. The higher the blood flow, the smaller the area under the dilution curve, i.e. the 
lower the measured indicator concentration.
Several indicators are used, such as indocyanine green, Evans blue and brilliant red in 
dye dilution, cold solutions in thermodilution, lithium in lithium dilution, and isotonic 
saline in ultrasound dilution cardiac output.
Theoretical prerequisites for the application of the indicator dilution method for 
cardiac output m easurements are: fast, instantaneous injection of indicator, small 
indicator volume, fast and complete mixing of indicator and blood, no indicator loss 
between site of injection and detection, no change in blood volume, uniform volume 
flow, no shunting, minimal valve regurgitation, flow of indicator m ust be identical to 
blood flow, blood flow is not influenced by (the volume of) injected indicator, steady 
state, and stable hemodynamics during measurement. General limitations of the 
indicator dilution technology are the lack of indicator stability, inaccuracy in indicator 
m easurem ent and accumulation of indicator.
Dye dilution
The direct and continuous invasive blood sampling through a cuvette for measurem ent 
of indicator (for example indocyanine green) concentration in arterial blood for the 
reconstruction of a dye dilution curve is nowadays only used in a research setting. 
Because of the necessity to withdraw a substantial volume of blood this original technique 
for cardiac output m easurem ent is not feasible in (small) children.
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Pulse dye densitometry
However, a new dye dilution technology has been developed, called pulse dye 
densitometry (PDD). This method is introduced in 1990 to measure cardiac output and 
circulating blood volume (71). After a venous bolus injection of indocyanine green (ICG) 
the arterial concentration of ICG is detected non-invasively via a fingertip sensor by 
analyzing the pulsatile change in ICG concentration. In this way an ICG-concentration- 
time curve is obtained and the cardiac output is subsequently calculated. ICG is 
considered non-toxic, although rare cases of anaphylaxis and allergic reactions have been 
described. Also indigo carmine can be used as an indicator in pulse dye densitometry (72).
PDD has only been validated in adult patients and notin children (73-79). It appeared 
to be very difficult to obtain reliable pulse waveforms from small infants and neonates 
(80). A way in which it was attempted to solve this problem was by the use of an 
additional wavelength (81) and the development of another type of probe (reflection 
type instead of transmission type).
Taguci et al. evaluated the accuracy of PDD using three wavelengths for pediatric 
application to monitor cardiac output in an animal model with an improved probe 
that can be attached to a small patient and at a location closer to the heart (80). In 
this animal model the reflection-type probes provided more accurate cardiac output 
measurements in comparison with transmission-type probes, but this is probably more 
related to the site of application than to the type of the probe. Several points of attention 
are recommended for the application of PDD, namely optimal signal quality by guarding 
the temperature of the probe site, avoid vasoconstriction, avoid excess light at the probe 
site, avoid motion of the patient or probe, check signal quality during the measurement, 
observe the concentration curve for adequacy of fit of the first circulation and adjust the 
interval for back-extrapolation, if necessary (79).
Bergstra et al. analyzed the feasibility of PDD in patients with an intracardiac shunt 
and proved that this non-invasive method is applicable to quantify intracardiac left-to- 
right shunt flows over a wide range in both children and adults with congenital heart 
defects (82).
The advantages and limitations of pulse dye densitometry for cardiac output 
measurement are summarized in Table 7.
Table 7. Advantages and limitations of pulse dye densitometiy
Advantages
Non-invasive cardiac output monitoring; additional information: intravascular 
blood volume; possibly useful in the quantification of intracardiac left-to-right 
shunt(82)
Limitations
Limited repeated measurements; rarely severe side effects described (allergic re­
actions, anaphylaxis) after ICG injection; inaccuracy due to: poor peripheral per­
fusion, motion of probe or patient, and excess light at probe site; no continuous 
cardiac output monitoring
Pulmonary artery thermodilution (PATD)
The method of thermodilution was introduced in 1954 by Fegler (83). He described 
that an injection of a cold fluid (saline or glucose) can be used to obtain an indicator
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dilution curve by measuring the change in blood temperature downstream to the 
site of injection. In order to minimize loss of temperature, Branthwaite described a 
thermistor-tipped pulmonary artery catheter in 1968 (84), that detected the cold 
indicator injected in the right atrium. Swan and Ganz added a small inflatable balloon 
to the tip of the catheter and introduced the flow directed pulmonary artery catheter 
(Swan-Ganz catheter), which has become the most widely used method of cardiac output 
measurement in adult patients (85, 86). The insertion of a flow directed pulmonary 
artery catheter is not feasible in small infants. Despite several sources of error the 
pulmonary artery thermodilution is unfortunately regarded as one of the clinical 'gold 
standards’. Manual intermittent measurements of thermodilution cardiac output with 
the pulmonary artery catheter are nowadays replaced by automatic (continuous) 
measurements, in which intermittently warmed volumes of indicator are injected every 
few seconds and averaged (87, 88).
Gnaegi et al. showed that a rather large percentage of clinicians had insufficient 
knowledge of the interpretation of pulmonary artery catheter derived parameters (89). 
This implies an additional riskof iatrogenic injury due to potentially harmful therapeutic 
interventions based on the assumed results of pulmonary artery thermodilution, next 
to the pulmonary artery catheter related complications.
The advantages and limitations of pulmonary artery thermodilution for cardiac 
output measurement are summarized in Table 8.
Table 8. Advantages and limitations ofpulmonaiy arteiy thennodilution
Advantages
Most widely used method of cardiac output monitoring; additional information pro­
vided: CVP, PAP, PCWP, and SmvO,; continuous cardiac output monitoring possible
Limitations
Highly invasive; several sources of error, for example due to indicator loss and 
structural cardiac abnormalities (19,90, 91); mechanical ventilation influences the 
measurement of cardiac output, especially in hypovolemic patients (92, 93). This 
potential source of error can be minimized by timing measurements in the same 
phase of the respiratory cycle; complications: valvular damage, pulmonary artery 
rupture, pulmonary embolism, and catheter knotting (94-99); less accurate in low 
and high flow states (100); not applicable in the presence of intra- and extracardiac 
shunts; transient decrease in heart rate caused by fast injection of cold saline (in 
approximately 20%  of measurements AHR > 10% ) (101)
To avoid potential complications with the insertion of a pulmonary catheter 
the technique of transpulmonary indicator dilution is developed. For this method 
the indicator is injected into a vein and detected in a systemic artery. Examples of 
transpulmonary indicator dilution methods are lithium dilution, transpulmonary 
thermodilution and ultrasound dilution.
Lithium dilution (LiDCO)
The use of lithium as an indicator to produce a dilution curve was first described 
in 1993 by Linton et al. (102). Advantages of lithium as an indicator are the minimal 
indicator loss during first passage and the rapid redistribution that makes it possible
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to perform multiple measurements (103 ,104). A lithium ion sensitive electrode is used 
to detect the lithium that is intravenously injected in a known quantity via a central 
venous catheter or large bore peripheral cannula. The lithium sensor is attached to 
a peripheral arterial catheter. Blood flows through this sensor at a specific rate (4 
mL/h) with the use of a roller pump. About 3 mL of blood is withdrawn with each 
measurement. A correction is needed for sodium concentration and hematocrit for 
accurate measurement of cardiac output with lithium dilution. Sodium is the main 
determinant of potential difference across the sensor in the absence of lithium and 
therefore determines the base line voltage. As lithium is only distributed in plasma the 
hematocrit is needed for a correct calculation of cardiac output (105). Cardiac output is 
calculated using a modified Stewart-Hamilton equation.
Equation 20
co -------L;x6°-----
AUC x (1 -  Ht)
CO = cardiac output; Li = Lithium dosage (mmol); AUC = area under the lithium concentration/time curve 
(m m ol/l/s); Ht = hematocrit
Lithium dilution can be used to calibrate software for continuous arterial pulse 
contour analysis.
For an average adult the dose of lithium is 0.15 -  0.30 mmol, which has no known 
pharmacological effect (106, 107). The dosage of lithium for LiDCO measurements in 
children is 0.002-0.009 mmol/kg and a total dose of 0.075 mmol/kg should not be 
exceeded (108). There are data that suggest that in adults the injection of lithium via a 
peripheral catheter is as accurate as via a central venous catheter (109).
The advantages and limitations of lithium dilution technology for cardiac output 
measurement are summarized in Table 9.
Table 9. Advantages and limitations of lithium dilution cardiac output measurement
Advantages
Easy and rapid set up; regular arterial and venous catheters can be used; provides 
additional parameters: central blood volume (CBV), pulse pressure variation, stroke 
volume variation; continuous monitoring possible when used to calibrate arterial 
pulse contour analysis (PulseCO®); measurement of cardiac output and shunt frac­
tion (recirculation) during venovenous ECMO possible (110)
Limitations
Non-depolarizing muscle relaxants may interfere with the lithium ion sensitive 
electrode; contraindicated in patients on therapeutic lithium; withdrawal/loss of 
blood (±3 mL per measurement); recalibration needed at least every 8 hours (107); 
unreliable calibration in the presence of a severe hyponatremia; limited repeated 
measurements (lithium injection); too many measurements to close together will 
cause an overestimation of cardiac output; inaccurate in the presence of intra-/ex- 
tracardiac shunts; limitations related to arterial pulse contour analysis (see Table 
29)
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Transpulmonary thermodilution (TPTD)
Isotonic saline (cold or room temperature) is used as an indicator in a volume of 3-5 
mL and injected via a central venous catheter. A thermistor-tipped catheter, positioned 
in the femoral or brachial artery, detects the indicator. Using blood temperature, 
injectate temperature, injectate volume, area under the thermodilution curve and 
a correction factor the actual cardiac output is measured with the use of a modified 
Steward-Hamilton equation, which can subsequently be used to calibrate the software 
for continuous arterial pulse contour analysis. It is advised to avoid a close position of 
the central venous and arterial catheter, for example the femoral vein and artery on the 
same side, because of a so-called "cross-talk phenomenon” (111). This phenomenon 
can be registered as a biphasic thermodilution curve, that is caused by the injection of 
cold isotonic saline via the central venous catheter in close proximity to the thermistor- 
tipped arterial line, especially in a low flow state.
In comparison to pulmonary artery thermodilution there is a longer path length 
between the sites of injection and detection, which implies a higher risk of indicator 
loss, but also less variation in measurements induced by the respiratory cycle. TPTD 
excludes the need for a pulmonary artery catheter with its relatively high complication 
rate. Cardiac output measurement by pulmonary artery thermodilution represents right 
ventricular output, while transpulmonary thermodilution measures left ventricular 
output. In most studies cardiac output measured with TPTD is slightly higher than with 
PATD. This might be caused by loss of indicator with TPTD, reduction in heart rate in 
response to injection of cold indicator leading to decreased cardiac output in the right 
heart compared with the left heart (112) and difference in sensitivity to respiratory 
fluctuation.
The advantages and limitations of transpulmonary thermodilution technology for 
cardiac output measurement are summarized in Table 10.
Table 10. Advantages and limitations oftranspuhnonaiy thennodilution
Advantages
Regarded as 'gold standard’ for pediatric cardiac output measurement (21); easy 
and rapid set-up; ancillary data are provided, like extravascular lung water volume, 
global end-diastolic volume, pulse pressure variation, and stroke volume variation; 
continuous monitoring possible when used to calibrate arterial pulse contour anal­
ysis (PiCCO®); suitable for cardiac output measurement during intra-aortic balloon 
pumping (113).
Limitations
Requires a specific thermistor-tipped catheter; catheterization of the femoral, bra­
chial or axillary artery necessary; repeated injection of cold isotonic saline with risk 
of fluid overload and/ or hypothermia; inaccurate in presence of intra- and extracar­
diac shunts; valvular insufficiency will affect accuracy; enhanced loss of indicator 
due to pulmonary edema resulting in overestimation of cardiac output; possible 
loss of indicator in heterogeneous perfused lungs; repeated calibration required (at 
least every 8 hours) for continuous cardiac output measurement with pulse con­
tour analysis; in critically ill adult patients it is advised to recalibrate every hour 
(114); limitations related to arterial pulse contour analysis (see Table 29).
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Ultrasound Dilution (UDCO)
Ultrasound dilution technology was introduced in 1995 and has been used to measure 
several hemodynamic parameters in patients during hemodialysis (115-119). More 
recently this technique has been adapted for cardiac output measurement and tested 
in vitro(120) and in vivo in animals (121-124), adults (125-127) and infants (123 ,128) 
using isotonic saline as an indicator, that is injected in a low volume extracorporeal 
arteriovenous (AV) tubing loop, that is inserted between an indwelling arterial and 
central venous catheter.
The velocity of ultrasound in blood varies between 1560 and 1585 m /s depending 
on total blood protein, temperature and ion concentration in plasma. In contrast, the 
ultrasound velocity in isotonic saline is only 1533 m/s. Injection of isotonic saline into 
the blood stream will thus lead to a decrease in ultrasound velocity and this phenomenon 
is used to obtain a dilution curve. For placement of flow and dilution sensors on both 
the venous and arterial site of the circulation, an extracorporeal circuit is constructed 
by connecting a disposable arteriovenous (AV) loop in between an arterial and central 
venous catheter. AV loops are available for different patient sizes with a priming volume 
varying from 0.9 to 2.4 mL. Re-usable sensors, that both detect transit time blood flow 
and ultrasound velocity, are clamped on the arterial and venous limbs of the AV loop. A 
peristaltic pump is used to circulate the blood through the AV loop at a speed of 6-12 
mL/min for a period of 5-6 minutes during cardiac output measurements. This pump 
is to prevent a periodically unstable blood flow. Isotonic saline (NaCl 0.9%), heated to 
body temperature, is quickly injected in a volume of 0.5-1.0 mL/kginto the venous limb 
of the AV loop. The venous sensor calculates the exact amount of injected isotonic saline 
automatically and also measures ultrasound velocity of the used saline (120). The 
arterial sensor measures the decrease in ultrasound velocity and an ultrasound dilution 
curve is obtained. With the use of the Stewart-Hamilton principle cardiac output can be 
calculated with the following equation (120).
Equation 21
CO = cardiac output (mL/min); Vinj = volume o f  injected isotonic saline, measured by the venous sensor (mL); 
Ca(t) = concentration o f  injected saline in arterial blood (mL[saline]/mL[blood]); ¡Ca(t)dt = area under dilution 
curve o f  saline concentration in arterial blood, measured by the arterial sensor (mL[saline]/mL [blood] x min)
The interventions that are required for cardiac output measurement (starting and 
stopping blood flow through extracorporeal loop, and fast injection of 0.5-1.0 ml.kg1 
of isotonic saline on body temperature) did not cause clinically relevant changes in 
cerebral and systemic circulation and oxygenation (129).
The advantages and limitations of ultrasound dilution technology for cardiac output 
measurement are summarized in Table 11.
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Table 11. Advantages and limitations ultrasound dilution cardiac output measurement
Advantages
Non-toxic indicator (isotonic saline on body temperature); relative small injection 
volume (0.5-1.0 mL/kg); operator-independent because of automatic calculation of 
injected indicator volume; utilization of regular intravascular catheters; no blood 
loss; re-usable; no calibration required; ancillary data provided; no influence on 
cerebral and systemic oxygenation and circulation in animal model (129)
Limitations
Shunting of blood will produce abnormal dilution curves; repetitive measurements 
will affect fluid balance; possible indicator loss in non-homogeneous perfused 
lungs; use of an extracorporeal loop
Validation studies indicator dilution technology
Statistical data (accuracy and precision) of cardiac output measurement using the 
indicator dilution technology from animal (63, 72, 8 0 ,1 1 3 ,1 2 4 ,1 3 0 -1 3 9 )  and human 
pediatric (46, 4 7 ,1 0 8 ,1 4 0 ) studies are summarized in Tables 12 -18 .
Table 12. Dye dilution technology; animal studies
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Taguchi, 2004 (80) PDD AAo-flow
15 piglets (7.5-14 kg) 
73 measurements Reflection-type probe 0.0034 0.574 NA NA (0 .5 -1 .5 )
Trans miss io n-type probe 0.4698 0.766 NA NA
Fujita, 2004 (72) 
9 dogs
22 measurements
PDD PATD 0.09 1.05 30% NA (1 .99-5 .83)
AAo-flow = ascending aortic flow; CO = cardiac output; NA = 
pulse dye densitometry
not available; PATD = pulmonary artery thermodilution; PDD =
Table 13. Pulmonaiy arteiy thermodilution; animal study
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Bajorat, 2006 (63) PATD DAo-flow
6 pigs (26-32 kg) 
366 measurements all data -0.69 1.58 49% 3 .2 5 (0 .5 -7 .0 )
< 4  L/min -0.52 1.08 44% 2.46 ( 0 .5 -4 .0 )
>4  L/min -1.05 2.1 43% 4.93 (4.0 -  7.0)
CO = cardiac output; NA = not available; PATD =  pulmonary artery thermodilution; DAo-flow = descending aorta flow
Table 14. Lithium dilution technology; animal studies
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Kurita, 1997 (130)
10 swine (10-15.5 kg) 
80 measurements
LiDCO EMFP“ 0 0.11 0.35 NA NA (0.2 -2.8)
CO = cardiac output; E M F P = electromagnetic flow probe ascending aorta; LiDCO = lithium dilution cardiac output; NA = 
not available; PATD = pulmonary artery thermodilution; TTE = transthoracic echocardiography
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Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Corley, 2002 (139) 
Neonatal foals LiDCO PATD 0.05 2.8 NA NA (5 -2 0 )
CO = cardiac output; EMFPMo = electromagnetic flow probe ascending aorta; LiDCO = lithium dilution cardiac output; NA = 
not available; PATD = pulmonary artery thermodilution; TTE = transthoracic echocardiography
Table 15. Lithium dilution technology; pediatric study
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Linton, 2000 (108)
N=17 (3 weeks-9 years; 2.6- 
28.2 kg) PICU 
48 measurements
LiDCO TPTD -0.1 0.61 32% 1.9 (0 .4 -6 .0 )
CO = cardiac output; LiDCO = lithium dilution cardiac output; NA = not available; TPTD = transpulmonary thermodilution
Table 16. Ti'anspulmonaiy thermodilution technology; animal studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Marx, 2000 (131)
15 pigs (10.2 ±  1.1 kg) 
165 measurements
TPTD PATD 0.12 0.24 20% 1.2 (0 .3 -3 .2 )
Hüter, 2004 (132) 
48 pigs (26-42 kg) 
144 measurements
TPTD PATD 0.2 0.98 22% 4.5 (1 .0 -9 .1 )
Ruperez, 2004 (133)
16 pigs (10.4 ±  1.6 kg; range 
9-16 kg)
78 measurements
TPTD PATD 0.2812 0.635 33% 1.9 (NA)
Löpez-Herce, 2006(134) 
51 pigs (9-16 kg)
209 measurements
TPTD PiCCO 0.04 1.08 62% 1.73 (NA)
Bajorat, 2006 (63) 
6pigs (26-32 kg) 
366 measurements
TPTD DAo-flow
all data -1.22 1.39 43% 3 .2 5 (0 .5 -7 .0 )
< 4  L/min -1.03 1.15 46% 2.46 (0 .5 -4 .0 )
> 4  L/min -1.6 1.65 33% 4.93 (4.0 - 7.0)
Janda, 2006 (113)
9 pigs (26.7± 1.7 kg) 
236 measurements
TPTD PATD
without IABP 0.30 0.47 NA
NA (1 .4 -4 .9 )
during IABP 0.26 0.52 NA
Hüter, 2007(135) 
10 pigs TPTD PATD 3.8% 21.7% NA NA
Piehl, 2008 (136)
10 piglets (24-37 kg) TPTD PATD 0.14 0.47 11% 4.13 (NA)
Lemson, 2008 (137)
11 lambs (4.2-12.5 kg) 
78 measurements
TPTD t t f p mpa 0.19 0.24 14.7% NA (0 .4 -3 .1 )
Beaulieu, 2009 (138) 
5 cats (2.4-5.6 kg)
32 measurements
TPTD PATD -3.7
mL/kg/min
32.2
mL/kg/min
29% 112 (NA) 
mL/kg/min
CO = cardiac output; DAo-flow = descending aorta flow; IABP = intra-aortic balloon pump; NA = not available; PATD = pul­
monary artery thermodilution; PiCCO = arterial pulse contour analysis, calibrated by transpulmonary thermodilution; TPTD 
= transpulmonary thermodilution; TTFPMPA = transit time flow probe main pulmonary artery
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Table 17. Ti'anspulmonaiy thennodilution technology; pediatric studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
McLuckie, 1996 (140) 
N=9 TPTD PATD
0.191
mL/kg/m2 NA NA NA
Tibby, 1997 (46)
N= 24 (0.3-175 months; 2.5- 
60 kg); PICU
TPTD 0 2-Fick 0.03 0.49 20% 2.51 (0 .2 4 -8 .7 1 )
Tibby, 1997 (46) 
N= 19 (<30 kg) 
PICU
TPTD 0 2-Fick -0.03 0.24 15% 1.60 (0 .2 8 -5 .5 4 )
Pauli, 2002 (47)
N=18 (12.1 ±  6.4 years; 39.6 ± 
22.7kg))
Cardiac intensive care 
18 measurements
TPTD 0 2-Fick 0.06 0.37 10% 3 .5 7 (0 .4 0 -6 .0 6 )
CO = cardiac output; NA = not available; PATD = pulmonary artery thermodilution; TPTD = transpulmonary thermodilution
Table 18. Ultrasound dilution technology; animal study
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
de Boode, 2009 (124) UDCO TTFPMPA
9 piglets (3.7-7.0 kg) 
339 measurements injection volume 0.5 mL/kg 0.040 0.258 27%
injection volume 1.0 mL/kg 0.058 0.267 28% 0.962 (0 .48 -1 .1912)
all data 0.050 0.263 27%
CO = cardiac output; TTFPMPA = transit time flow probe main pulmonary artery; UDCO = ultrasound dilution cardiac output
»  DOPPLER ULTRASOUND
When ultrasound is emitted and penetrates tissues with a variable acoustic density, 
it will cause reflection of a fraction of the ultrasound signal. An ultrasound beam can 
be used to measure blood flow velocity, because the moving erythrocytes will cause a 
frequency shift in the reflected signal, i.e. Doppler shift (Equation 22 & 23). This was 
named after Christian Doppler, who described the phenomenon in 1842.
Equation 22
d C x V  x c o s a
Equation 23
F ^ C x  cos a
cl
Fd = Doppler shift; f  = transmitted frequency; V = velocity of blood; C = ultrasound velocity in blood; 
cosa = cosine of the angle [a] between the direction of ultrasound beam and blood flow.
Spectral analysis of the Doppler shift will produce velocity-time waveforms. One 
can calculate the traveled distance by multiplying velocity by time. The area under the
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velocity-time curve gives the stroke distance, which is the distance that a column of 
blood will travel during a defined time period. This is also called velocity time integral
VTI = velocity time integral; V = velocity o f  blood; T = time
Stroke volume through a vessel can be calculated if the velocity-time integral and the 
cross sectional area of the vessel are known.
Equation 25
SV = VTI x CSA
SV = stroke volume; VTI = velocity-time integral; CSA = cross sectional area
From an ideal round vessel the cross sectional area can be calculated by measuring 
the diameter.
Equation 26
CSA = jt {D /2f
CSA = cross sectional area; D = diameter
When both stroke volume and heart rate are known the cardiac output can be 
calculated.
Equation 27
Cardiac Output = SV  x HR
SV = stroke volume; HR = heart rate
In 2003 Chew and co-workers published a review concerning Doppler cardiac output 
measurements in children, focusing on repeatability, bias and precision in comparison 
to dye dilution, Fick and thermodilution technologies (141). The bias of Doppler 
cardiac output measurements is <10%, with a rather wide range (-37% to +16% ); the 
precision, defined as ± 2SD, is ± 30%. The intraobserver and interobserver variability 
for Doppler cardiac output measurements ranges from 2.1% to 22%  and 3.1% to 21.7% 
respectively. The authors stated that Doppler derived cardiac output measurement is 
most useful as trend monitoring instead of the measurement of absolute values.
The relatively large variation in Doppler cardiac output measurements is caused by 
several factors, such as the difficulty in assessment of the area under the Doppler flow 
velocity signal (velocity time integral), calculation error due to the angle of insonation 
and problems with correct measurement of the cross-sectional area, which is known to 
be the major source of error. An error of 5°-10° in intercept angle will lead to an error of 
± 20%  in blood flow velocity measurement (142).
There are several ways to monitor cardiac output with Doppler ultrasound, like 
transthoracic echocardiography (TTE), transesophageal echocardiography (TEE), 
transesophageal Doppler (TED) and transcutaneous Doppler (TCD).
(VTI).
Equation 24
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Transthoracic echocardiography (TTE)
The term "functional echocardiography” was introduced by Kluckow et al. to describe 
the bedside use of echocardiography to longitudinally assess myocardial function, 
systemic and pulmonary blood flow, intracardiac and extracardiac shunts, organ flow, 
and tissue perfusion in critically ill newborn infants (143). An increasing number of 
neonatologists are using functional echocardiography in clinical practice (144-148). 
The intraobserver variability of measurements with functional echocardiography is 
about 10% with an interobserver variability of 15% -20%  (149). With transthoracic 
echocardiography one can measure left ventricular output (LVO), right ventricular 
output (RVO) or superior vena cava flow (SVC-flow).
Left and/or right ventricular output measurement
The determination of ventricular output is the most commonly used method of cardiac 
output measurement using Doppler ultrasound. For LVO assessment the diameter of 
the ascending aorta is measured either at the level of the aortic valve ring or just distal 
to the coronary sinus. The blood flow velocity in the ascending aorta is best measured in 
the apical or suprasternal view. Special attention should be paid to minimize the angle 
of insonation. For calculation of RVO the blood flow velocity is measured in the main 
pulmonary artery just distal to the pulmonary valve leaflets, while the diameter can be 
assessed at the insertion of the pulmonary valves.
Both LVO and RVO are influenced by blood flow through the fetal channels (ductus 
arteriosus and foramen ovale) (150-152). This means that systemic blood flow can be 
overestimated up to 100%  in the presence of a left-to-right shunt (152). In a patient 
with a left-to-right ductal shunt LVO will represent pulmonary blood flow (Qp) (the 
sum of systemic blood flow and ductal shunt flow), while RVO equals systemic blood 
flow (Qs). An atrial left-to-right shunt will influence RVO measurement, since measured 
RVO will represent systemic blood flow increased by atrial shunt flow. The normal value 
of ventricular output in normal preterm infants without shunting through the fetal 
channels is 150 to 300 mL/kg/min (6 ,153-155). On a neonatal intensive care unit the 
incidence of a patent ductus arteriosus varies between 20%  to 60% depending on the 
diagnostic criteria and the population studied (156). An interatrial shunt is frequently 
seen in preterm infants with a patent ductus arteriosus with a left-to right shunt. In 
preterm infants < 1500 grams with a 'wide open’ ductus Evans and Iyer found a left- 
to-right and bidirectional interatrial shunt in respectively 44.5%  and 55.5% of the 
selected population (151). However, during the first two days of life large atrial shunts 
are uncommon in preterm infants (157). Because of this high incidence of left-to-right 
shunting in preterm infants measurement of LVO and/or RVO will not provide the 
clinician with an accurate estimation of systemic blood flow.
Only LVO and not RVO measurements have been validated against accepted gold 
standard methods of cardiac output measurement like pulmonary artery thermodilution 
(158 ,159) and 0 2-Fick (160).
Superior vena cava flow measurement
To avoid the influence of potential shunting through the fetal channels the concept of 
cardiac input has been developed in which the superior vena cava (SVC) flow is measured 
as a surrogate for systemic blood flow (149). SVC flow is the systemic venous blood flow 
that returns from the upper body, including the brain. SVC flow equals approximately 
30-50%  of ventricular output (149, 161). Blood flow velocity is measured in the
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superior vena cava at the entrance into the right atrium. The assessment of the velocity 
time integral (VTI) in the SVC is more complex, because of the influence of breathing 
activity and retrograde flow during atrial systole. Therefore it is advised to average 10 
measurements of VTI. The measurement of SVC diameter is also more complex, since 
the diameter generally varies during the cardiac cycle. For the calculation of SVC flow 
the minimum and maximum SVC diameter are averaged.
This technique of cardiac input measurement has not been validated against accepted 
gold standard methods.
The advantages and limitations of transthoracic echocardiography for cardiac output 
measurement are summarized in Table 19.
Table 19. Advantages and limitations of transthoracic echocardiography
Advantages
Non-invasive technology; detailed evaluation of cardiac function and anatomy pos­
sible; additional information about potential intra- and extracardiac shunts
Limitations
Requires significant training and expertise; accuracy highly dependent on operator 
skills and quality of echocardiographic views; not an easy, bedside method of car­
diac output monitoring; high intra- and interobserver variability; inaccuracy due 
to errors in VTI, CSA and angle of insonation; more useful in trend monitoring than 
in measurement of absolute values; overestimation of systemic blood flow in the 
presence of significant ductal and/or atrial left-to-right shunt (LVO and RVO]; only 
part of total systemic venous return measured (excluding lower body) (SVC-flow)
Transesophageal echocardiography (TEE)
Transesophageal echocardiography provides real time imaging of the heart from 
which both the velocity time integral in the left and/or right ventricular outflow tract 
and the cross-sectional area of the aortic and/or pulmonary valve can be measured. 
Subsequently left and right ventricular output can be measured and Qp:Qs-ratio can 
be estimated. In addition the cardiac anatomy, preload status and contractility can be 
assessed. TEE is mainly used in children with congenital heart defects for functional and 
structural imaging during cardiac surgery. It is advised to perform TEE only in children 
with a body weight more than 3 kg (162), although thanks to miniaturization of probes 
intraoperative TEE has successfully been used in low birth weight infants < 1.6 kg with or 
without prior dilation of the esophagus (163 ,164). The smallest patients, however, are 
at highest risk for complications, like tracheal and bronchial compression, inadvertent 
tracheal extubation, esophageal perforation, aortic compression and compression of 
the left atrium (165).
The advantages and limitations of transesophageal echocardiography for cardiac 
output measurement are summarized in Table 20.
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Table 20. Advantages and ¡imitations of transesophageal echocardiography
Advantages
Detailed evaluation of cardiac performance possible; additional information about 
potential intra- and extracardiac shunts; less invasive
Limitations
Requires significant training and expertise; accuracy highly dependent on operator 
skills and quality of echocardiographic views; much larger probe than esophageal 
Doppler probe; technically difficult to obtain a good view (166); inaccuracy due to 
errors in VTI, CSA and angle of insonation; small risk of complications: airway ob­
struction (1%), inadvertent extubation (0.5%), vascular compression (0.6%) and 
advancement of the endotracheal tube (0.2%) (167); overestimation of systemic 
blood flow in the presence of significant ductal and/or atrial left-to-right shunt 
(LVO and RVO); not tolerated by conscious patients
Transesophageal Doppler (TED)
The 'non-invasive' measurement of cardiac output with the use of transesophageal 
Doppler was first described in 1971 and refined in 1989 (168,169). With the esophageal 
Doppler technique the blood flow velocity is measured in the descending aorta using an 
ultrasound probe positioned in the esophagus. The reported use in children is limited. 
Because of the size of this probe this method is only applicable in infants > 3 kg. The 
ultrasound beam is aimed towards the aorta and the signal quality must be checked. 
This manual positioning and optimum signal acquisition implies a certain operator- 
dependency. With TED the velocity time integral (VTI) is measured in the descending 
aorta, called the stroke distance. Changes in stroke distance are representative of 
changes in stroke volume. Multiplying the stroke distance (SD) with heart rate results in 
minute distance (MD), which is the distance traveled by a column of blood during a one- 
minute period. Cardiac output, or actually descending aorta blood flow, is the product 
of MD and aortic cross sectional area (CSA). The aortic CSA can either be measured by 
M-mode echocardiography or estimated using a nomogram based on age, sex, height, 
weight or body surface area (170,171). It is known however, that the aortic CSA is not a 
static parameter, since it may vary with changes in mean arterial blood pressure (172). 
Tibby and co-workers showed that stroke distance measured with TED can be used to 
guide volume therapy in critically ill children (173).
Another hemodynamic parameter that can be assessed with TED is the corrected flow 
time (FTc), which is the length of time of systolic blood flow adjusted for heart rate 
(173).
Equation 28
FTc = corrected flow  time; FT = flow  time; CT = cycle time (see Figure 1 )
yfcT
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Figure 1
The velocity-time waveform and hence FTc is influenced by changes in contractility, 
preload and afterload. The value of FTc as hemodynamic parameter in children still has 
to be elucidated.
The advantages and limitations of transesophageal Doppler for cardiac output 
measurement are summarized in Table 21.
Table 21. Advantages and limitations of transesophageal Doppler
Advantages
Easy of use; fast assessment of cardiac output; continuous, real-time cardiac output 
measurement; less invasive
Limitations
Only part of total systemic blood flow measured (excluding head, upper extremities 
and coronary circulation); not tolerated by conscious patients; necessity of anes­
thesia or sedation; contraindicated in severe esophageal pathology; not feasible in 
newborn infants less than 3000 gram; not reliable in the presence of a intra-aortic 
balloon pump (turbulent flow in descending aorta); the assumption that the aorta 
is cylindrical is not always valid; operator dependency; angle of insonation impor­
tant source of inaccuracy
Transcutaneous Doppler (TCD)
Blood flow velocity can be measured in the ascending aorta with a non-invasive 
ultrasound probe positioned in the sternal notch. Blood flow velocity is measured with 
continuous-wave Doppler in the assumed position of the ascending aorta. The measured 
cardiac output represents total systemic blood flow, excluding coronary blood flow The 
probe can also be aimed at the pulmonary artery to measure pulmonary blood flow The 
cross-sectional area of the aortic and/or pulmonary valve is derived from an algorithm 
using height, weight and age.
The advantages and limitations of transcutaneous Doppler for cardiac output 
measurement are summarized in Table 22.
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Table 22. Advantages and limitations of transcutaneous Doppler
Advantages
Non-invasive measurement; easy and rapid set up; portable device
Limitations
Relatively large interobserver variability; user dependency; ‘blind’ aiming of the 
transducer; error due to insonation angle deviation and estimated aortic or pulmo­
nary valve diameter; difficulty to assess a representative aortic Doppler flow signal; 
Doppler flow signal quality influenced by intrathoracic air and patients position; 
more useful as trend monitor
Validation studies Doppler ultrasound technology
Statistical data (accuracy and precision) of cardiac output measurement using 
Doppler ultrasound from animal (63, 174) and human pediatric (159, 160, 171, 175- 
182) studies are summarized in Tables 23 -28 .
Table 23. Transesophageal Doppler; animal study
Study Comparator Reference Mean bias Precision Error% CO, mean (range)
(L/m in) (L/m in) (L/m in)
Bajorat, 2006 (63) TED DAo-flow
6 pigs (26-32 kg) 
366 measurements all data 0.03 1.96 60% 3 .2 5 (0 .5 - 7.0)
< 4  L/min -0.16 1.58 64% 2.46 (0 .5 - 4.0)
>4  L/min 0.38 2.41 49% 4.93 (4.0 7.0)
CO = cardiac output; DAo-flow = descending aorta flow; TED = transesophageal Doppler
Table 24. Transcutaneous Doppler; animal study
Study Comparator Reference Mean bias Precision Error% CO, mean (range)
(L/m in) (L/m in) (L/m in)
Critchley, 2005 (174) 
6 dogs (11-22 kg) 
319 measurements
TCD (USCOM®) XTFP“ 0 -0.01 0.325 13% 2.62 (0.79 to 5.73)
CO = cardiac output; TCD = transcutaneous Doppler; TTFP'A° = transit time flow  probe ascending aorta
Table 25. Transthoracic echocardiography, pediatric studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Alverson, 1982 (160) 
N= 33
Heart catheterization
TTE (LVO) 02-Fick 5% 27% NA NA (0 .4 -5 .5 )
Notterman, 1989 (159) 
N= 17 (0.7-15 years; 
5-75 kg) PICU 
40 measurements
TTE (LVO) PATD 0.12 (range: 
-3 .13-2 .03)
NA NA NA (1.02 -6.26)
Wippermann, 1992 (175) 
N=18 (4-25 months; 
4.1-10 kg)
Cardiac surgety 
96  measurements
TTE PATD 0.026 0.23 NA NA (0 .4 -2 .2 )
CO = cardiac output; LVO = left ventricular output; NA = not available; PATD = pulmonary artery thermodilution; TTE = 
transthoracic echocardiography
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Table 26. Transesophageal echocardiography; pediatric studies
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Murdoch, 1995 [176)
N = ll (median age 39 months; 
median weight 14.9 kg); PICU 
5 measurements
TED PATD 0.5% change NA NA NA
Wodey, 2001 (177) 
N=20 (8.3 ±  2.5 years; 
2 7 ±8 kg)
Elective surgery
TED TTE 2.2 2.16 NA NA
CO = cardiac output; NA = not available; PATD = pulmonary artery thermodilution; TED 
transthoracic echocardiography
=  transesophageal Doppler; TTE =
Table 27. Transesophageal Doppler; pediatric studies
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Tibby, 2000 (171)
N=100 (4 days-18 years) 
PICU
TED TPTD 0.87%changes NA NA NA (0 .32-9 .19)
Schubert, 2008 (178) 
N =26(l m-17.5year; 
2.6-47 kg)
Post cardiac surgery
TED TTE (LVO) 0.36 1.67 73% 2.3 (NA)
Knirsch, 2008 (179) 
N=40 (0.5-16.7 years) 
Heart catheterization 
120 measurements
TED PATD 0.66 1.79 60% 3.0 (0 .7 -6 .7 )
CO = cardiac output; LVO = left ventricular output; NA = not available; PATD = pulmonary artery thermodilution; TED = trans­
esophageal Doppler; TPTD = transpulmonary thermodilution; TTE = transthoracic echocardiography
Table 28. Transcutaneous Doppler; pediatric studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Mohan, 2002 (180) 
N=20 (2-192 months; 
5-60 kg); PICU 
140 measurements
TCD (USCOM®) TED 27.6%change NA NA NA
Phillips, 2006 (181) 
N=37 preterms 
(1.13 ±  0.47 kg) NICU 
66 measurements
TCD (USCOM®) TTE 0.00 0.16 43% 0.37 ± 0 .1 4  (NA)
Knirsch, 2008 (182) 
N=24 (0.1-16.7 years; 
3.4-51.0 kg)
Heart catheterization 
72 measurements
TCD (USCOM®) PATD -0.13 1.34 36.4% NA (1 .3 -5 .3 )
CO = cardiac output; NA = not available; PATD = pulmonary artery thermodilution; TCD = transcutaneous Doppler; TED = 
transesophageal Doppler; TTE = transthoracic echocardiography
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»  ARTERIAL PULSE CONTOUR ANALYSIS
The technology of arterial pulse contour analysis measures and monitors stroke 
volume on a beat-to-beat basis from the arterial pulse pressure waveform. The idea 
of using the arterial pressure waveform to calculate cardiac output was postulated by 
Frank in 1899 (183). Frank suggested calculation of total peripheral resistance from 
the time constant of diastolic aortic pressure decay and arterial compliance, which 
was estimated by the measurement of the aortic pulse wave velocity. Cardiac output 
could then be calculated by dividing the measured mean arterial pressure by the total 
peripheral resistance. Kouchoukos described in 1970 the calculation of cardiac output 
by measuring the area under the systolic part of the arterial pressure waveform in an 
animal model (184). Wesseling and co-workers developed a technique to calculate 
stroke volume from aortic impedance and the change in arterial pressure during systole 
(185,186).
Equation 29
SV = stroke volume; P = arterial pressure; t = time from  end diastole to end systole; Z = aortic impedance
The arterial pressure waveform is the resultant of an initial pressure wave that is 
proportional to stroke volume, and a reflected pressure wave back from the peripheral 
vessels. The arterial pressure wave will vary under different (patho-) physiological 
circumstances. The site of registration will also influence the form of the arterial 
pressure waveform. There is no linear relationship between pressure and flow in the 
aorta, which is primarily due to aortic impedance, which is influenced by compliance, 
(vascular) resistance and inductance (inertia of blood). The complexity of arterial 
pulse contour analysis is related to the dependency of the aortic impedance on both 
cardiac output and aortic compliance. This implies that pulse contour analysis can be 
used to detect changes in cardiac output and that the measurements generally need to 
be calibrated with another technology. Two APCA monitors are commercially available 
that require an invasive calibration procedure, namely the PiCCO1 system, calibrated by 
transpulmonary thermodilution, and the PulseCO1 system, calibrated by lithium dilution.
Several models are used to estimate stroke volume from the aortic pressure 
waveform, like the lumped windkessel model, the modified three-element windkessel 
model, and other advanced models (18, 187-189). Another principle that is used for 
arterial waveform analysis is the conservation of mass in order to calculate changes in 
pulse power (66). This theory is based on the assumption that the net power change 
in a heartbeat is the balance between the stroke volume of blood entering the arterial 
vessels minus the blood loss to the periphery during the heartbeat. After correction for 
compliance and after calibration the power change can be correlated to flow.
The Vigileo/FloTrac1 system (Edwards Life Sciences, Munich, Germany) and pressure 
recording analytical method (PRAM1, Mostcare, BioSi, Florence, Italy) do not need a 
prior calibration procedure according their manufacturers. The Vigileo/FloTrac1 
system is not validated or labeled for use in pediatric patients (190).
The advantages and limitations of arterial pulse contour analysis for cardiac output 
measurement are summarized in Table 29.
Z
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Table 29. Advantages and limitations of arterial pulse contour analysis
Advantages
Real time, continuous cardiac output measurement; "non-invasive” technology
Limitations
Frequent (invasive) calibration required, especially when changes occur in the he­
modynamic status; based on a reliable arterial waveform without artifacts, such as 
caused by air in or kinking of arterial catheter; use of small catheters (24-gauge) can 
cause distortion of the wave shape and overdamped curves; accuracy influenced by: 
changes in arterial compliance, changes in vasomotor tone, and irregular heart rate; 
not applicable in patients with severe peripheral vascular disorder, aortic valve dis­
ease or intra-aortic balloon pump
Validation studies arterial pulse contour analysis
Statistical data (accuracy and precision) of cardiac output measurement using arterial 
pulse contour analysis from animal (136, 191-194) and human pediatric (195-198) 
studies are summarized in Tables 30 & 31.
Table 30. Arterial pulse contour analysis; animal studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Scolletta, 2005 (191) 
9 pigs (27-106 kg) 
108 measurements
PRAM PATD 0.05 0.62 NA
NA (1 .8 -1 0 .4 )
PRAM EMFPAAo -0.03 0.58 NA
Bein, 2007 (192) 
13 pigs (43-48 kg)
PiCCO PATD
baseline 0.54 1.46 NA NA
after hemorrhage -3.49 6.12 NA NA
after NE administration -8.01 9.9 NA NA
after recalibration -0.51 1.28 NA NA
Johansson, 2007 (193) 
15 pigs (20-25 kg)
TPTD PiCCO
control - before calibration 0.11 0.53 NA NA
control - after calibration -0.02 0.38 NA NA
sepsis - before calibration 0.08 1.02 NA NA
sepsis - after calibration 0.01 0.31 NA NA
Piehl, 2008 (136)
10 piglets (24-37 kg) PiCCO PATD 0.11 0.45 11% NA
Romagnoli, 2009 (194) 
8 pigs (27-60 kg)
PRAM PATD -0.0067 0.87 23% NA
PRAM TEE -0,007 0.86 22% NA
CO = cardiac output; EMFFUo =  electromagnetic flow probe ascending aorta; NA = not available; NE = norepinephrine; PATD 
= pulmonary artery thermodilution; PiCCO = arterial pulse contour analysis, calibrated by transpulmonary thermodilution; 
PRAM = pressure recording analytical method; TEE = transesophageal echocardiography; TPTD = transpulmonary thermo­
dilution
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Table 31. Arterial pulse contour analysis; pediatric studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Mahajan, 2003 (195)
N=16 (1-36 years, median 7 
years)
Cardiac surgery
PiCCO TPTD
OR, before CPB (shunts incl.) -0.13 /m 2 1.82 /m 2 NA NA
OR, after CPB (shunts excl.) 0.05 /m 2 1.84 /m 2 NA NA
ICU (shunts excl.) 0.24 /m 2 2.04 /m 2 NA NA
all data after correction 0.08 /m 2 1.94 /m 2 NA NA
all data, all periods 0.10 /m 2 1.90 /m 2 51% 3.7 (1.40 - 9.70) /m 2
Kim, 2006(196)
N=20 (2.6-15.5 years; 13- 
77kg)
Heart catheterization 
73 paired measurements
PulseCO PATD
all data 0.19 /m 2 0.28 /m 2 NA NA
< 20 kg 0.23 /m 2 0.39 /m 2 12% 3.3 (1.9 - 5.9) /m 2
Fakler, 2007 (197) 
N=24 (1.4-15.2 years) 
Cardiac surgery
PiCCO TPTD 0.05 /m 2 0.78 /m 2 NA NA (1 .8 6 -7 .0 4 ) /m 2
Calamandrei, 2008 (198) 
N=48 (1-204 months) 
PICU
PRAM TTE 0.12 0.53 19% 2.7 (0.89 - 7.48)
CO = cardiac output; CPB = cardiopulmonary bypass; ICU = intensive care unit; NA = not available; OR = operating room; PATD 
= pulmonary artery thermodilution; PiCCO = arterial pulse contour analysis, calibrated by transpulmonary thermodilution; 
PRAM = pressure recording analytical method; PulseCO = arterial pulse contour analysis, calibrated by lithium dilution; TTE 
= transthoracic echocardiography; TPTD = transpulmonary thermodilution
»  THORACIC ELECTRICAL IMPEDANCE
Thoracic Electrical Impedance technology is probably the only true non-invasive 
method of cardiac output monitoring. Kubicek published the first study about the 
application of impedance cardiography in 1966 (199). It was developed by NASA to 
analyze the effects of zero gravity on cardiac function in astronauts.
Electrical bioimpedance (EBI)
The electrical conductivity ofbloodis higher than thatofmuscle, fat and air. Application 
of a high-frequency very low-magnitude current across the chest via topical electrodes 
distributes therefore mainly to blood. Hence pulsatile changes in thoracic blood volume 
will cause changes in electrical thoracic impedance. The changes in impedance during 
systole are proportional to cardiac output. The reduced impedance during systole is 
caused by an increased blood volume, increased flow velocity and alignment of the 
erythrocytes.
Kubicek described the method to estimate stroke volume out of the changes in 
thoracic electrical impedance in 1966 (199).
Equation 30
SV = p - [ L / Z j - [ V E T - [ d z / d t mJ ]
SV = stroke volume; p = resistivity of blood; L = distance between the two inner voltage-sensing 
electrodes, Z0= mean thoracic impedance between the inner sensing electrodes; VET = ventricular 
ejection time; [dz/dtm J  = maximum negative slope of bioimpedance signal
94
To account for the non-cylindrical shape of the thorax this equation was modified 
by Bernstein, who also introduced a calibration factor, related to gender and degree of 
obesity (200). The overall thoracic bioimpedance is determined by changes in tissue fluid 
volume, volumetric changes in pulmonary and venous blood induced by respiration, 
and volumetric changes in aortic blood flow produced by myocardial contractility.
Electrical velocimetry (EV)
Electrical velocimetry is a new variation of thoracic bioimpedance with a refined 
algorithm and based on the theory that the change in the alignment of red blood 
cells from an arbitrary orientation during diastole to a parallel alignment during 
systole induces an increase in the electrical conductivity of blood. From this change in 
conductance the stroke volume and hence cardiac output can be calculated.
The advantages and limitations of thoracic electrical impedance for cardiac output 
measurement are summarized in Table 32.
Table 32. Advantages and limitations of thoracic electrical impedance
Advantages
Only real non-invasive method of cardiac output monitoring; continuous monitor­
ing
Limitations
Very sensitive to any alteration in position or contact of the electrodes to the patient 
(perspiration); accurate measurement relies on a constant heart rate (R-R interval); 
acute change in tissue water content alters bioimpedance (chest wall edema, pleu­
ral effusions, pulmonary edema) and leads to inaccurate cardiac output measure­
ments (201); limited accuracy in pediatric patients
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Validation studies thoracic electrical impedance technology
Statistical data (accuracy and precision) of cardiac output measurement using 
thoracic electrical impedance technology from animal (202-204) and human pediatric 
(48 ,178 , 205-208) studies are summarized in Tables 33 & 34.
Table 33. Thoracic Electrical Impedance; animal studies
Study Comparator Reference Mean bias 
(L/m in)
Precision
(L/m in)
Error% CO, mean (range) 
(L/m in)
Broomhead, 1997 (202) 
4  piglets (40-50 kg)
145 measurements
EBI PATD 0.01 1.00 NA NA (1 .7 -8 .6 )
Bloch, 2002 (203)
9 piglets (8.5-10.2 kg) 
49 measurements
EBI PATD 3% 32% NA NA (0.25 -3.26)
Osthaus, 2007(204) 
5 pigs (11.2-13.8 kg) 
169 measurements
EV TPTD -0.63 1.25 83% NA
CO = cardiac output; EBI = electrical bioimpedance; EV= electrical velocimetry; NA = not available; PATD = pulmonary artery 
thermodilution; TPTD = transpulmonary thermodilution
Table 34. Thoracic electrical impedance; pediatric studies
Study Comparator Reference Mean bias Precision Error%  CO, mean (range)
(L/m in) (L/m in) (L/m in)
Tibballs, 1989 (205) 
N= 26 (0.75-4.96 kg; 
PNA 0-121 days); NICU
TEI TTE -0.23
mL/kg/min
NA NA NA
Pianosi, 1997 (206) 
N=21 (8-16 years) 
CF-patients
EBI C02r -0.09 1.84 NA NA
Schubert, 2008 (178)
N=26 (1 m-17.5 year; 2.6-47 
kg); post cardiac surgery
EV TTE (LVO) 0.87 3.26 142% NA
Norozi, 2008 (48)
N=32 (lld ay s-17.8 years) 
Heart catheterization 
32 measurements
EV 0 2-Fick 0.01 0.46 NA NA
Tomaske, 2008 (207) 
N=50 (0.5-16.5 years) 
Heart catheterization 
150 measurements
EV PATD 0.66 1.49 48% 3.1 ±  1.7 (NA)
Tomaske, 2009 (208)
N = 36 (0.5-16.0 years) 
Heart catheterization 
108 measurements
EV TCD 0.31 1.92 73% 2.62 (0 .55 - 5.58)
CO = cardiac output; CO-R = C02 rebreathing; EBI = electrical bioimpedance; EV = electrical velocimetry; LVO = left ven­
tricular output; NA = not available; PATD = pulmonary artery thermodilution; TCD = transcutaneous Doppler; TE1 = thoracic 
electrical impedance; TTE = transthoracic echocardiography
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»  SUMMARY AND CONCLUSIONS
Cardiac output monitoring in neonates remains very challenging despite the 
availability of many different technologies (Table 35). The updated ACCM guidelines 
for hemodynamic support of pediatric and neonatal shock recommended to monitor 
cardiac output in patients with catecholamine-resistant shock and to titrate therapy to 
achieve a cardiac index of 3.0-6.0 l.minMn2 (209). Until now there is limited evidence 
to confirm the assumption that cardiac output monitoring is beneficial for patients 
by reducing mortality and/or morbidity (210). Moreover, there is concern about the 
clinician’s ability to interpret the assessed hemodynamic variables correctly (89, 211, 
212). Misinterpretation would imply an incorrect application of a monitoring system 
with potential severe side effects and a high risk of iatrogenic injury. Any person who 
uses any method of cardiac output monitoring is obliged to thoroughly understand the 
basic principles of the applied technology and its respective advantages and limitations 
in order to prevent erroneous hemodynamic interpretation and management. It is 
extremely important that newly designed systems of cardiac output monitoring are 
carefully validated and evaluated for safety.
At present there is no clinical gold standard for neonatal cardiac output measurement 
that can be used to guide hemodynamic management. Transpulmonary indicator 
dilution, arterial pulse contour analysis and thoracic electrical impedance are all 
candidates as diagnostic tool for the assessment of neonatal hemodynamics in the 
future. However, transthoracic (functional) echocardiographic evaluation of potential 
ductal and/or atrial shunts remains essential for a correct interpretation of obtained 
cardiac output values, irrespective of the methodology used. Further research needs to 
focus on refinement of existing methods or the development of new techniques that are 
feasible in (preterm) newborns in order to safely monitor systemic blood flow.
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Table 35. Characteristics of various cardiac output monitoring techniques
Method
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Fick principle
0 -Fick + AC, CVC + - CO, O,-consumption + -
c o 2r - - + ± CO, ventilatory data - -
niCOF + AC, CVC + - CO, ventilatory data + -
Indicator dilution
PATD +++ PAC + + CO, CVP, PAP, PCWP, SmvO, - -
PDD + CVC + - CO, IBV + -
LiDCO ++ AC, CVC +
+
(APCA)
CO, SPV, PPV, SVV, 
HRV, ITBV - -
TPTD ++ AC, VCV +
+
(APCA)
CO, GEDV, EVLW, 
ITBV, PPV, SVV - -
UDCO ++ AC, CVC + - CO, TEDV, CBV, ACV + -
Doppler ultrasound
TTE - - + -
CO, anatomic & 
functional assessment
+ +
(141)
TEE + - + -
CO, anatomic & 
functional assessment
± -
TED + - + + CO, FTc ± -
TCD - - + - CO +
+
(181)
Arterial Pulse Contour Analysis
PulseCO ++ AC, CVC - +
CO, SPV, PPV, SVV, 
HRV, ITBV - -
PiCCO ++ AC, CVC - +
CO, GEDV, EVLW, 
ITBV, PPV, SVV - -
FloTrac/Vigileo + AC - + CO, SVV - -
PR4AI + AC - + CO, SVV, PPV - -
Thoracic Electrical Impedance
EBI - - - + CO +
+
(205)
EV - - - + CO + -
*  Validated against an accepted reference method: AC: arterial catheter: ACV: active circulating volume: CBV: 
central blood volume: CO: cardiac output: CVC: central venous catheter: EVLW: extravascular lung water: 
FTc: corrected flow  time: GEDV: global end-diastolic volume: HRV: heart rate variation: IBV: intravascular 
blood volume: ITBV: intrathoracic blood volume: PAC: pulm onary artery catheter: PAP: pulmonary artery pres­
sure: PCWP: pulmonary capillary wedge pressure: PPV: pulse pressure variation: S m vO j mixed venous oxygen 
saturation: SPV: systolic pressure variation: Si  7 ? stroke volume variation: TEDV: total end-diastolic volume
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ABSTRACT
Cardiac output can be measured using a modified carbon dioxide Fick (mC02F) method. 
A validation study was perform ed comparing mC02F-derived cardiac output (QmC02F)  with 
invasively measured pulmonary blood flow. In 7 randomly bred ventilated newborn lambs, 
cardiac output was manipulated by creating hemorrhagic hypotension. When steady state 
was reached, mC02F-derived cardiac output was measured. Gas analysis was performed  
in simultaneous obtained arterial and venous blood samples (right atrium [RA], superior 
vena cava [SVC] and inferior vena cava [¡VC]). Carbon dioxide exchange and pulmonary 
blood flow was measured continuously using a C02SM0 Plus monitor and a pulmonary 
ultrasonic flow probe (Qufp)  respectively. Mean bias, defined as QmC02p minus Qufp, was small 
( respectively; -0 .082  L/min, -0.085 L/min and -0.183 L/min fo r  venous sampling from  RA, 
SVC and 1VC). The limits o f agreem ent w ere-0.328 to 0.164 L/min (RA), -0.335 to 0.165 L /  
min (SVC), and 0.415 to 0.049 L/min (IVCJ. In conclusion, m easurement o f cardiac output 
with the mC02Fm ethod is reliable and easily applicable in ventilated newborn lambs. For 
clinical use, the site o f venous blood sampling is o f minor importance.
»  INTRODUCTION
Monitoring cardiac output is essential in the treatment of critically ill patients. It may 
improve the indication and choice of treatment in a hemodynamic unstable patient. 
Furthermore, the response to the intervention can be monitored and evaluated.
Bedside cardiac output monitoring is feasible in adult and pediatric patients, but 
remains complicated in the newborn. Several techniques for cardiac output monitoring 
in children are available (1-3). Most techniques for cardiac output measurement are not 
feasible in newborns. In critically ill neonates cardiac output is usually estimated from 
the interpretation of several clinical variables, such as blood pressure, urine output, 
blood gas analysis, and capillary refill. Tibby and colleagues showed that clinicians 
using these indirect parameters of cardiac performance were unable to predict the 
actual cardiac output in ventilated children and infants (4). The same was shown in 
ventilated adults (5). Nonetheless, this clinical estimation of cardiac output is nowadays 
still the most frequently used method. This emphasizes the need for a reliable, (semi) 
continuous , preferably non-invasive, accurate method of cardiac output monitoring 
in critically ill newborns. Only in this way can objective hemodynamic parameters be 
obtained on which a rational therapeutic regime can be based.
Theoretically, cardiac output can be measured in ventilated patients using a modified 
carbon dioxide Fick (mC02F) method. We performed a validation study of this technique 
in a lamb model.
»  METHODS
We compared the mC02F-derived cardiac output (Qlii0)>l) with measured pulmonary 
blood flow using a perivascular ultrasonic flow probe (ufp) positioned around the 
common pulmonary artery (Qu,p)-
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Modified carbon dioxide Fick method
The mC02F method is based on the principle that in a steady state, carbon dioxide 
production in tissue [CO P] equals pulmonary carbon dioxide exchange (VCO).
VC02 can be measured in a ventilated patient using a computer-aided analysis of 
expiratory airflow (Q ,p) and carbon dioxide fraction in expiratory air (FeCO).
Equation 1
T
VC02 = { jQ EXp[tyF eC 02[t y d t }x T - '
0
VCO = carbon dioxide exchange (L/min); Qexp = expiratory airflow (L/min) ; FeC02 = carbon dioxide fraction in 
expiratory air (gradient); T = time (min)
Carbon dioxide production [CO P] is the product of cardiac output (Q) and the veno­
arterial difference in carbon dioxide concentration (C(v jC02].
Equation 2
C02P = Q-[CvC02 -CaC02)
C02P = carbon dioxide production (mL/min); Q = cardiac output (L/min); CvC02 = venous carbon dioxide concen­
tration (mL/L); CaC02 = arterial carbon dioxide concentration (mL/L)
Carbon dioxide concentration in blood can be measured using different methods, 
depending on the calculation method of carbon dioxide concentration in the erythrocyte 
(6-10). In this study, we used the Douglas equation (10):
Equation 3
™  r, (0-0289-cHb)c, CO, = c CO -{1 ------------- -------------- ------------ }
b 2 p 2 (3.352 -  0.456 • s0 2 )• (8.142 -  pH)
cCO = total carbon dioxide concentration in plasma (mL/100 mL); ctCO, = total carbon dioxide concentration in 
blood (mL/100 mL); cHb = hemoglobin concentration (g/dL); sO, = oxygen saturation (gradient)
Total carbon dioxide concentration in plasma is calculated with the use of the 
Henderson-Hasselbalch equation:
Equation 4
c CO2 = 2.226 • s • pC02 ■ (1 + 10pH"pr)
cC 0 2 = total carbon dioxide concentration in plasma (mL/100 mL); 2.226 = conversion factor mEq to mL/100 
mL; s = solubility coefficient o f  carbon dioxide in plasma (mEq/mmHg); pK'= apparent pK; pC02 = partial carbon 
dioxide pressure (mmHg)
Equation 5
s = 0.0307 + 0.00057 • (3 7 - T ) - (3 7 - T ) 2
s = solubility coefficient o f  carbon dioxide in plasma (mEq/mmHg); T = temperature (°C)
Equation 6
pK' =  6.086 + [0.042• (7.4 -  pH)] + {(38 - T ) - [0.0047 + 0.00139 • (7.4 -  pH )]}
For use in calculations C02P and VC02 need to be converted to 'Standard Temperature 
Pressure, Dry’ (STPD) conditions.
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T {PBTPS-pHO^  
CO P STPD = CO PBTPS ■ ■ —______
2 2 rjiBTPS p
0
Equation 7
C02Pstpd = carbon dioxide production under STPD conditions; C02 P BTPS = carbon dioxide production under BTPS 
conditions; BTPS = Body Temperature Pressure, Saturated; Tg = standard temperature (273K); t btps = tem pera­
ture under BTPS (K); P BTPS = pressure under BTPS conditions (kPa); pH20 = partial pressure o f  water vapor at 
TBTPS (kPa); Pg = standard pressure (101.4 kPa)
Equation 8
v c o '" "  = VCOA1
2  2
TQ (PATPS- p H 20 )
p0
VC02stpd = pulmonary carbon dioxide exchange under STPD conditions; VC02 ATPS = pulmonary carbon dioxide 
exchange under ATPS conditions; ATPS = Ambient Temperature Pressure, Saturated; Tg = standard temperature 
(273K); TATPS = ambient temperature (K); P ATPS = pressure under ATPS conditions (kPa); pH20 = partial pressure 
o f  water vapor at t atps (kPa); Pg = standard pressure (101.4 kPa)
Then, cardiac output can be calculated using the following equation.
Equation 9
[V C O jTPD
Q— ---------------
(C CO f ™(v-a) 2 J
Q = cardiac output (L/min); (VCOJSTm = pulmonary carbon dioxide exchange under STPD conditions (mL/min);
Animal preparation
The study was approved by the Ethical Committee on Animal Research of the Radboud 
University Nijmegen and performed in 7 random-bred newborn lambs (2.9 -  6.4 kg). 
After anesthesia induction using midazolam (2.0 mg-kg1) and pentobarbital (15-20 
mg-kg1) the lambs were orotracheally intubated with a cuffed endotracheal tube. The 
cuff was inflated to a standard pressure. It was verified by auscultation that there was 
no air leak around the cuffed tube. Animals were artificially ventilated with a Babylog 
8000 Plus ventilator (Drager Medizintechnik, Liibeck, Germany) using pressure control. 
Anesthesia was maintained with fentanyl (loading dose 0.2 mg-kg1; maintenance dose
0.2 mg-kg '-h ') and midazolam (0.3 mg-kg '-h ') and muscle paralysis was performed 
using pancuronium (loading dose 0.1 mg-kg1; maintenance dose 0.02 mg-kg '-h '). 
Ventilator settings were adjusted in order to maintain normoxaemia (pa02 12-15 
kPa; Sa02 90-95% ) and normocapnia (paC02 4.0-5.5 kPa). A servo-controlled heating 
mattress was used to maintain the rectal temperature between 38 and 40°C. In clinical 
practice, it is difficult to position the tip of a central venous catheter exactly in the right 
atrium. To be able to evaluate the effect of different venous sample sites on the accuracy 
of the mC02F method, we surgically inserted intravascular lines with the tip positioned 
in the right atrium (RA), the inferior vena cava (IVC), and superior vena cava (SVC) 
respectively. The position of the tip of the catheters was estimated using the registered 
pressure waves during insertion. The final position of the catheters was verified by 
post mortem evaluation. An intra-arterial catheter was inserted in the abdominal aorta 
through the femoral artery. A left-sided thoracotomy was performed, and after cautious
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preparation and identification of major structures the ductus arteriosus was ligated. 
This was done to exclude any possible influence of a ductal shunt (left-to-right and/ 
or right-to-left) on the measurement. An adequately sized ultrasonic transit time flow 
probe (Transonic Systems Inc, Ithaca, NY, USA) was placed around the pulmonary trunk.
Experimental protocol
Measurement of the pulmonary blood flow (Qufp) was considered the gold standard, 
because it is equal to systemic flow, when any shunts are excluded. Measurement of 
aortic flow will underestimate the systemic flow because the coronary flow will be 
missed.
After a 30-min period of stabilization, cardiac output was reduced by creating 
hemorrhagic hypotension. Blood was withdrawn in a stepwise manner in order to 
obtain a decrease of mean arterial blood pressure (MABP) of 10 mmHg After each 
reduction in blood pressure a 15-min stabilization period ensured steady state. Steady 
state was assumed when carbon dioxide exchange was stable for at least six min. The 
mC02F-derived cardiac output was measured before manipulating cardiac output and 
after each stabilization period. Blood samples were taken from the different sampling 
sites for blood gas analysis, i.e. arterial blood from the abdominal aorta, and venous 
blood from the right atrium, superior vena cava and inferior vena cava. Gas analysis of 
the blood samples was done immediately after sampling using a Synthesis 25 analyzer 
(Instrumentation Laboratory, Barcelona, Spain). The stated 90%  confidence interval 
is ±2 mmHg for pC02, ±10 mpH for pH, ±0.25 mmol/L for hemoglobin concentration 
and ±1.5%  for oxygen saturation. Carbon dioxide exchange was measured using the 
C02SM0 Plus Respiratory Profile Monitor (Model 8100, Novametrix Medical Systems 
Inc, Wallingford, Connecticut, USA). According to the manufacturer, the bias of 
carbon dioxide measurement is -0 .8%  with a precision of ± 3.6% (11). At the time of 
measurement, the following data were recorded: atmospheric pressure (Patm), positive 
end-expiratory pressure (PEEP) level, systolic arterial blood pressure (SABP), mean 
arterial blood pressure (MABP), diastolic arterial blood pressure (DABP), rectal 
temperature (Trect J  and pulmonary blood flow via the Transonic flow probe (Qu,p).
At the end of the experiment the lamb was killed and the positions of the intravascular 
catheters were verified by autopsy.
Statistical analysis
The mC02F method-derived cardiac output (Q11'" ’1) was calculated using the results 
of blood gas analysis from the three different venous sample sites, respectively, right 
atrium, superior vena cava and inferior vena cava.
In order to evaluate the applicability of the mC02F method in monitoring the trend 
of cardiac output, correlation coefficients were assessed between Q -C02F and Qufp. Bias, 
defined as Q -C02F minus Qufp, was calculated for each measurement. For every venous 
sampling site mean bias with standard deviation (SD) was calculated. A t test was used 
to determine whether the bias was significantly different from zero. Bland-Altman plots 
were used to assess the agreement between cardiac output measurement using the 
mC02F method versus the pulmonary flow probe (12).
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» RESULTS
Table 1 shows the major hemodynamic data for each lamb at the start and the end of 
the experiment. Also the numbers of measurements per lamb and the total amount of 
blood withdrawn during the experiment are shown.
In all the lambs, a correct position of the intravascular catheters was observed during 
autopsy at the end of the experiment.
Agreement and correlation of cardiac output measurement obtained by the mC02F 
method and pulmonary flow probe for the three different venous sample sites are 
listed in Table 2. The mean bias was lowest with venous blood from the right atrium 
or superior vena cava. The biases were statistically significant different from zero 
(p < 0.01). Bland-Altman plots for the three different venous sample sites are shown in 
Figures 1 to 3. There was no significant relation between the bias and cardiac output.
Table 1. Hemodynamic data for each lamb during the experiment
Lamb# N delta CO 
(mL/min)
delta MABP 
(mmHg)
delta Sv02 
(percent)
Total
hemorrhage
(mL/kg)Start End Start End Start End
1 5 1050 460 71 39 78 40 41.0
2 4 700 480 31 17 72 59 31.0
3 5 740 230 57 19 66 14 37.1
4 4 1470 720 50 29 48 15 29.9
5 4 710 280 70 29 75 37 31.7
6 6 1150 250 64 21 62 13 48.9
7 2 1120 1010 83 60 63 55 21.9
CO: cardiac output; N: number o f  measurements; MABP: mean arterial blood pressure; SvO,; central venous 
oxygen saturation (sampled in right atrium)
Table 2 . Agreement and correlation ofQ"co2p and Q*»for thè 3 different venous sampling sites
Central venous 
sampling site
Mean bias* 
(L/min)
SD
(L/min)
LOA
(L/min)
Correlation
coefficient
RA -0.082 0.123 -0.328 to 0.164 0.93**
SVC -0.085 0.125 -0.335 to 0.165 0.92**
IVC -0.183 0.116 -0.415 to 0.049 0.93**
* bias = QmC°2F minus Q* ;  ** p<0.01 (t test fo r  correlation); IVC: inferior vena cava; LO A: limits o f  agreement; 
RA: right atrium; SD: standard deviation; SVC: superior vena cava
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(QmC02F + QUFP) /2 (m L/m iti)
Figure 1. Bland-Altman plot for the cardiac output bias (QmCO'r-0*) sampling the rizht atrium. Dashed 
line represents mean bias. Dotted lines represent limits o f agreement.
(Qmco2F + Qupp) / 2 (mL/min)
Figure 2. Bland-Altman plot for the cardiac output bias (QmCO'r-0*) sampling the superior vena cava. 
Dashed line represents mean bias. Dotted lines represent limits o f agreement.
(Qmco2F + q ufp) / 2 (m L/m in)
Figure 3. Bland-Altman plot for the cardiac output bias (QmCO'r-0*) sampling the inferior vena cava. 
Dashed line represents mean bias. Dotted lines represent limits o f agreement.
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»  DISCUSSION
This study shows that cardiac output can be measured reliably in ventilated newborn 
lambs with the mC02F method.
Monitoring cardiac function in neonates is difficult as there are no clinical parameters 
(solitary or in combination) that reliably predict cardiac output (4). This illustrates the 
need for an accurate method of cardiac output monitoring. Objective data reflecting the 
hemodynamic status of a critically ill newborn may lead to a more rational treatment.
In 1870 Adolph Fick described a method for cardiac output measurement using 
the principle of preservation of oxygen (13). Cardiac output can be calculated using 
oxygen consumption and arteriovenous oxygen concentration difference. This 
principle can be modified by using carbon dioxide exchange and venoarterial carbon 
dioxide concentration difference. In several methods of non-invasive cardiac output 
monitoring, the Fick principle is used. In the majority of these Fick-derived noninvasive 
methods, oxygen consumption is estimated by measuring carbon dioxide exchange 
and calculating oxygen consumption from an assumed respiratory quotient. The direct 
oxygen Fick method is regarded as the gold standard in cardiac output monitoring. We 
preferred a modified carbon dioxide Fick method, because this does not require any 
specific additional equipment, like a metabolic monitor. Rebreathing techniques are not 
safely applicable in newborns, because of its potential effect on cerebral blood flow by 
a fluctuating partial carbon dioxide pressure in blood (14). Several studies show that 
modified carbon dioxide methods are at least as accurate as the oxygen Fick method 
(15-17).
From all published methods for calculating total carbon dioxide concentration in 
blood, we selected the Douglas equation (10). Unfortunately, it is not known whether 
this algorithm is also applicable to fetal and/or neonatal blood.
In this study the ductus arteriosus was ligated to exclude any influence of a ductal 
shunt on the measurement of pulmonary blood flow. Theoretically, the carbon dioxide 
Fick equation for calculating systemic blood flow should not be influenced by any 
intracardiac and/or intrapulmonary shunt, as long as the measurement is performed 
in steady state. Steady state is a prerequisite for the Fick principle, as only under 
these circumstances does carbon dioxide exchange equal carbon dioxide production. 
As with every method of cardiac output measurement, the obtained value of cardiac 
output should be interpreted with knowledge of the actual hemodynamic circuit with 
the potential existence of shunts. Possible limitations of the mC02F method are the 
potential calculation errors due to a too small venoarterial carbon dioxide concentration 
difference.
In this study, the lambs were ventilated via a cuffed endotracheal tube. However, 
newborns are always intubated with an uncuffed tube. One should be cautious in 
interpreting cardiac output values in the presence of an endotracheal tube leakage. 
A large leakage of the endotracheal tube leads to an underestimation of pulmonary 
carbon dioxide exchange and will result in a falsely lower cardiac output.
The mC02F method of measuring cardiac output requires a steady state. The most 
interesting moments for cardiac output measurements are probably characterized by 
an absence of steady state. However, in our model, we were able to determine cardiac 
output reliably in hemodynamic unstable lambs, when defining steady state as steady
114
carbon dioxide exchange for at least 6 min.
Sampling the right atrium for measuring the venous carbon dioxide concentration 
resulted in the most accurate calculated cardiac output. In general, in patients in a 
neonatal intensive care unit, the tip of a central venous catheter is positioned in the 
transition zone between the right atrium and superior or inferior vena cava. However, 
this study shows that the position of the tip of the central venous catheter, in the inferior 
or superior vena cava, has no significant influence on the measurement of cardiac 
output with the modified carbon dioxide Fick method.
In this study, mC02F-derived cardiac output underestimated pulmonary blood flow. 
Although statistically significant, the bias is small and of no clinical relevance.
An evaluation of the mC02F method according to the eight desirable characteristics 
for cardiac output monitoring described by Shephard et al. (18) shows that the accuracy 
and reproducibility are adequate and that the method is easy to apply and operator 
independent.
Several methods for cardiac output measurement in children are available, such as 
thermodilution, oxygen Fick and dye indicator techniques, bioimpedance, and Doppler 
echocardiography. These methods differ in applicability due to technical and size 
constraints and reliability (1-3). In comparison with published data concerning bias 
and precision of several methods of cardiac output measurement in animals (19-22), 
children (23-30), and adults (31-38), this study produced favorable results.
Without the use of additional equipment, one can measure cardiac output by the 
mC02F method. It requires gas analysis of both arterial and central venous blood as 
well as of expiratory air by in-line capnography and simultaneous measurement of 
expiratory airflow. Usually, this is feasible in critically ill patients in a neonatal intensive 
care. This suggests that the method may be cost-effective without a risk of additional 
morbidity or mortality. Unfortunately, the response time of this method is not very fast 
because steady state is a prerequisite. This also implies a semicontinuous method of 
cardiac output monitoring.
We conclude that measurement of cardiac output with the mC02F method is reliable 
in newborn lambs without a ductal shunt and can be used for trend monitoring. Venous 
blood sampling from the right atrium, superior vena cava or inferior vena cava can be 
used for this measurement. The mC02F method is a promising technique that can be 
used to measure cardiac output in critically ill newborns.
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ABSTRACT
Background: It remains a great challenge to measure systemic blood flow in critically 
ill newborns. In a fo rm er study we validated the modified carbon dioxide Fick (mCOF) 
method fo r  measurement ofcardiac output in a newborn lamb model. In this new study we 
studied the influence o f a left-to-right shunt on the accuracy o f the mCOF method. 
Objective: To analyze the influence o f a left-to-right shunt on the agreem ent between 
cardiac output measurement with the mCO F method and ultrasonic transit time 
pulmonary blood flow in a lamb model.
Methods: The study was approved by the Ethical Committee on Animal Research o f  
the Radboud University Nijmegen and perform ed in 8  random-bred lambs. A Gore-Tex 
shunt was placed between the left pulmonary artery and the descending aorta. This 
aortopulmonary shunt was intermittently opened and closed, while cardiac output was 
manipulated by creating hemorrhagic hypotension. Cardiac output m easurement with the 
mCO F method ( QmC02F)  was compared with pulmonary blood flow obtained by a transit 
time ultrasonic flow probe positioned around the common pulmonary artery (QAK). 
Results: Bias, defined as QmC02F minus Q "', was calculated fo r  each measurement. With 
an open shunt there was a significant left-to-right shunt (mean Qp/Qs ratio 2.26; range 
1.56-3.69). Mean bias (SD) was -12,3 (50.4) m l/kg/m in and -12,3 (42.7) ml/kg/m in  
fo r  measurements with a closed and open shunt, respectively (no statistical significant 
difference).
Conclusions: Cardiac output measurement with the mCO F method is reliable and easily 
applicable in ventilated newborn lambs, also in the presence o f a significant left-to-right 
shunt.
INTRODUCTION
In neonates, cardiac output is usually estimated from indirect parameters of systemic 
blood flow, like blood pressure, urine output, blood gas analysis and capillary refill time, 
but these clinical variables are unreliable [1], Objective cardiac output measurement 
remains very complicated in newborns. This is related to the specific cardiovascular 
changes that occur in the transition from fetus to newborn. The presence of intra- and/ 
or extracardiac shunts potentially reduces the reliability of most methods of cardiac 
output measurement available in infants and adults. Moreover, several technologies 
of cardiac output monitoring cannot be applied to critically ill newborns due to size 
restraints and the use of potentially toxic indicators. Functional echocardiography is 
increasingly used in neonatal intensive care units for the assessment of cardiac output 
(left ventricular output and right ventricular output) and cardiac input (superior vena 
cava flow). It also provides the clinician with information about myocardial function, 
intra- and extracardiac shunts, organ blood flow, and tissue perfusion [2, 3], However, 
not every neonatologist is skilled in functional echocardiography.
In search of a reliable, easy applicable, (semi)continuous method of objective cardiac 
output measurement in critically ill newborns, we previously validated the modified 
carbon dioxide Fick (mC02F) [4], In general, the direct oxygen Fick method is regarded 
as the gold standard in cardiac output measurement. We prefer the mC02F method, 
because it does not require any specific additional equipment, such as metabolic
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monitor. We concluded that measurement of cardiac output with the mC02F method 
is reliable in newborn lambs without a ductal shunt and that it can be used for trend 
monitoring. It was shown that venous blood sampling from the right atrium, superior 
vena cava or inferior vena cava could all be used, although sampling the right atrium 
for measurement of the venous carbon dioxide concentration resulted in the most 
accurate calculated cardiac output. In that study, the ductus arteriosus was ligated to 
exclude any influence of a potential shunt on the cardiac output measurement. We 
stated that theoretically the mC02F method is not influenced by any intracardiac and/ 
or intrapulmonary shunt, as long as the measurement is done in a phase of steady state.
In the current study we analyzed the influence of a left-to-right shunt on the accuracy 
of the mC02F method in a lamb model.
»  MATERIALS AND METHODS
We compared mC02F-derived cardiac output (Q11'" ’1] with pulmonary blood flow mea­
sured with a perivascular ultrasonic flow probe (Q pc] positioned around the common 
pulmonary artery.
Modified carbon dioxide Fick method
According to the Fick principle, carbon dioxide production [CO P] in tissue equals 
pulmonary carbon dioxide exchange [VCO ] in a steady state.
In a ventilated patient pulmonary carbon dioxide exchange can be measured using 
a computer-aided analysis of expiratory airflow (Q ,p] and carbon dioxide fraction in 
expiratory air (FeCO J .
Equation 1
T
VC02 = { jQ Exp[tyF eC 02[t y d t }x T - '
0
VCO = carbon dioxide exchange (L/min); Q = expiratory airflow (L/min) ; FeC02 = carbon dioxide fraction in 
expiratory air (gradient); T = time (min)
Carbon dioxide production [CO P] is the product of cardiac output [Q] and the veno­
arterial difference in carbon dioxide concentration (C(v jC02].
Equation 2
C02P = Q-[CvC02 -CaC02)
C02P = carbon dioxide production (mL/min); Q = cardiac output (L/min); CvC02 = venous carbon dioxide concen­
tration (mL/L); CaC02 = arterial carbon dioxide concentration (mL/L)
Carbon dioxide concentration in blood (chCO] can be measured using different 
methods, depending on the calculation method of carbon dioxide concentration in the 
erythrocyte [5 -8 ], In this study we used the Douglas equation [8]:
Equation 3
™  [0 . 0 2 8 9 -cHb)
c CO = c  CO ■{ 1 ----------------------------------------------- }
b 2 p 2 (3 .352  -  0 .456  • s02 )• (8 .142  -  pH)
c CO = total carbon dioxide concentration in plasma (m L/100 mL); cbC02 = total carbon dioxide concentration in 
blood (mL/100 mL); cHb = hemoglobin concentration (g/dL); s02 = oxygen saturation (gradient)
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Total carbon dioxide concentration in plasma [c CO ] is calculated with the use of the 
Henderson-Hasselbalch equation:
Equation 4
cC 0 2 = total carbon dioxide concentration in plasma (mL/100 mL); 2.226 = conversion factor mEq to mL/100 
mL; s = solubility coefficient o f  carbon dioxide in plasma (mEq/mmHg); pK' = apparent pK; pC02 = partial carbon 
dioxide pressure (mmHg)
Equation 5
s = 0.0307 + 0.00057 -(37 -  T)-{37  -  T f
s = solubility coefficient o f  carbon dioxide in plasma (mEq/mmHg); T = temperature (°C)
Equation 6
p K ’ = 6.086 + [0.042• [7.4 -  p H )] + {[38  -  T ) • [0.0047 + 0.00139• [7.4 -  p H )]}
For use in calculations C02P and VC02 need to be converted into 'Standard Temperature 
Pressure, Dry’ (STPD) conditions.
Equation 7
T  ( P BTPS- p H O )
CO p STPD = CO PBTPS ■ ■ —______
2 2 rpBTPS p
CO2P STPD = carbon dioxide production under STPD conditions; CO2P BTPS = carbon dioxide production under BTPS 
conditions; BTPS = Body Temperature Pressure, Saturated; Tg = standard temperature (273K); t btps = tem pera­
ture under BTPS (K); P BTPS = pressure under BTPS conditions (kPa); pH20 = partial pressure o f  water vapor at T 
Brps (kpa] ; = standard pressure (101.4 kPa)
VC02stpd = pulmonary carbon dioxide exchange under STPD conditions; VC02 ATPS = pulmonary carbon dioxide 
exchange under ATPS conditions; ATPS = Ambient Temperature Pressure, Saturated; Tg = standard temperature 
(273K); TATPS = ambient temperature (K); P ATPS = pressure under ATPS conditions (kPa); pH20 = partial pressure 
o f  water vapor at t atps (kPa); Pg = standard pressure (101.4 kPa)
Then, cardiac output can be calculated using the following equation.
Equation 9
Q = cardiac output (L/min); (VCOJSTPO = pulmonary carbon dioxide exchange under STPD conditions (mL/min); 
(C a)COJSTPD = veno-arterial difference in carbon dioxide concentration under STPD conditions (mL/L)
Animal preparation
The study was approved by the Ethical Committee on Animal Research of the Radboud 
University Nijmegen (RU-DEC #2005-034) and performed in 8 random-bred lambs (4.7-
c C 0 2 = 2.22 6 -s-pC02 •(! + 10pH"pr)
Equation 8
iSTPD
i STPD
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12.5 kg) in accordance with the Dutch national legislation concerning the guidelines for 
the care and use of laboratory animals. After intramuscular administration of midazolam 
(2 mg/kg), pentobarbital (15-20 mg/kg) and ketamine (10-15 mg/kg) the lambs were 
orotracheally intubated with a cuffed endotracheal tube (ID 5-6 mm; Kruse, Marslev, 
Denmark). The lambs were mechanically ventilated in a pressure control mode with a 
Babylog 8000 Plus ventilator (Dràger Medizintechnik, Lübeck, Germany). Anesthesia 
was maintained using the continuous intravenous administration of sufentanil (20 \vg/ 
kg/min), midazolam (0.2 mg/kg/hr), ketamine (0.16 mg/kg/min) and pancuronium 
(loading dose 0.05 mg/kg; maintenance dose 0.02 mg/kg/hr). The ventilator settings 
were adjusted in order to aim at normoxemia (pa02 75-113 torr (10-15 kPa)) and 
normocapnia (paC02 30-41 torr (4.0-5.5 kPa)). A servo-controlled heating mattress was 
used to maintain the rectal temperature between 38 and 40°C. Intravascular catheters 
were surgically inserted. The arterial catheter was inserted via the femoral artery 
with a position of the tip in the abdominal aorta. The venous catheter was inserted via 
the femoral vein with the tip in the right atrium. The position of the tip of the venous 
catheter was estimated using a pressure curve during insertion. The final position of 
the venous line was evaluated post mortem. A left-sided thoracotomy was performed 
and after preparation of the common pulmonary artery, the left pulmonary artery and 
the descending aorta the native ductus arteriosus was ligated. A non-stretch, thin- 
walled vascular graft (ID 6 mm, Gore-Tex", W.L. Gore & Associates Inc., Arizona, USA) 
was inserted between the left pulmonary artery and the descending aorta. Adequately 
sized perivascular ultrasonic flow probes (PAX series, Transonic1 Systems Inc., Ithaca, 
USA) were placed around the common pulmonary artery (QAPC) and proximal (Q "'"') and 
distal (QA°posi) to the aortopulmonary shunt on the descending aorta.
Experimental protocol
After a stabilization period of 30 minutes the study protocol was started (Figure 1). 
Figure 1. Study protocol. Crosses indicate the timing of measurements.
Intermittently the aortopulmonary shunt was fully opened and closed during the 
experiment. Next to this, cardiac output was manipulated by creating hemorrhagic 
hypotension by stepwise withdrawal of blood from the venous catheter to obtain a 
decrease in mean arterial blood pressure (MABP) of 10 mmHg. After each intervention 
(shunt opening or closure, blood withdrawal) a 30-min period of stabilization was used 
in order to ensure steady state. Steady state was assumed when pulmonary carbon
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dioxide exchange was stable for at least 6 min. After stabilization blood samples were 
taken from the right atrium and abdominal aorta. Blood gas analysis was performed 
immediately after sampling using a GEM Premier 3000™ analyzer combined with co­
oximetry with the GEM OPL™ (Instrumentation Laboratory Barcelona, Spain).
Carbon dioxide exchange was measured continuously with the C02SM0 Plus 
Respiratory Profile Monitor (Model 8100, Respironics, Pittsburgh, USA). Accordingto the 
manufacturer the bias of carbon dioxide measurement is -0.8% with a accuracy of ± 3.6% 
[9], We used biomedical data acquisition software (Poly, Inspektor Research Systems 
BV, Amsterdam, The Netherlands) to store the following data during the experiment 
with a 200 Hz sampling rate: pulmonary blood flow (QAPC), aortic blood flow proximal
(Q op") and distal (Q ...sl) to aortopulmonary shunt, systolic arterial blood pressure
(SABP), mean arterial blood pressure (MABP), diastolic arterial blood pressure (DABP), 
rectal temperature (Trect J  and PEEP-level. The shunt flow was calculated as the difference 
between Q'.... and Q'!)|il". The Qp/Qs ratio was calculated using the following equation:
Equation 10
r)APC r\AOpre /-xAOpost
Qp/Qs = ------ ------—-----x  q A P C
Qp = pulmonary blood flow ; Qs = systemic blood flow; QAPC = main pulmonary blood flow; QAOpre = aortic blood flow  
proximal to aortopulmonary shunt; Q A0P°st = aortic blood flow  distal to aortopulmonary shunt
The lamb was sacrificed at the end of the experiment after which the position of the 
venous catheter was verified by autopsy. Likewise the flow probes were checked for 
zero flow value directly post mortem.
Statistical analysis
After each intervention mC02F-derived cardiac output (Q11'" ’1) was measured and 
compared with pulmonary blood flow (QAPC). The method described by Bland and Alt­
man was used to assess the agreement between the two methods of cardiac output 
measurement (Qlii0)'>r and QAPC) [10]. Mean bias, defined as Q»™2p minus QAPC, with standard 
deviation (SD) was calculated for the measurements with an open aortopulmonary 
shunt versus the measurements with a closed shunt. Limits of agreement are defined as 
mean bias ± 1.96 SD. The differences in mean bias between measurements with a closed 
and an open aortopulmonary shunt were statistically analyzed using the Mann-Whitney 
test. A p value of < 0.05 is considered statistically significant. Data management was 
performed using Excel for Windows1 (Office 2003, Microsoft, Seattle, USA) and SPSS 
14.0.2 for Windows1 (SPSS Inc., Chicago, USA) was used for statistical analysis.
»  RESULTS
Hemodynamic data for each lamb are shown in Table 1. With an open shunt mean Qp/ 
Qs ratio was 2.26 (range: 1.56 - 3.69). With the aortopulmonary shunt opened the mean 
aortic blood flow proximal to the shunt (QA°p™) was 1395 mL/min (range: 830-1950 mL/ 
min) and distal to the shunt (QA°p°s') the mean aortic blood flow was 511 mL/min (range: 
310-952 mL/min). At autopsy a correct position of the venous line with the tip in the 
right atrium was observed in all the lambs.
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Table 1. Hemodynamic data for each lamb during the experiment
Lamb#
MABP (mmHg) Scv0 2  (%) Qp/Qs-
ratio
Total hemorrhage 
(mL/kg)
N
Max Min Max Min
1 8 56 2 8 62 42 2 .1 6 13.2
2 8 53 35 70 48 1 .56 5.1
3 5 78 29 60 18 1.65 3.2
4 8 6 4 38 61 40 1.93 7.4
5 8 76 4 0 63 32 3 .10 15 .8
6 8 68 4 4 59 43 1.95 9.5
7 8 62 43 66 49 3.69 7.5
8 8 5 4 36 57 41 2 .03 1 8 .4
N: number o f  measurements; MABP: mean arterial blood pressure; Scv02: central venous oxygen saturation 
(sampled in right atrium); Qp: pulmonary blood flow ; Qs: systemic blood flow
The difference between cardiac output obtained by the mC0 2F method and pulmonary 
blood flow is listed in Table 2 . Mean bias (SD) was -12.3  (4 2 .7 ) ml/kg/min and -12.3 
(5 0 .4 ) ml/kg/min for measurements with an open and closed aortopulmonary shunt 
respectively. There was no significant difference between cardiac output measurements 
during an open or a closed shunt. The mean bias was not statistically significant different 
from zero.
Table 2. Difference between cardiac output obtained by the modified carbon dioxide Fick method 
(Q”co!p) and pulmonaiy blood flow (Qafc] with or without aortopulmonaiy left-to-right shunt.
Q m C 0 2 F  _  QAPC
mL/kg/min
Left-to-right shunt
p value*present absent
Mean -12.3 -12.3 0 .629
(9 5 % Cl) (-2 7 .9  to 3 .3 9 ) (-31.2  to 6 .4 9 )
SD 4 2 .7 5 0 .4
LOA -9 6 .0  to 7 1 .4 -1 1 1 .1  to 85.5
* Mann-Wlìitney test; CI: confidence interval; SD: standard deviation; LOA: limits o f  agreement
We excluded one measurement from the 5 ,h experiment because there was a non- 
physiological negative venoarterial carbon dioxide concentration difference in a phase 
with a closed aortopulmonary shunt. This was probably due to a pre-analytical error 
in the measurement of the venoarterial carbon dioxide concentration difference. The 
Bland-Altman plot is shown in Figure 2 for the combined measurement with an open 
and closed aortopulmonary shunt. Mean bias was -12.3  ml/kg/min with a precision 
(1 ,96  SD) of ± 9 0 .5  ml/kg/min. The limits of agreement are -1 0 2 .8  and 78.2  ml/kg/min, 
respectively.
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Figure 2. Bland-Altman plot for comparison of the modified carbon dioxide Fick-derived cardiac 
output (Q^o!r) and pulmonaiy blood flow (QAFC], The dashed line represents mean bias and the dotted 
lines represent limits of agreement for all data (open and closed shunt],
»  DISCUSSION
Treatment of critically ill and hemodynamically unstable newborns remains a major 
challenge. It is very difficult to estimate cardiac output from clinical variables like blood 
pressure, heart rate, urine production, blood gas analysis et cetera [1 1 -1 3 ], Knowledge 
of the actual cardiac output likely improves the indication and choice of subsequent 
treatment and the response to the intervention can be monitored and evaluated. This 
could prevent iatrogenic damage due to both under- and overtreatment. For example, 
recent studies show that a too vigorous fluid therapy is associated with increased 
morbidity and mortality in adults [1 4 -1 6 ], It still has to be proven that goal-directed 
therapy using cardiac output measurement will eventually lead to a better outcome 
on the short and long term. Cardiac output measurement is available in children using 
several techniques [1 7 -2 1 ], but remains complicated in the newborn.
In a former study we validated the mC0 2F method for measurement of cardiac output 
in newborn lambs [4 ], In that study, the ductus arteriosus was ligated on purpose to 
exclude any influence of a ductal shunt on the measurements. However, in a neonatal 
intensive care unit the incidence of a patent ductus arteriosus varies between 20%  to 
6 0 % depending on the diagnostic criteria and the population studied [2 2 ], Theoretically, 
as long as measurements are performed in a steady state, the mC0 2F method should 
not be influenced by any intracardiac and/or intrapulmonary shunt. Carbon dioxide 
production is calculated as the difference between carbon dioxide concentration in 
venous and arterial blood. This carbon dioxide is produced in the peripheral tissues. 
Although the venous and/or arterial carbon dioxide concentration can be influenced 
by any shunt (left-to right or right-to-left), in case of a steady state there cannot be 
a misbalance between systemic carbon dioxide production and pulmonary carbon 
dioxide exchange. mC0 2F derived cardiac output can represent systemic blood flow 
and/or pulmonary blood flow, which depends on the site of blood sampling in relation
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to the position of a possible shunt. Shunting of blood will influence the venoarterial 
carbon dioxide concentration difference. One should be aware whether the systemic 
or the pulmonary venoarterial carbon dioxide concentration difference is measured. 
Regardless of the method of cardiac output measurement used, it is of the utmost 
importance to be informed about potential intra- and extracardiac shunts in order to 
correctly interpret the assessed cardiac output. This emphasizes the importance of 
functional echocardiography in critically ill newborns [2, 3], In case of a left-to-right 
shunt distal to the right atrium, for example a patent ductus arteriosus, Q1"01-’1 will 
represent systemic blood flow (Qs), because the venous carbon dioxide concentration is 
not influenced by the left-to-right shunt. A significant left-to-right shunt through a patent 
ductus arteriosus will lead to an increased left ventricular output and a decreased right 
ventricular output. Measurement of cardiac output with the mC02F method in patients 
with a patent ductus arteriosus will inform the clinician about the systemic blood flow,
i.e. the right ventricular output. Q1"01-’1 in a patient with a left-to-right shunt proximal to 
or at the right atrium, for example an open foramen ovale, will represent pulmonary 
blood flow (Qp). This is explained by the fact that venous carbon dioxide concentration 
is decreased by mixing of central venous blood with pulmonary venous blood through 
the foramen ovale. In fact, by sampling venous blood in the right atrium one measures 
the pulmonary carbon dioxide concentration difference instead of the systemic carbon 
dioxide concentration difference. The interpretation of Q1"01-’1 in the presence of a shunt is 
summarized in Table 3.
Table 3. Interpretation ofmCO,F-derived cardiac output (Q^o!f) in the presence of shunts.
No shunt Qm C02F _  QS _  Qp
Left-to-right shunt
Venous sampling site
Proximal to shunt Q „ C 0 2 F  =  Qs
Distal to/at level of shunt Q „ C 0 2 F  =  Qp
Right-to-left shunt
Arterial sampling site
Proximal to shunt Q „ C 0 2 F  =  Qp
Distal to/at level of shunt Q „ C 0 2 F  =  Qs
Qs: systemic blood flow ; Qp: pulmonary blood flow
In this study, we verified the assumption that a persistent left-to-right shunt does not 
have any influence on cardiac output measurement using the mC02F method. In order to 
verify this hypothesis, we conducted this study after construction of an aortopulmonary 
shunt (artificial ductus arteriosus) and measurements were done intermittently with 
an open and closed left-to-right shunt. As is shown in Table 2, the mC02F method is 
not influenced by the shunt, which suggests that this method is applicable for cardiac 
output measurement in critically ill newborns.
The bias and precision found in this study during a closed aortopulmonary shunt are 
consistent with the results of our former study [4], when sampling venous blood from 
the right atrium. This implies a good reproducibility of cardiac output measurements 
with the mC02F method.
Systemic blood flow was underestimated by the mC02F method (mean -12,3 mL/kg/ 
min) with or without a left-to-right shunt, but this bias was not significantly different
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from zero. For clinical purposes one is interested in categorizing the level of systemic 
blood flow (high, high-to-normal, normal, normal-to-low or low) and being able to 
monitor fluctuations in response to different interventions. This implies that small 
biases are clinically irrelevant.
A prerequisite for the Fick principle is that measurements are done in a steady state. 
Despite the fact that the lambs were hemodynamically very unstable with a Qp/Qs ratio 
up to 3.5, systemic blood flow was measured reliably when defining steady state as 
steady pulmonary carbon dioxide exchange for at least 6 min.
Cardiac output measurements in this study were done using a cuffed endotracheal 
tube. Newborns are generally intubated with an uncuffed endotracheal tube. Because 
endotracheal tube leakage will result in a falsely decreased pulmonary carbon dioxide 
exchange and therefore an underestimation of systemic blood flow, one should be 
cautious measuring cardiac output with the mC02F method in the presence of a large 
expiratory endotracheal tube leakage. Tube leakage is usually defined as the difference 
between inspiratory tidal volume (VTins) and expiratory tidal volume (VTexp) [23,24], 
The leak size is expressed in percentage, calculated by the following equation:
Equation 11
^  i i i VTexn-VTins
Tube leakage = -------------------- 100%
VTins
VTexp= expiratory tidal volume; VTins = inspiratory tidal volume
Kondo et al. demonstrated that endotracheal tube leakage was predominantly 
observed during the inspiratory phase, especially at end-inspiration [25], In this model 
study they showed that with a volume leak of 22%  the error in expiratory volume 
measured at the airway opening was only 3%. In a worst-case scenario the 3% missed 
expiratory volume solely consists of carbon dioxide, which would mean a falsely 
decreased pulmonary C02 exchange (VCO J  of 3%. According the equation to calculate 
the mC02F-derived cardiac output (VC02 + (C(v jC02]], this means that an endotracheal 
tube leakage of 22%  can lead to a underestimation of cardiac output with 3% at most.
Acute changes in pulmonary gas exchange (for example pneumothorax or atelectasis) 
will influence pulmonary carbon dioxide exchange for a specific period. In this acute 
phase the mC02F method cannot be used to measure cardiac output, because a steady 
state is a prerequisite. But as soon as a new homeostasis has been established with 
a stable pulmonary carbon dioxide exchange (in general within minutes), one can 
measure systemic blood flow with the mC02F method.
The accuracy of the mC02F method is highly dependent on accurate measurement 
of both pulmonary carbon dioxide exchange and carbon dioxide concentration 
measurements in arterial and venous blood. We chose the equation of Douglas to 
calculate the carbon dioxide concentration in blood [8], although it is not known 
whether this equation can be used for fetal and neonatal blood as well. In this study we 
used routine blood gas analysis and pulmonary carbon dioxide exchange measurement 
with satisfactory results.
Most methods of cardiac output measurements, especially indicator dilution 
techniques, are not applicable in patients with shunts. This excludes several categories 
of patients that could potentially benefit from measurements of systemic blood flow, like 
premature neonates with a patent ductus arteriosus and patients with cardiac defects. 
In these patients cardiac output can be measured with the mC02F method despite their
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shunts.
The mC02F method can be applied without any additional equipment, because it 
only requires gas analysis of arterial and central venous (right atrial) blood, as well 
of expiratory air by in-line capnography and simultaneous measurement of expiratory 
airflow. This is usually feasible in critically ill patients on an intensive care.
Our study has several limitations. It was not possible to directly measure blood flow in 
the aortopulmonary shunt, because of the limited length of the shunt and the material 
used (Gore-Tex1). Ultrasound does not pass the Gore-Tex1 material, which implies we 
could not use the ultrasound transit time flow probe to measure the blood flow in the 
aortopulmonary shunt. Although the registered flow patterns in the descending aorta
distal to the shunt (Q ...sl) were not consistent with a partly right-to-left shunt, we
cannot rule out that there was some right-to-left shunting in early systole.
An interatrial shunt is frequently seen in preterm infants with a patent ductus 
arteriosus with a left-to right shunt. In preterm infants < 1500 grams with a 'wide 
open’ ductus Evans and Iyer found a left-to-right and bidirectional interatrial shunt in 
respectively 44.5%  and 55.5% of the selected population [26], As no echocardiographic 
studies could be performed during the experiment, we are not informed about a possible 
interatrial shunt in the phases with an open aortopulmonary shunt. In the presence of a 
left-to-right shunt at both the ductal and interatrial level the veno-arterial carbon dioxide 
concentration difference will be decreased because of the interatrial shunting of blood. 
This will lead to a decreased veno-arterial carbon dioxide concentration difference and 
therefore an overestimation of systemic blood flow (Qs). Because the site of venous 
blood sampling is proximal to the ductal shunt the mC02F-derived cardiac output will 
underestimate the pulmonary blood flow (Qp). In conclusion, in case of a left-to-right 
shunt both at the interatrial and ductal level the mC02F method will represent a level in 
between Qp and Qs. The greater the ductal shunt in relation to the interatrial shunt, the 
more Q1"01-’1 will approach Qs.
»  CONCLUSION
We conclude that cardiac output (systemic blood flow) can be measured reliably in 
newborn lambs with the use of the mC02F method, even in the presence of a significant 
left-to-right shunt. This makes the mC02F method a promising technique for cardiac 
output measurement in critically ill patients with or without intra- and/or extracardiac 
shunts.
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ABSTRACT
Objective: To assess agreem ent between a new method o f cardiac output monitoring, 
using ultrasound dilution technology and ultrasound transit time-based measurement o f  
pulmonary blood flow in a piglet model.
Design; Prospective, experimental juvenile animal study.
Setting: Animal laboratory o f a university hospital.
Subjects: Nine random-bred piglets.
Interventions: After the animals received general anesthesia, we placed intravascular 
catheters with the tip positioned in the abdominal aorta and the right atrium, respectively. 
The catheters were connected to the ultrasound dilution cardiac output monitor. An 
ultrasound transit time perivascular flow probe was positioned around the common 
pulmonary artery and served as the standard reference measurement. Cardiac output was 
manipulated during the experiment by creating hemorrhagic hypotension. Ultrasound 
dilution cardiac output was measured intermittently with injection volumes o f 0.5 mL/kg 
and 1.0 m L/kg o f isotonic saline at body temperature.
Measurements and main results: Ultrasound Dilution Cardiac Output (Q"""’]  
measurement was compared with pulmonary blood flow (Q/IC). Bias, defined as Q"DC0 
minus Qapc, was calculated fo r  each measurement. Mean bias with standard deviation was 
calculated fo r measurements with volumes o f injected saline o f 0.5 m L/kg and 1.0 mL/kg, 
and compared using the Mann-Whitney U test. Mean bias (SD) between QUDC0 and QAPC was 
0.040 (0.132) and 0.058 (0.136) L /m infor measurement with 0.5 mL/kg and 1.0 mL/kg 
isotonic saline, respectively (no statistically significant difference).
Conclusions: Ultrasound dilution cardiac output measurement is reliable in piglets with 
the use o f  a small volume o f a nontoxic indicator (isotonic saline).
INTRODUCTION
Several techniques of cardiac output measurement in critically ill patients have been 
described in the literature (1 -5 ). Objective measurement of systemic blood flow remains 
very complicated in newborns. The most used technique for the assessment of cardiac 
output in the neonatal intensive care unit is clinical estimation. This clinical estimation 
of cardiac output, based on the interpretation of indirect parameters of systemic blood 
flow, like blood pressure, urine output, capillary refill time, core-peripheral temperature 
difference, and blood gas analysis has been proven to be unreliable (6).
Ultrasound dilution technology was introduced in 1 9 9 5  and has been used to measure 
several hemodynamic parameters in patients during hemodialysis (7 -1 1 ). More recently, 
this technique has been adapted for cardiac output measurement and tested in vitro 
(1 2 ) and in vivo in animals (1 3 -1 5 ), adults (1 6 , 1 7 ) and infants (1 5 , 1 8 ), using isotonic 
saline as an indicator that is injected in a low-volume extracorporeal arteriovenous 
(AV) tubing loop inserted between an indwelling arterial and central venous catheter.
The velocity of ultrasound in blood varies between 1 5 6 0  and 1 5 8 5  m/s depending 
on total blood protein, temperature, and ion concentration in plasma. In contrast, the 
ultrasound velocity in isotonic saline is only 1 5 3 3  m/s. Injection of isotonic saline into 
the blood stream will thus lead to a decrease in ultrasound velocity and this can be 
used to obtain a dilution curve. For placement of flow and dilution sensors on both
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the venous and arterial site of the circulation, an extracorporeal circuit is constructed 
by connecting a disposable AV loop between an arterial and central venous catheter 
(Figure 1).
Figure 1. Schematic set-up ofultrasounddilution cardiac output measurement.
AV loops are available for different patient sizes with 
a priming volume varying from 0.9 to 2.4 mL. Reusable 
sensors, which both detect transit time blood flow and 
ultrasound velocity, are clamped on the arterial and 
venous limbs of the AV loop. A peristaltic pump is used 
to circulate the blood through the AV loop at a speed 
of 6-12 mL/min for a period of 5-6 minutes during 
cardiac output measurements. This pump is to prevent 
a periodically unstable blood flow. Isotonic saline 
(NaCl 0.9%), heated to body temperature, is quickly 
injected in a volume of 0.5 to 1.0 mL/kg into the venous 
limb of the AV loop. The venous sensor calculates the exact amount of injected isotonic 
saline automatically and also measures ultrasound velocity of the used saline (12). The 
arterial sensor measures the decrease in ultrasound velocity and an ultrasound dilution 
curve is obtained. With the use of the Stewart-Hamilton principle, cardiac output can be 
calculated with the following equation (12).
Equation 1
CO = cardiac output (mL/min); Vinj = volume o f  injected isotonic saline, measured by the venous sensor (mL); 
Ca(t) = concentration o f  injected saline in arterial blood [mL[saline]/mL[blood]); $Ca(t)dt = area under dilution 
curve o f  saline concentration in arterial blood, measured by the arterial sensor (mL[saIine]/mL [blood] x min)
The primary objective of this study was to assess the agreement between cardiac 
output measurements with the ultrasound dilution technology (QUDC0) and pulmonary 
blood flow (QAPC) measured with an ultrasound transit time flow meter in a piglet model. 
The secondary objective was to evaluate the difference in accuracy of the ultrasound 
dilution technique with the use of an injection volume of 0.5 mL/kg versus 1.0 mL/kg 
of isotonic saline.
»  MATERIALS AND METHODS
We compared the measurement of cardiac output with ultrasound dilution technology 
(qudcoj wj^1 simultaneously measured pulmonary blood flow with a perivascular 
ultrasonic transit time flow probe (QAPC) positioned around the common pulmonary 
artery. Measurement of pulmonary blood flow with a transit time ultrasonic flow probe 
is regarded as the gold standard for cardiac output measurement in an animal model 
(19).
Ultrasound dilution cardiac output (UDCO)
For the measurement of QUDC0, we used the HCM 101 monitor, which is a prototype of
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the CO status™ System (Transonic Systems Inc., Ithaca, USA) that recently received Food 
and Drug Administration (FDA) approval for hemodynamic monitoring in children (> 2 
years of age), adolescents, and adults. Before injection, the isotonic saline was heated to 
body temperature in a fluid warmer (HFW 1 0 0 0 , Transonic Systems Inc., Ithaca, USA). 
Isotonic saline was injected as fast as possible in the venous limb of the extracorporeal 
circuit of the UDCO system.
Animal preparation
The study was approved by the Ethical Committee on Animal Research of the Radboud 
University Nijmegen (RU-DEC # 2 0 0 7 -1 4 4 ) and performed in 9 random-bred piglets 
(3 .5 -7.0 kg) in accordance with the Dutch national legislation concerning the guidelines 
for the care and use of laboratory animals. The piglets were not fed for 12  hours 
before the experiment. Ketamine (1 0  mg/kg), atropine (0.03  mg/kg) and midazolam 
(0.5  mg/kg) were administered intramuscular as premedication. After intravenous 
injection of propofol (2-3  mg/kg) the piglets were orotracheally intubated with a 
cuffed endotracheal tube (ID 4-5  mm; Kruse, Marslev, Denmark). The animals were 
mechanically ventilated in a pressure control mode, using a Datex Ohmeda Excel 2 1 0  SE 
anesthesia machine (GE Healthcare (formerly Datex Ohmeda), Waukesha, Wisconsin, 
USA). Anesthesia was maintained with inhalation of isoflurane (0 .5 -2.0  vol%), and the 
intravenous administration of fentanyl (5 -2 0  |.ig/kg/hr) and midazolam (0.5  mg/kg/hr). 
During the thoracotomy muscle paralysis was achieved with pancuronium (0.1  mg/kg 
intravenous). The ventilatory settings were adjusted to maintain normoxemia (sa0 2 9 0 - 
9 5 %) and normocapnia (paC0 2 3 0 -4 5  mmHg [4 .0 -6.0  kPa]; etC0 2 3 0 -4 5  mmHg [4 .0 -6.0 
kPa]). A servo-controlled heating mattress was used to maintain a rectal temperature 
between 38  and 3 9 °C.
Intravascular catheters were surgically inserted. The tip of the arterial catheter 
(polyurethane umbilical vessel catheter, 3 .5 Ch/1.2 mm, Tyco Healthcare Ireland Ltd., 
Tullamore, Ireland) was positioned in the abdominal aorta via the left femoral artery for 
connection with the arterial limb of the extracorporeal circuit for UDCO measurement. 
A central venous catheter (polyurethane umbilical vessel catheter, 5 Ch/1.7  mm, Tyco 
Healthcare Ireland Ltd., Tullamore, Ireland) was inserted via the left femoral vein 
with the position of the tip in the right atrium. The position of the tip of this venous 
line was estimated using a registered pressure curve during insertion. This central 
venous catheter was used for connection with the venous limb of the AV loop for UDCO 
measurement.
A left-sided thoracotomy was performed and after preparation an adequately sized 
perivascular ultrasonic transit time flow probe (PAX series, Transonic1 Systems Inc., 
Ithaca, USA) was placed around the common pulmonary artery. The ductus arteriosus 
was found to be closed in all animals.
Experimental protocol
The study protocol (Figure 2 ) was started after a 3 0 -min stabilization period. Each 
session of measurements consisted of four consecutive injections with isotonic saline 
(NaCl 0 .9 %) in the venous limb of the extracorporeal circuit of the UDCO system. Every 
session with an injection volume of 0.5  mL/kg isotonic saline was alternated with an 
injection volume of 1.0 mL/kg.
Cardiac output was manipulated by creating hemorrhagic hypotension by stepwise
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withdrawal of blood via the venous catheter in order to obtain a reduction in mean 
arterial blood pressure of 10 mmHg within a time period of approximately 5 minutes.
Figure 2. Study protocol
In all animals, blood was withdrawn three times to 
decrease cardiac output during the experiment. After 
each intervention (session of measurements and 
blood withdrawal) a 15-min period was observed 
for stabilization. Research data were stored using 
biomedical data acquisition software (Poly, Inspektor 
Research Systems BV, Amsterdam, The Netherlands) 
with a sampling rate of 200 Hz. Before every 
measurement, the adequacy of signal strength of the 
pulmonary flow probe was checked. Additional gel 
was applied in case of a decreased signal strength 
(signal amplitude < 0.7 on analog meter in 'TEST” 
mode).
At the end of the experiment the piglet was 
sacrificed. The flow probe reading (QAPC) was checked 
for zero value directly post mortem.
Statistical analysis
Every measurement of cardiac output with the ultrasound dilution technology 
(Quoco) was compared with the pulmonary blood flow (QAPC). Mean bias, defined as QUDC0 
minus QAPC, was calculated with standard deviation (SD). Limits of agreement (LOA) are 
defined as mean bias ± 1.96 SD (precision). To assess the agreement between QUDC0 and 
QAPC a Bland-Altman analysis was performed (2 0). The Mann-Whitney U test was used to 
analyze the difference in mean bias between measurements with an injection volume of 
normal saline of 0.5 mL/kg versus 1.0 mL/kg. A p value < 0.05 is considered statistically 
significant. Mean bias and limits of agreement were calculated for QUDC0 based on only the 
first injection of saline and the mean of the first two, first three and all four injections, 
respectively.
Data management was performed, using Excel (Office 2008 for Mac®, Microsoft, 
Seattle, USA) and SPSS 16.0.01 for Windows® (SPSS Inc., Chicago, USA) was used for 
statistical analysis.
»  RESULTS
Table 1 shows the decrease in pulmonary blood flow, the total amount of blood 
withdrawn, and the number of measurements of UDC0 during the experiment per 
piglet. The mean weight of the piglets was 5.8 kg (range: 3.5-7.0 kg) and the mean age 
was 25 days (range: 18-28 days). Five ofthe nine piglets were postweaning. This implies 
that four piglets can be classified as newborn and five piglets as juvenile. The range in 
pulmonary blood flow for all the experiments was 0.457 L/min to 1.912 L/min with a 
mean value of 0.962 L/min.
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Table 1. Characteristics o f the piglets during the experiment
Piglet Weight(kg) QUDC0 n
Range in QAPC 
(L/min)
A QAPC
Volume Blood 
Withdrawn(mL//ig)
1 7.0 35 1.912-1.102 42.4% 14.9
2 6.4 32 1.146-0.917 2 0 .0 % 19.8
3 6.2 39 1.064-0.637 40.1% 19.7
4 3.5 40 0.573-0.457 2 0 .2 % 37.4
5 4.5 37 0.913-0.569 37.7% 23.6
6 4.7 40 0.815-0.526 35.5% 18.3
7 6 .6 39 1.275-0.993 2 2 .1 % 16.5
8 6.9 39 1.110-0.716 35.5% 1 1 .0
9 6.7 38 1.512-0.978 35.3% 15.5
(y c = pulmonary blood flow; Q'' jd c o  n  = numi,er of ultrasound dilution cardiac output measurements
Data concerning the agreement of cardiac output measurement with the ultrasound 
dilution technology (Ql l:"co] and the measured pulmonary blood flow (QAPC] are listed 
in Table 2. The UDCO overestimates pulmonary blood flow with 0.040 L/min (LOA: ± 
0.258 L/min) and 0.058 L/min (LOA: ± 0.136 L/min) for measurements with 0.5 mL/ 
kg and 1.0 mL/kg injection volume, respectively. Combining the data (0.5 and 1.0 mL/ 
kg injection volume) results in a bias of 0.050 L/min (LOA: ± 0.263 L/min). A Bland- 
Altman plot is shown in Figure 3.
Table 2. Agreement of cardiac output measured with ultrasound dilution technology (QUDCO) and 
pulmonaiy blood flow [QAPC],
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Figure 3. Bland-Altman plot for the comparison of ultrasound dilution cardiac output (QUDCO) 
and pulmonaiy blood flow [QAPC], The mean bias is 0.050 L/min with an upper limit of agreement 
(ULOA] of 0.313 L/min and a lower limit of agreement [LLOA] of-0.213 L/min for all data [0.5 and 
1.0 mL/kg injection volume].
Figure 4. Box and whisker plots for the bias between pulmonaiy blood flow [QAPC] and 
ultrasound dilution cardiac output measurement [QUDCO] based on only the first injection of nor­
mal saline [a], and the mean value of the first two [b], the first three [c] and all four [d] injections, 
respectively. The box represents the 95% confidence interval of the mean bias and the whiskers 
express the limits of agreement.
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In Figure 4 box and whisker plots are shown for the bias between QUDC0 and QAPC with 
the former method based on only the first injection of saline (a) and respectively the 
mean of the first two (b), the first three (c) and all four (c) injections. With additional 
injections, the accuracy (bias) remains unchanged with a slight improvement in 
precision (LOA). The LOA change from ± 0.292 L/min with one injection to ± 0.270 L/ 
min, ± 0.266 L/min, and 0.268 L/min with two, three and four injections (no statistical 
significant difference), respectively.
»  DISCUSSION
Cardiac output measurement with the ultrasound dilution technique is compared with 
a transit time ultrasound flow probe positioned around the common pulmonary artery, 
what is considered the standard reference method for cardiac output measurement in 
an animal model (19). We preferred to place the flow probe around the pulmonary trunk 
instead of the ascending aorta, because with the latter position the coronary blood flow 
would be missed as part of the total cardiac output.
There is an increased interest in objective methods of cardiac output measurement 
(21) and further research is required to determine the best methods (22). Several 
techniques are available for cardiac output measurement in children (23-28), although 
measurement of systemic blood flow remains very complex in newborns. Cardiac output 
monitoring in newborn infants could provide essential information for hemodynamic 
decision-making.
Our group is interested in validating different methods of cardiac output monitoring 
that can be applied to the critically ill newborn. The population of piglets in this study 
can partly be classified as newborn, as only four piglets were pre-weaning (44%). We 
inserted umbilical intravascular catheters to mimic the instrumentation of critically 
ill newborns. This study demonstrates that cardiac output can be measured reliably 
in juvenile piglets in a wide range of systemic blood flow with the ultrasound dilution 
technique. Cardiac output is overestimated with the ultrasound dilution technique, but 
this overestimation - although statistically significant (p value < 0.05) - is small and, in 
our opinion, of no clinical importance.
As recommended by Critchley and Critchley (29), we used the method described by 
Bland and Altman (20) to assess the agreement between two techniques of cardiac 
output measurement. The bias and precision should be expressed as a percentage. In 
our study, the range in pulmonary blood flow was 0.457 L/min to 1.912 L/min with a 
median value of 0.934 L/min. The expression of bias and precision as a percentage is 
based on the observed mean cardiac output in the study population (bias percentage 
= 100% x mean bias/mean cardiac output; error percentage = 100% x (1.96 x SD)/ 
mean cardiac output). Analysis of any technique in the lower cardiac output range will 
thus automatically lead to higher values of bias percentage and error percentage. This is 
demonstrated in Figure 5, where the bias percentage and error percentage are calculated 
for a fictitious technique with an mean bias of 0.100 L/min and a SD of 0.150 L/min over 
a range of mean cardiac output from 0.5 to 5.0 L/min. In younger patients, especially 
newborns, a method of cardiac output measurement with even a small mean bias and 
a small standard deviation will result in a relatively large error percentage because of 
the lower range of cardiac output. In our opinion, this is the reality for any technique of 
cardiac output measurement in the smallest patients. Critchley and Critchley (29) stated
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that 'objective criteria, i.e. percentages rather than absolute values should be used, 
unless the mean cardiac output approximates 5 L/min’. They recommended that LOA
up to ±30% are acceptable. Despite 
a much lower mean cardiac output 
than 5 L/min (0.962 L/min), the 
observed error percentages in this 
study are 26.9% and 27.7% for 
measurement with an injection 
volume of 0.5 mL/kg and 1.0 mL/ 
kg, respectively.
Figure 5. Bias percentage and error 
percentage in relation to the mean car­
diac output in a study population for a 
fictitious technique of cardiac output 
measurement with a mean bias of 0.100 
L/min and a standard deviation of 0.150 
L/min. Bias percentage = 100% x mean 
bias/mean cardiac output; error percentage = 100% x (1,96 x SD]/mean cardiac output. The shaded 
area represents the neonatal range of cardiac output.
Possible limitations
The limitations of the ultrasound dilution technique for cardiac output measurement 
are summarized in Table 3. Prerequisites for cardiac output measurement with any 
method of indicator dilution are no loss of indicator, a constant blood flow, and complete 
mixing of blood and indicator.
Loss o f indicator
It is assumed that none of the injected saline is lost in the pulmonary vasculature 
during its first pass. Moser and Kenner measured a loss of only 0.08% of isotonic saline 
during its first pass through the lung circulation, using a blood densitometry technique 
(30). In theory, it is possible that, in non-homogeneous perfused lungs, the indicator 
(isotonic saline) will have a substantial longer transit time in some areas of the lungs. 
In this situation, the cardiac output will be overestimated because of a relative loss of 
indicator.
Injection Volume
An injection volume of 0.5 to 1.0 mL/kg of isotonic saline is recommended with a 
maximum of 30 mL. It is known that cardiorespiratory interaction causes a variable 
pulmonary blood flow (31, 32). To acquire an accurate value of cardiac output with an 
indicator dilution method, an average of 3-4 consecutive injections randomly spread 
over the respiratory cycle is advised.
As the total blood volume of a newborn is about 80 mL/kg, each injection of isotonic 
saline will increase the total blood volume with 0.6% and 1.3 % for an injection volume 
of 0.5 and 1.0 mL/kg, respectively. One should be cautious with frequently repeated 
measurements, as a high fluid intake is associated with an increased risk of a patent 
ductus arteriosus and necrotizing enterocolitis (33).
Mean cardiac output (mL/min)
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Table 3. Benefits and limitations o f the ultrasound dilution technique fo r  cardiac output measurement.
Benefits Limitations
0 Non-toxic indicator (isotonic saline on • Shunting of blood will produce abnormal
body temperature] dilution curves
0 Relative small injection volume (0.5-1.0 • Repetitive measurements will affect fluid
mL/kg] balance
0 Operator independent because of • Possible indicator loss in non-
automatic calculation of injected indicator homogeneous perfused lungs
volume
0 Utilization of existing intravascular 
catheters
0 No blood loss
0 Reusable
0 Set up time less than 6 minutes
0 No calibration required
0 Ancillary data (hemodynamic volume 
parameters]
In this study, we did not observe a decrease in bias and only a small increase in 
precision when multiple estimates are averaged for cardiac output measurement 
(Figure 4). The error percentage decreased from 30.4% with one injection to 28.1%, 
27.6%, and 27.9% when averaging respectively the first two, the first three and all four 
estimates. This study shows that an injection volume of 0.5 mL/kg is as accurate as
1.0 mL/kg; therefore we advise to use 0.5 mL/kg of isotonic saline as an indicator in 
future clinical studies in the smaller patients, especially the extremely low birth weight 
infants. Generally, two injections should suffice, and only if these estimates differ, for 
example, > 1 0  percent should a third injection be administered.
Shunting o f blood
The indicator dilution curve will be influenced by shunting of blood flow, which 
will affect the accuracy of cardiac output measurement. Any detection of an abnormal 
dilution curve will lead to an alarm message on the screen. This shortcoming is similar 
to other methods that are based on an indicator dilution technology.
Benefits.
The possible benefits of UDCO are summarized in Table 3. With the ultrasound 
dilution technique, the cardiac output can be calculated with the use of a non-toxic 
indicator, i.e. isotonic saline at body temperature. This excludes, for example, the 
potential risks of lithium or ice-cold saline that are used in other methods of cardiac 
output measurements.
The relative small injection volumes (0.5 mL/kg) will make it possible to use this 
method of cardiac output monitoring in patients that are at risk for fluid overload. As the 
injected volume of isotonic saline is automatically calculated, this method is relatively 
operator independent.
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Regular indwelling arterial and central venous catheters can be utilized for UDCO 
measurements, excluding the need for any catheter exchange or purchase of special 
catheters. There is no loss of sampled blood, because all blood is redirected to the 
patient via the reusable extracorporeal circuit. Set up time is limited (< 6  mins] and no 
calibration procedures are required.
The ultrasound dilution technology can provide ancillary data, reflectinghemodynamic 
volume parameters like central blood volume, total end-diastolic volume, and active 
circulation volume (1 2 ).
Shephard et al. defined the following eight desirable characteristics for a monitoring 
technique: accurate; reproducible results; rapid response; operator independent; 
easily applied; no morbidity; continuous use; and cost effective (34). In our opinion the 
method of ultrasound dilution cardiac output fulfills these criteria.
»  CONCLUSIONS
Ultrasound dilution cardiac output measurement is feasible in juvenile piglets with 
the use of a small volume of a nontoxic indicator with a clinically acceptable bias and 
precision. Measurement with an injection volume of 0.5 mL/kg of isotonic saline is as 
accurate as with a volume of 1.0 mL/kg.
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ABSTRACT
Objective: Analysis of cerebral and systemic hemodynamic consequences of ultrasound 
dilution cardiac output (UDCO) measurements.
Design: Prospective, experimental piglet study.
Setting: Animal laboratory.
Subjects: Nine random-bred piglets.
Interventions: Ultrasound dilution cardiac output measurements were performed in 
ventilated, anesthetized piglets. Interventions that are required for UDCO measurement 
were evaluated for its effect on cerebral and systemic circulation and oxygenation. 
Measurements and main results: AcHbD and ActHb, representing changes in cerebral 
blood flow and cerebral blood volume respectively, were measured with near infrared 
spectrophotometry. Pulmonary artery (QMFA) and left carotid artery (Q"A) blood flow were 
assessed with transit time flow probes. Starting and/or stopping blood flowing through 
the arteriovenous loop did not cause relevant hemodynamic changes. Fast injection of 
isotonic saline caused a biphasic change in AcHbD and ActHb. After injection of 0.5 mL/ 
kg the mean (SD) increase in AcHbD and ActHb was 0.175 (0.213) /imol/L and 0.122 
(0.148) ¡xmol/L, respectively, with a subsequent mean decrease o f-0.191 (0.299) /imol/L 
and -0.312 (0.266) ¡.imol/L. Injection of 1.0 mL/kg caused a mean increase in AcHbD and 
ActHb of 0.237 (0.203) /.imol/L and 0.179 (0.162) followed by a mean decrease o f-0.334 
(0.407) iimol/L and -0.523 (0.335) ¡imol/L, respectively. QMPA and QLCA changed shortly 
with a mean increase of 5.9 (3.0) mL/kg/min and 0.23 (0.10) mL/kg/min after injection 
of 0.5 mL/kg and with 12.0 (4.2) mL/kg/min and 0.44 (0.18) mL/kg/min after injection 
of 1.0 mL/kg, respectively. The observed changes were more profound after an injection 
volume of 1.0 mL/kg compared to 0.5 mL/kg for AcHbD (p = 0.06), ActHb (p=0.09), QMPA 
and QLCA (p<0.01). No relevant changes in MABP and HR were detected in response to the 
indicator injection.
Conclusions: Cardiac output measurement by ultrasound dilution does not cause clinically 
relevant changes in cerebral and systemic circulation and oxygenation in a piglet model.
INTRODUCTION
Measuring cardiac output may improve decision-making in critically ill patients. 
Although many different techniques of cardiac output measurement are available (1- 
5], the application in newborns remains veiy complex, especially in low birth weight 
infants. In a former study we validated the ultrasound dilution technology in a piglet 
model (6 ], We concluded that ultrasound dilution cardiac output measurement is 
feasible with a clinically acceptable bias (0.040 L/min] and precision (± 0.259 L/min] 
with the use of a small volume of isotonic saline (0.5 mL/kg] at body temperature. A 
volume-primed extracorporeal tubing loop is inserted between an indwelling arterial 
and central venous catheter. During cardiac output measurement, blood circulates 
through this extracorporeal loop, which is controlled by a peristaltic pump with an 
adjustable flow between 6 and 12 mL/min. To obtain a reliable dilution curve, it is 
advised to inject the indicator (isotonic saline] in a volume of 0.5 to 1.0 mL/kg in the 
venous limb of the extracorporeal loop as fast as possible. It is known that blood sampling 
via an arterial and/or venous umbilical catheter influences cerebral hemodynamics and
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oxygenation secondary to a loss of intravascular volume (7-9], Likewise, reinjection of 
draw-up volume after blood sampling via a venous umbilical catheter induces changes 
in cerebral blood flow (9], We speculated that the insertion of an extracorporeal loop 
with intermittent blood flow and the fast intravenous injection of isotonic saline might 
cause changes in cerebral and systemic circulation and oxygenation.
The primaiy objective of this study was to analyze the effects of ultrasound dilution 
cardiac output measurement on cerebral oxygenation and circulation determined by 
near infrared spectrophotometiy (NIRS). Furthermore, we studied the resultant changes 
in heart rate, blood pressure, main pulmonaiy blood flow, and left carotid blood flow.
»  MATERIALS AND METHODS
Ultrasound dilution cardiac output (UDCO)
The ultrasound dilution technology was introduced by Krivitski et al. in 1995 (10] 
and has recently been introduced to measure cardiac output in critically ill patients (1 1 - 
17). The basic principles of ultrasound dilution cardiac output measurement have been 
described in detail (6 ,11). Before measurement of ultrasound dilution cardiac output, 
a disposable arteriovenous (AV) loop is connected in between an arterial and venous 
catheter (Figure 1).
Figure 1. Schematic set-up of ultrasound
AV loops are available for different patient sizes 
with a priming volume vaiying from 0.9 to 2.4 mL. 
Reusable sensors, that both detect transit time 
blood flow and ultrasound velocity, are clamped 
on the arterial and venous limbs of the AV loop. 
A peristaltic pump is used to circulate the blood 
through the AV loop at a speed of 6-12 mL/min 
for a period of 5-6 minutes of cardiac output 
measurements. This pump (IVantage™ Infusion 
Pump, Delphi Medical Systems, Troy USA) is to 
prevent a periodically unstable blood flow. In the 
present study a pump flow of 8 mL/min was used 
in all experiments. Isotonic saline (0.5-1.0 mL/ 
kg), heated to body temperature in a fluid warmer 
(HFW 1000, Transonic Systems Inc., Ithaca, USA), is injected as quickly as possible into 
the venous limb of the AV loop. The arterial sensor measures the decrease in ultrasound 
velocity proportional to the saline concentration in the blood and an ultrasound dilution 
curve is obtained. With the use of the Stewart-Hamilton principle, cardiac output can 
be calculated. The resultant cardiac output value is displayed on a monitor (HCP 101, 
Transonic Systems Inc., Ithaca, USA). In this study we used the HCP 101 monitor, which 
is a prototype of the COstatus™ System (Transonic Systems Inc., Ithaca, USA). The 
COstatus™ System recently received US Food and Drug Administration (FDA) approval 
for hemodynamic monitoring in children (> 2 years of age), adolescents, and adults.
dilution cardiac output measurement.
Pumn
145
C
H
A
P
T
E
R
 
r^
>-
For the measurement of the ultrasound dilution cardiac output, several actions 
are required, which are schematically displayed in Figure 2. All the necessary 
events were evaluated for its effect on cerebral oxygenation and circulation and 
on changes in systemic circulation with special emphasis on pump actions (action 
B, G, J & K in Figure 2) and fast injections of the indicator (action D in Figure 2).
A ctio n
• Opening stopcocks connecting arterial and venous catheter to 
extracorporeal loop6• Starting pump at preset rate (6-12 mL/min)
8
• Diversion of pump flow into redirection syringe
• Fast injection of isotonic saline (0.5-1.0 mL/kg)
6• Close stopcock to redirection syringe
• Repeat C, D& E for a total of 2-4 measurements
6• Stop pump6• Flush arterial side with isotonic saline from flush syringe
• Return blood from redirection syringe to patient
6• After closure of stopcock to arterial catheter the pump is restarted to flush the entire loop with saline
f i
• Closure of stopcock to venous catheter
• Stop pump
Figure 2. Actions required during ultrasound dilution cardiac output measurement.
Near infrared spectrophotometry
Near InfraRed Spectrophotometry (NIRS) was used to measure changes in cerebral 
blood oxygenation and cerebral blood volume during the experiment. The method is 
based on the continuous measurement of oxygen-dependent changes in the absorption 
properties of hemoglobin in the near infrared region (18). NIRS was performed with 
a monitor that was developed by the Department of Physiology in close collaboration 
with the Instrumentation Department of the Radboud University Nijmegen Medical 
Centre (Oxymon1, Artinis, The Netherlands) (19). Near infrared light was transmitted 
at three wavelengths (908, 859 and 783 nm). The transmitting and receiving optodes 
were fixed to the skull between the midline and the ear on each side as previously 
described (20). Changes in the cerebral concentration of oxyhemoglobin (Ac02Hb) and 
deoxyhemoglobin (AcHHb) were calculated from changes in light absorption with the 
use of the modified law of Lambert-Beer and the modified Keele absorption matrix 
(21). The differential path length factor was stated to be 4.39 (22, 23) and considered 
to be constant, because in all piglets the interoptode spacing was > 2.5 cm (24). The 
NIRS data were continuously stored with a frequency of 2 Hz. AcHbD, also called the 
hemoglobin oxygenation index, was calculated as the difference between Ac02Hb and
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AcHHb. AcHbD represents changes in global cerebral oxygenation. Changes in cHbD are 
caused by alterations in cerebral oxygen delivery (cerebral blood flow, arterial oxygen 
content) or cerebral metabolic rate of oxygen (CMRO J. AcHbD is closely related to 
cerebral blood flow provided that arterial oxygen content and CMR02 are constant (25). 
A concentration change in total hemoglobin (ActHb), reflecting changes in cerebral 
blood volume when the hematocrit is constant, is calculated by the sum of Ac02Hb and 
AcHHb.
NIRS data are expressed in ^imol/L. With a brain-specific mass of 1.05 g/mL, as 
described by Nelson et al., one can express the concentration in umol/lOOg brain tissue 
by multiplying with a conversion factor of 0.095 (26).
Animal preparation
After approval by the Ethical Committee on Animal Research of the Radboud 
University Nijmegen (RU-DEC #2007-144) the study was performed in nine random- 
bred newborn piglets (3.5-7.0 kg) in accordance with the Dutch national legislation 
concerning the guidelines for the care and use of laboratory animals. The piglets were 
not fed in the 12 hours prior to the experiment. The animals were premedicated with an 
intramuscular injection ofketamine (10 mg/kg), atropine (0.03 mg/kg) and midazolam 
(0.5 mg/kg). After intravenous injection of propofol (2-3 mg/kg), the piglets were 
orotracheally intubated with a cuffed endotracheal tube (ID 4-5 mm; Kruse, Marslev, 
Denmark). The animals were artificially ventilated in a pressure control mode using 
a Datex Ohmeda Excel 210 SE anesthesia machine (GE Healthcare (formerly Datex 
Ohmeda), Waukesha, Wisconsin, USA). Anesthesia was maintained with inhalation of 
isoflurane (0.5-2.0 vol%), and intravenous administration of fentanyl (5-20 |.ig/kg/hr) 
and midazolam (0.5 mg/kg/hr). During thoracotomy, muscle paralysis was achieved 
with pancuronium (0.1 mg/kg intravenous). The ventilatory settings were adjusted in 
order to maintain normoxemia (Sa02 90-95%) and normocapnia (paC02 30-45 mmHg; 
etC02 30-45 mmHg). A servo-controlled heating mattress was used to maintain a rectal 
temperature between 38 and 39°C. Intravascular catheters were surgically inserted. The 
tip of the first arterial catheter (polyurethane umbilical vessel catheter, 3.5Ch/1.2 mm, 
Tyco Healthcare Ireland Ltd., Tullamore, Ireland) was positioned in the abdominal aorta 
via the left femoral artery for connection with the arterial limb of the extracorporeal 
circuit for UDCO measurement. A venous catheter (polyurethane umbilical vessel 
catheter, 5Ch/1.7 mm, Tyco Healthcare Ireland Ltd., Tullamore, Ireland) was inserted 
via the left femoral vein with the position of the tip in the right atrium. The position 
of the tip of this venous line was estimated using a registered pressure curve during 
insertion. This venous catheter was used for connection with the venous limb of the AV 
loop for UDCO measurement.
A second arterial catheter (polyurethane umbilical vessel catheter, 3.5Ch/1.2 mm, 
Tyco Healthcare Ireland Ltd., Tullamore, Ireland) was inserted via the right femoral 
artery for continuous measurement of arterial blood pressure using a disposable 
pressure transducer (Truwave DPT, Edwards Lifesciences, Irvine, USA).
A left-sided thoracotomy was performed and after preparation, an adequately sized 
perivascular transit time ultrasonic flow probe (PAX series, Transonic® Systems Inc., 
Ithaca, USA) was placed around the main pulmonary artery to continuously measure 
the pulmonary blood flow (cardiac output, QMPA). We decided to measure blood flow in 
the main pulmonary artery, as this is the true value of cardiac output in the absence of
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A perivascular transit time ultrasonic flow probe was positioned around the left 
carotid artery (QLCA) to measure a constant part of cerebral blood flow, because it is 
known that changes in total brain blood flow are represented reliably by changes in 
carotid arterial blood flow (27). The flow probes were connected to the flow meter, 
which displayed the values of the measured blood flow (T206 Dual Channel Flow Meter, 
Transonic® Systems Inc., Ithaca, USA). The adequacy of the signal strength of the transit 
time ultrasound flow probes was checked regularly and additional gel was applied, 
when decreased signal strength was noted (signal amplitude < 0.7 on analog meter in 
“TEST" mode).
Experimental protocol
The study protocol (Figure 3) was started after a stabilization period of 30 minutes. 
Each session of cardiac output measurements consisted of four consecutive injections 
with isotonic saline (NaCl 0.9%) at body temperature in the venous limb of the 
extracorporeal circuit of the UDCO system. Every session with an injection volume of 0.5 
mL/kg of normal saline was alternated with an injection volume of 1.0 mL/kg. During 
the experiment, cardiac output was manipulated by creating hemorrhagic hypotension 
by stepwise withdrawal of blood through the venous catheter to obtain a reduction 
in mean arterial blood pressure of 10 mmHg. After each intervention, a stabilization 
period was observed. At the end of the experiment the piglet was sacrificed. The flow 
probe was checked for zero value directly post mortem.
Figure 3. Study protocol.
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Data processing and statistical analysis
Hemodynamic data, collected from a neonatal monitor (Hewlett Packard, M1094B), 
were stored using biomedical data acquisition software (Poly, Inspektor Research 
Systems BV, Amsterdam, The Netherlands) with a sampling rate of 200 Hz (ECG and 
ABP) and 1 Hz (QMPA and QLCA), respectively. NIRS data were stored on the Oxymon® 
computer. Simultaneous to every manipulation or action, an event was marked in the 
data of both computers. The data were then imported in Matlab® (version R2007a, The 
MathWorks™, Natick, MA, USA) for further processing and analysis. NIRS data were 
resampled to 1 Hz, synchronized, and merged with the hemodynamic parameters. 
Instantaneous beat-to-beat heart rate was calculated from the electrocardiogram and 
mean arterial blood pressure was calculated for each heart beat. We analyzed the 
response to fast injections of indicator and to the pump actions. Data processing and 
analysis were different for these two separate interventions.
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Response to injection voiumes 
Each session of UDCO measurements consisted of at least four consecutive injections 
with isotonic saline. The mean value of c02Hb and cHHb in the 5 seconds period 
prior to the injection was determined to be the baseline (zero reference) value. All 
detected responses during one session of cardiac output measurements with the 
same injection volume (0.5 or 1.0 mL/kg) were averaged. Then the correlation of each 
separate response with the average response was calculated. In case of a correlation 
coefficient less than 0.7, the response was considered fault and excluded from the data 
analysis. Additionally, all responses, including those with an correlation coefficient <
0.7, were visually inspected to confirm proper selection. After this, a plot of the average 
signal was generated (Figure 4). Figure 4 shows a typical example of the changes in 
cerebral oxyhemoglobin concentration in response to 4 consecutive ultrasound dilution 
cardiac output measurements with an injection volume of 1.0 mL/kg of isotonic saline. 
We calculated both the root mean square (RMS) and the standard deviation of the 
averaged signal. A response with a signal to noise ratio (RMS/SD) > 1 is considered a 
representative signal. If the signal ratio was less than 1, the signals were again visually 
inspected for artifacts.
Figure 4. Typical example of changes in cerebral oxyhemoglobin concentration in response to 4 
consecutive ultrasound dilution cardiac output measurements with an injection volume of 1.0 mL/ 
kg of isotonic saline.
Both Ac02Hb and AcHHb showed a biphasic response after injection of the indicator 
(isotonic saline) with an initial increase in concentration, followed by a decrease. The 
peak and through value were calculated from a moving parabolic fit using 5 points over 
the averaged signal with the use of a Matlab routine ('lsqcurvefit').
The pulmonary and left carotid blood flow showed a transient increase secondary to 
the injection of indicator and generally leveled out on a slight higher value than the initial 
value. We calculated the peak value of these parameters with the same methodology as
described above. Next to that the ‘end’ level was obtained by averaging the signal in the 
period from 25 to 30 seconds after the injection.
Response to pump actions
The pump was manipulated in two phases of the cycle of cardiac output measurements,
i.e. in the ‘injection’ phase (actions B-G in Figure 2) and the ‘redirect’ phase (actions J-L 
in Figure 2). In the ‘injection’ phase, the pump is started in order to start cardiac output 
measurements. In the ‘redirect’ phase, the pump is started to flush the extracorporeal 
loop with isotonic saline. Visual inspection revealed no specific (phasic) response 
after starting or stopping the pump in both the ‘injection’ and ‘redirect’ phase. For all 
parameters (Ac02Hb, AcHHb, AcHbD, ActHb, QMPA, QLCA, MABP, and HR) the difference 
was calculated between the mean value in the 1 0  seconds period prior to the pump 
action (starting or stopping the pump) and the mean value in the 30 seconds after the 
pump action in the ‘injection’ phase. In the ‘redirect’ phase, we used 15 seconds after 
the pump action, because the period between starting and stopping the pump was 
generally shorter than 30 seconds.
The difference in mean changes after an injection volume of 0.5 mL/kg and 1.0 mL/kg 
of isotonic saline were statistically analyzed using the Mann-Whitney test. A p value < 
0.05 is considered statistically significant. Data management was performed using Excel 
(Office 2008 for Mac®, Microsoft, Seattle, USA) and SPSS version 16.0.01 for Windows® 
(SPSS Inc., Chicago, USA) was used for statistical analysis.
»  RESULTS
Table 1 shows the weight, the interoptode distance, the range in main pulmonary 
blood flow, and left carotid blood flow for each piglet. The mean weight of the piglets 
was 5.8 kg and the mean age was 25 days (range: 18-28 days). Five of nine piglets were 
postweaning, which implies that four piglets can be classified as newborn (44%) and 
five piglets as juvenile (56%). The range in main pulmonary blood flow was 103.8 to 
273.1 mL/kg/min with a mean value of 154.7 mL/kg/min.
Table 1. Characteristics of the piglets during the experiment.
Piglet
Weight
(kg)
Interoptode 
distance (cm)
Range in QMPA 
(mL/kg/min)
Range in QLCA 
(mL/kg/min)
# 1 7.0 5.9 157.4-273.1 5.3-13.2
# 2 6.4 6.4 143.3 -179,1 5.0-10.2
#3 6.2 5.8 102.7-171.6 4.1-10.7
#4 3.5 5.1 130.6-163.7 7.6-12.9
#5 4.5 5.3 126.4-202.9 5.6-12.3
# 6 4.7 6 .0 111.9-173.4 4.4-14.0
#7 6 .6 8 .1 150.5 - 193.2 4.9 - 9.4
# 8 6.9 4.7 103.8-160.9 3.1-11.1
#9 6.7 4.5 146.0-225.7 7.1-12.6
QMPA: pulmonary blood flow; QLCA: left carotid artery blood flow
The responses were similar in all piglets, except for piglet #5. The responses in this 
piglet were the exact opposite from that which was seen in all the other piglets. We 
noticed a decrease in pulmonary and left carotid pulmonary blood flow in response
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to the injection of indicator (isotonic saline). This could be caused by a malposition of 
the central venous catheter, as we noticed a bradycardia in response to the injection of 
isotonic saline with simultaneous changes in the ECG (ST-segment). We excluded piglet 
#5 for this reason.
Changes in NIRS parameters (Ac02Hb, AcHHb, AcHbD, ActHb) in response to the 
injection of isotonic saline in a volume of, respectively, 0.5 mL/kg and 1.0 mL/kg are 
shown in Table 2.
Table 2. Changes in NIRS parameters in response to the injection of isotonic saline in a 
volume of respectively 0.5 mL/kg and 1.0 mL/kg.
Peak, mean [SD] Trough, mean [SD]
0.5 mL/kg 1.0 mL/kg p-value 0.5 mL/kg 1.0 mL/kg p-value
AcOHb 0.148
°-19°  0.07#
-0.266 -0.424
< 0 .0 1 #
(umol/L) [0.175] [0.171] [0.253] [0.329]
AcHHb 0.026
0 '0 5 1  0 07# 
[0.062]
-0.123 -0.160
0.62*
(umol/L) [0.036] [0 .1 1 1 ] [0.189]
AcHbD 0.175 0 237
[0.203] ° '°6#
-0.191 -0.334
0.03#
(umol/L) [0.213] [0.299] [0.407]
ActHb 0 .1 2 2
°-1 7 9  0.09#
-0.312 -0.523
< 0 .0 1 #
(umol/L) [0.148] [0.162] [0.266] [0.335]
* Mann-Wlutney test, injection volume of 0.5 mL/kg versus 1.0 mL/kg
The changes in hemodynamic parameters (QMPA, QLCA, MABP, and HR) resulting from 
the indicator injection are summarized in Table 3. In general, after injection of isotonic 
saline, there was a transient increase in c02Hb and cHHb directly followed by a decrease. 
This biphasic response was more pronounced after an injection volume of 1.0 mL/kg 
compared to a volume of 0.5 mL/kg of isotonic saline.
Table 3. Changes in hemodynamic parameters in response to the injection of isotonic saline in a 
volume of respectively 0.5 mL/kg and 1.0 mL/kg.
Peak, mean [SD] End, mean [SD]
0.5 mL/ 
k g
1.0 mL/
k g
p-value
0.5 mL/ 
k g
1.0 mL/
k g
p-value
Q M P A 5.9 1 2 .0
< 0.01#
2 .0 4.4
<0.01#
(mL/kg/min) [3.0] [4.2] [1 .6] [2 .6]
Q L C A 0.23 0.44
< 0.01#
0.14 0.33
<0.01#
(mL/kg/min) [0 .1 0 ] [0.18] [0 .1 2 ] [0.15]
MABP 1.3 2 .0
< 0.01#
0.6 1.4
0 .0 2 #
(mmHg) [1 .0] [1.4] [1.3] [1 .8 ]
HR 0.5 0.9
0.54#
-0.2 -0.15
0.44#
(bpm) [0 .6] [1.7] [0.7] [1 .1]
" Mann-Whitney test, injection volume of 0.5 mL/kg versus 1.0 mL/kg
A fast injection of a bolus of isotonic saline at body temperature in a volume of 0.5 
to 1.0 mL/kg through a central venous caused a transient increase in blood flow in the 
main pulmonary artery (QMIA) and left carotid artery (Qlf:A). This increase in blood flow 
was statistically significant more pronounced after an injection of 1.0 mL/kg of isotonic 
saline in comparison with 0.5 mL/kg (AQMPA: 12.0 mL/kg/min versus 5.9 mL/kg/min; 
p<0.01 and AQLCA: 0.44 mL/kg/min versus 0.23 mL/kg/min; p<0.01). This represented 
a mean (SD) increase in main pulmonary blood flow of 4.6 (2.4) % after injection of 0.5 
mL/kg isotonic saline and 7.8 (3.7) % after 1.0 mL/kg. With this finding, we evaluated 
the accuracy of the ultrasound dilution cardiac output measurement (QUDC0) in relation 
to the peak ( Q MPA Peak)  and mean (Qv",'v"1''''1") level of main pulmonary blood flow as the 
reference value. The mean bias (SD) between Q UDC0 and Q MPAmean was 8 .8  (23.0) mL/ 
kg/min and 12.2 (24.4) mL/kg/min for measurements with an indicator volume of 0.5 
mL/kg and 1.0 mL/kg, respectively. When Q UDC0 was compared to the peak value of the 
pulmonary blood flow ( Q MPA-Peak) ( the mean bias (SD) was smaller, i.e. 3.4 (24.1) mL/kg/ 
min and 3.3 (25.6) mL/kg/min, respectively, after injection of 0.5 mL/kg and 1.0 mL/ 
kg of isotonic saline.
Table 4 shows the changes of both the NIRS (Ac02Hb, AcHHb, AcHbD, ActHb) and 
hemodynamic (QMPA, QLCA, MABP, and HR) parameters in response to switching the pump 
on and off in the ‘injection’ phase and the ‘redirect’ phase, respectively. The observed 
changes after pump actions were similar in the ‘injection’ and ‘redirect’ phase.
Table 4. Changes in NIRS and hemodynamic parameters in response to pump actions.
Injection Phase
Mean [± SD]
(9 5%-Cl mean)
Redirect Phase
Mean [± SD] 
(95%-CI mean)
0.5 mL/kg 1.0 mL/kg 0.5 mL/kg 1.0 mL/kg
AcOHb -0.07 [0.13] 0 .0 2  [0 .1 2 ] 0 .0 1  [0 .2 1 ] 0.03 [0.18]
(umol/L) (-0.11 — -0.04) (-0.02 to 0.05) (-0.06 to 0.07) (-0.02 to 0.09)
AcHHb 0.03 [0.09] 0.00 [0.07] -0 .0 1  [0.06] -0 .0 1  [0.08]
(umol/L) (0.00 to 0.05) (-0 .02  to 0 .0 2 ) (-0.03 to 0.01) (-0.03 to 0.01)
AcHbD -0.13 [0.24] 0 .02  [0.18] 0.02 [0.24] 0.04 [0.23]
(umol/L) (-0.19 to -0.06) (-0.03 to 0.06) (-0.05 to 0.09) (-0 .02  to 0 .1 1 )
ActHb -0.06 [0 .1 1 ] 0 .02  [0 .1 0 ] -0 .0 1  [0 .2 0 ] 0.02 [0.17]
(umol/L) (-0.09 to -0.03) (-0.01 to 0.04) (-0.07 to 0.05) (-0.02 to 0.07)
QM PA 1.3 [1.6] -0.9 [1.6] 0.3 [1.9] -0.3 [1.5]
(mL/kg/min) (0.8 to 1.7) (-1.3 to -0.5) (-0.2 to 0.9) (-0.7 to 0.1)
QLCA -0.06 [0.23] 0 .0 0  [0.16] 0.03 [0.24] 0.05 [0.13]
(mL/kg/min) (-0 .1 2  to 0 .0 0 ) (-0.05 to 0.04) (-0.04 to 0.10) (0 .0 1  to 0.08)
MABP -0 .8  [1 .0] 0.3 [0.8] 0.2 [1 .0] 0.1 [0 .6]
(mmHg) (-1.1 to -0.5) (0.1 to 0.5) (-0.1 to 0.5) (-0.1 to 0.3)
HR -0.1 [0.7] 0.2 [0 .6] 0.3 [1.1] 0.0 [0.7]
(bpm) (-0.2 to 0 .1 ) (0.0 to 0.4) (0 .0  to 0 .6 ) (-0.2 to 0 .2 )
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Figure 5 shows box and whisker plots for the changes in cHbD and ctHb categorized 
as the peak (a) and through (b) after injection with 0.5 mL/kg isotonic saline and the 
peak (c) and through (d) after injection with 1.0 mL/kg isotonic saline.
Figure 5. Box and whisker plots for the changes in cHbD (I) and ctHb (II). The box represents the 
interquartile range with the median presented as a solid line. The whiskers express the range fi'om 
maximum to minimum value up to 1.5 times the interquartile range from the border of the box and 
excluding the outliers (marked with a circle]. There are four categories displayed, i.e. the peak (a] 
and through (b] value in response to an injection volume of 0.5 mL/kg and the peak (c] and through 
(d) value in response to an injection volume of 1.0 mL/kg.
»  DISCUSSION
Ultrasound dilution cardiac output measurement has been validated in a piglet 
model and showed a clinically acceptable accuracy and precision in comparison to 
main pulmonary blood flow assessed with an ultrasonic transit time perivascular flow 
probe (6 ). In this study we evaluated the safety of the ultrasound dilution technology 
in a juvenile piglet model with the focus on systemic and cerebral hemodynamics and 
oxygenation.
Although the priming volume of the extracorporeal circuit is limited to 0.9 to 2.4 mL, 
we speculated that starting and stopping the pump might cause relevant hemodynamic 
changes. It is known that blood sampling via an arterial and/or venous umbilical 
catheter induces significant changes in cerebral hemodynamics and oxygenation as a 
result of a sudden loss of intravascular volume (7-9). The present study demonstrates 
that the initiation and/or stopping of blood flow through the extracorporeal loop with 
the pump did not cause relevant changes in systemic and cerebral hemodynamic and 
oxygenation parameters in juvenile piglets.
We hypothesized that fast injection of isotonic saline in a volume of 0.5 to 1.0 mL/ 
kg at body temperature through a central venous catheter might influence the cardiac 
performance with subsequently a potential change in cerebral blood flow. We showed 
that this injection of isotonic saline, performed as fast as possible, caused a transient 
increase in blood flow in the main pulmonary artery (QMPA) and left carotid artery (QLCA) 
that was statistically significant more pronounced with an injection volume of 1.0 mL/ 
kg in comparison to 0.5 mL/kg. Furthermore, we found that the UDCO had a closer 
agreement with the peak value of pulmonary blood flow after injection than with the
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mean pulmonary blood flow. This suggests that with the ultrasound dilution technology 
it is possible that one does not measure the actual cardiac output, but the cardiac output 
that is transiently influenced by the injection of the indicator volume. It is speculated 
that this is not unique for the UDCO method, but that it may also be extrapolated to 
all methods of cardiac output measurement that requires an injection of a indicator, 
even in a low volume of 0.5 mL/kg. This influence of indicator injection on cardiac 
output measurement might theoretically be minimized with several precautions, like 
a central venous injection of isotonic saline as distal as possible from the heart so 
the indicator will arrive to the heart and the recording point at the time the level of 
cardiac output will be returned to its initial level. It could also be beneficial to locate 
the recording point relatively distal from the heart provided that the strength of the 
signal is not reduced. The faster the indicator will be injected, the greater the chance 
that the cardiac output changes will be alleviated at the recording site. The smallest 
volume of indicator will also cause the smallest distortion of the level of cardiac output. 
The increase in cardiac output is most probably caused by an increase in preload with 
subsequently an increased stroke volume. The detected increase in pulmonary and left 
carotid blood flow by the ultrasonic transit time flow probes is not caused by a technical 
phenomenon, i.e. a transient dilution of blood with isotonic saline with its different 
ultrasound velocity, because an increase in c02Hb, cHHb, and ctHb was simultaneous 
detected with near-infrared spectrophotometry. The observation that fluctuations in 
main pulmonary blood flow and left carotid blood flow were less after injection of 0.5 
mL/kg of isotonic saline in comparison with 1.0 mL/kg supports the advise to use 0.5 
mL/kg as indicator volume to prevent fluid overload given the fact that the accuracy is 
similar for both injection volumes (6 ).
With NIRS, a consistent biphasic response of Ac02Hb was seen after injection of isotonic 
saline for UDCO measurement. A transient increase in c02Hb was direct followed by a 
short decrease. This first phase of the response can be explained by an initial increase 
in cardiac output (QMIA) and cerebral blood flow (Qlf:A). The subsequent decrease in 
concentration of oxyhemoglobin is caused by dilution of the blood with the injected 
isotonic saline. In comparison to c02Hb, the response of cHHb is blunted (statistical 
significant difference; p < 0 .0 1 ), which can be explained by the fact that venous cerebral 
blood volume comprises about 70% to 80% ofthe total cerebral blood volume (28-30), 
which implies a larger volume of distribution. The response of Ac02Hb, AcHHb, AcHbD, 
and ActHb was statistically significant larger (p < 0.01) after injection of 1.0 mL/kg 
than 0.5 mL/kg of isotonic saline as indicator. The fluctuations of cHbD (as presented 
in Table 2), which represents the oxygenation of cerebral blood, are within the limits of 
normal baseline variability in preterm infants, i.e. -1.260 to +1.365 ^imol/L, that were 
reported by Watkin et al. (31). It should, however, be noted, that these fluctuations 
were recorded over a mean (SD) period of 2.87 (0.81) hrs and not within 30 seconds 
as was seen in the present study. Hlining and co-workers evaluated the consequences 
of the procedure of blood sampling via umbilical vein catheters in preterm infants (9). 
Reinjection of the draw-up volume (mixture of blood and infusion solution) in a volume 
of 1.6 mL within 30 seconds resulted in a decrease in cHbD of 0.546 ^imol/L. Considering 
the median weight in this study population of 900 g, this means an injection volume of 
1.8 mL/kg. They reported only an increase in cHbD (0.677 umol/L) after flushing with 
0.6 mL of isotonic saline within 6 seconds. This probably represents the first part of the 
biphasic response, as only the 6 seconds after the start of the injection were analyzed.
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The clinical importance of the observed changes in the parameters reflecting cerebral 
and systemic hemodynamics and oxygenation in our study is not clear. Changes 
in cHbD are strongly correlated to changes in cerebral blood flow in animal models 
(32). A decrease in cerebral blood flow and acute changes in cerebral oxygenation and 
cerebral blood volume is associated with neuromorbidity in preterm infants (33-36). 
In contrast, in preterm infants on a neonatal intensive care unit, cerebral hemoglobin 
varies by about 2 0 % during baseline restful periods, and fluctuations of total cerebral 
hemoglobin due to minor manipulations, like auscultation, can be as much as >30% 
(36).
Limitations of the study
One should be cautious with extrapolating the results of the present study in piglets to 
the human population in a neonatal intensive care unit. Considering the weight and age 
of the piglets only 44% of the study population could be classified as (term) newborns. 
It is known that particularly preterm infants are more at risk for cerebrovascular injury 
as a result of an immature systemic and cerebral hemodynamic regulatory system 
(36). Further clinical studies are required to elucidate the potential consequences for 
systemic and cerebral hemodynamics and oxygenation in preterm and term newborns 
of different methods of cardiac output monitoring, under which the ultrasound dilution 
technology.
The tip of the venous umbilical catheter was positioned in the right atrium, which 
should be avoided in clinical practice, because this position is associated with major 
complications like arrhythmia and pericardial tamponade. Positioning the tip of the 
central venous catheter in the junction between the inferior or superior vena cava and 
the right atrium will lead to less distortion of pulmonary blood flow caused by the fast 
injection of isotonic saline for cardiac output measurement.
We used a relatively large extracorporeal arteriovenous loop with a priming volume 
of 4.5 mL in this animal study. Although these large AV-loops did not cause relevant 
changes in hemodynamics after diverting the blood through this extracorporeal circuit, 
it would be preferred to use the smallest AV-loops with the least priming volume as 
possible in the clinical situation.
»  CONCLUSIONS
The observed changes in parameters reflecting cerebral and systemic circulation 
and oxygenation during ultrasound dilution cardiac output measurements are within 
physiologic ranges in this juvenile piglet model. To minimize hemodynamic changes, it 
can be advised to use an injection volume of 0.5 mL/kg of normal saline. Further clinical 
studies are required to investigate the safety of methods of cardiac output measurement 
in newborns, under which the ultrasound dilution technology.
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ABSTRACT
Objective: This study was undertaken to validate the transpulmonary thermodilution 
cardiac output measurement (COTPTDj in a controlled newborn animal model under various 
hemodynamic conditions with special emphasis on low cardiac output.
Design: Prospective, experimental, pediatric animal study.
Setting: Animal laboratory of a university hospital 
Subjects: Twelve random-bred lambs
Interventions: We studied twelve lambs under various hemodynamic conditions. Cardiac 
output was measured using the transpulmonary thermodilution technique with central 
venous injections of ice-cold saline. An ultrasound transit time perivascular flow probe 
around the main pulmonary artery served as the standard reference measurement (COupp). 
During the experiment, animals were resuscitated from hemodynamic shock using fluid 
boluses. Cardiac output measurements were performed throughout the experiment. 
Measurements and results: The correlation coefficient between C0Tpw and COupp was 
0.97 (95%-Cl 0.94 to 0.98, p < 0.0001). Bland-Altman analysis showed a mean bias of 0.19 
L/min with limits of agreement of -0.04 and 0.43L/min (13.2% and ± 14.7%, respectively). 
The correlation coefficient between changes in CO and COupp during volume loading 
was 0.95 (95%-Cl 0.91 to 0.96, p < 0.0001). There was a significant correlation between 
changes in global end diastolic volume and changes in stroke volume (r = 0.59) but not 
between changes in central venous pressure and changes in stroke volume (r= 0.03). 
Conclusion: The transpulmonary thermodilution technique is a reliable method of 
measuring cardiac output in newborn animals. It is also capable of tracking changes in 
cardiac output.
INTRODUCTION
Invasive hemodynamic monitoring in critically ill children is cumbersome, and 
therefore clinical indices, such as capillary refill time or central to peripheral temperature 
difference, are commonly used to estimate the hemodynamic status (1). However, clinical 
assessment of hemodynamic parameters agrees poorly with invasive techniques (2, 3). 
Although cardiac output (CO) is an important component of the hemodynamic status, 
it cannot be predicted by easy obtainable parameters such as blood pressure and heart 
rate (4, 5). Therefore a reliable measurement of CO is important in the hemodynamic 
management of critically ill children. In contrast to adults, the pulmonary artery 
catheter (PAC) is infrequently used in infants. This technique has several limitations as 
it requires a rather large introducing sheath and has several specific complications such 
as tricuspid valve insufficiency, right-sided endocarditis and pulmonary artery rupture. 
Furthermore, some congenital cardiac defects preclude the use of a PAC. Only a few new 
CO measurement techniques are available for use in small children, and validation of 
these techniques is insufficient. Recently, a special pediatric 3-Fr 7 cm arterial catheter 
equipped with a thermistor was introduced to measure cardiac output in small children 
using the transpulmonary thermodilution (TPTD) method (Pulsion, Munich, Germany). 
Clinical validation in patients has shown an acceptable accuracy, although a true gold 
standard is lacking (6 -8 ). Validation in predominantly small subjects with emphasis on 
low cardiac output against a standard reference method has, to our knowledge, not been
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done. Because of their high reproducibility, high accuracy and fast response, ultrasound 
flow probes (UFP) offer an excellent reference technique (9,10). The TPTD technique 
also offers the opportunity to measure global end-diastolic volume (GEDV) and extra 
vascular lung water (EVLW). GEDV is a more reliable indicator of cardiac preload in 
adult patients compared to central venous pressure (CVP) (11). Measurement of EVLW 
could offer the clinician valuable information regarding the amount of pulmonary 
edema (12). However, their usefulness in children remains unknown.
This study was primarily undertaken to validate the transpulmonary thermodilution 
technique in a controlled newborn animal model under various hemodynamic 
conditions with special emphasis on hypovolemic circulatory shock and the capability 
of reliably tracking changes in cardiac output. Furthermore, we compared GEDV and 
CVP in relation to cardiac stroke volume and studied the course of EVLW during the 
experiment.
»  METHODS
General
This experiment was performed in accordance with Dutch national legislation 
concerning the guidelines for the care and use of laboratory animals and was approved 
by the local ethics committee on animal research of the Radboud University Nijmegen. 
Twelve lambs with a median bodyweight of 6 kg (range 4.2 - 12.5 kg) were studied 
under general anesthesia. Premedication consisted of the intramuscular administration 
of midazolam 2 mg/kg, pentobarbital 15-20 mg/kg and ketamine 10-15 mg/kg. 
General anesthesia was instituted using continuous intravenous administration of 
sufentanil 2 0  microgram/kg/min, midazolam 0 .2 mg/kg/hr, ketamine 0.16 mg/kg/hr, 
and pancuronium 0.02 mg/kg/hr after a loading dose of 0.05 mg/kg. The trachea was 
intubated using a 5- to 6 -mm (ID) cuffed endotracheal tube (Kruse, Marslev, Denmark), 
and the lungs were mechanically ventilated in a pressure-controlled mode using tidal 
volumes of approximately 10 mL/kg (Babylog 8000 Plus ventilator, Drager®, Germany). 
Normocapnia, guided by capnography, was achieved by adjusting the respiratory 
frequency to maintain an end tidal C02 tension between 30 and 38 torr [4-5 kPa], At 
the end of the experiment the animals were killed. The body surface area (BSA) of the 
animals was calculated using the following formula: BSA = weight(2,3) x 0.121 (13).
Instrumentation
Immediately after induction of anesthesia, the animals received a femoral artery 
catheter (3-Fr 7 cm, PV2013L07, Pulsion, Germany) and central venous lines in 
the inferior and superior caval vein positioned by means of a cut down procedure. 
Positioning was guided by recording appropriate pressure tracings. The correct 
positions of the central venous lines were also visually and manually confirmed post­
mortem. Thereafter, left sided thoracotomy was performed and the ascending aorta, 
pulmonary artery, and descending aorta were exposed and the ductus arteriosus was 
ligated. An ultrasonic perivascular flow-probe (PAX series 12 mm, Transonic® Systems 
Inc., Ithaca, USA) was placed around the main pulmonary artery in order to measure 
reference cardiac output (COUFp). Reference cardiac index (CIUFP) was calculated by 
dividing COUFp by BSA. The stroke volume index (SVI) was subsequently calculated by
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dividing CIUFp by heart rate. The flow probe was checked for zero flow value directly post­
mortem. Ultrasound transit time flow probes use a two-way ultrasound technique. By 
calculating the difference between transit times upstream and downstream the blood 
flow is measured. Care was taken to avoid any air within the flow probe by applying 
sufficient quantities of acoustic gel and flooding the thoracic cavity with saline during 
measurements.
Transpulmonary thermodilution for measuring cardiac output
Transpulmonary thermodilution cardiac output (C0T| T|i] is measured by injecting a 
known quantity of ice-cold saline into a central venous line. This injectate, mixed with 
blood, is transported by the blood flow through the right heart, the pulmonary system, 
and the left heart. Temperature changes are detected by the thermistor-tipped arterial 
line inserted in the femoral artery and connected to a commercially available device 
(PiCCOplus, software version 6.0, Pulsion, Munich, Germany). Using blood temperature, 
injectate temperature, injectate volume, area under the thermodilution curve, and a 
correction constant, the cardiac output can be calculated using the Stewart Hamilton 
equation (14).
Transpulmonary thermodilution for measuring blood volume 
and lung water
The time span between injection of the indicator and the time point when half of the 
indicator has passed the detection point is known as the mean transit time (MTt). By 
multiplying MTt by cardiac output, the volume between injection point and detection 
point, known as the intra thoracic thermal volume (ITTV), is calculated (ITTV = CO x 
MMt [mL]). The pulmonary blood volume and the extravascular lung water (EVLW) 
comprise the largest fraction of the intrathoracic blood volume. Therefore, this volume 
can be considered the largest mixing chamber, and it predominantly influences the rate 
of decline of the dilution curve. In this way, the exponential downslope time (DSt) of the 
thermodilution curve represents this mixing chamber. It is known as the pulmonary 
thermal volume (PTV) and is calculated by multiplying the DSt with cardiac output (PTV 
= CO x DSt [mL]). By subtracting the PTV from the ITTV it is possible to calculate GEDV. 
GEDV represents a virtual volume of the heart and great vessels within the thoracic 
space and reflects myocardial preload in adult patients (11). Its use might also be of 
importance in determining preload in children (5, 15). The relationship between the 
intra thoracic blood volume (ITBV) and GEVD has been studied in adult patients and 
appears to be linear (16). Therefore, the ITBV is calculated by multiplying GEDV with 
1.25 (ITBV = GEDV x 1,25 [mL]). The EVLW is calculated by subtracting the ITBV from 
the ITTV (EVLW = ITTV - ITBV [mL]). The above calculations are described in detail 
elsewhere (14).
We used the mean value of four bolus injections of 3-5 mL ice-cold saline to measure 
COTPTD. All thermodilution measurements were performed by manual injection 
through the central venous line with injectate temperature < 10° C. Care was taken 
not to position the venous injection point close to the arterial catheter thermistor tip 
in order to avoid a local change in temperature during injection, as this can influence 
the reading of the arterial thermistor, especially when cardiac output is low (17).
Measurements were stored using specially designed software (PiCCO-Volef Data 
Acquisition version 6.0, Pulsion, Munich, Germany). Before a series of thermodilution
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measurements, the central venous catheter was flushed with 1 to 2 mL of ice-cold saline. 
Afterward, all thermodilution measurements were visually inspected for a normal 
thermodilution curve.
Other measurements
Other measurements included invasively measured arterial blood pressure and 
central venous pressure, electrocardiogram, heart rate, capnography, arterial oxygen 
saturation, respiratory frequency, tidal volume, airway pressure, and body core 
temperature. During C0TPTD measurement, all other hemodynamic variables, including 
C0UFp, were recorded simultaneously with a 200-Hz sampling rate using a computer 
system with special biomedical registration software (Poly, Inspektor Research Systems, 
Amsterdam, the Netherlands). The exact time span of the thermodilution measurement 
was marked in the registration. The difference between C0TPTD and C0UFp was calculated 
using the mean value of four consecutive TPTD measurements and the mean value of 
C0UFp in the time span between start of the first TPTD measurement and the end of 
the last TPTD measurement. Also, the values of C0TPTD for the first injection and the 
mean of the first two and first three injections were determined. These were compared 
to the value of C0UFp obtained during these periods. In this way, bias and accuracy of 
C0TPTD, based upon one, two, three or four injections could be established. To analyze 
whether changes in C0UFp are adequately reflected by changes in C0TPTD, we selected 
measurements only performed during volume loading or institution of inotropic 
therapy.
Protocol
The first thermodilution measurements were made shortly after finishing the 
instrumentation phase when the animals were stable and normovolemic. Thereafter, 
the animals were subjected to a separate experiment in which a large aortic-pulmonary 
shunt was instituted. At the end of this experiment, the shunt was closed and the 
animals were left in hypovolemic shock Subsequently, thermodilution measurements 
were continued. Thereafter, several fluid challenges with 20 mL/kg hydroxyethyl starch 
HES 130/0.4 (Voluven®) were given to mimic clinical volume loading and to achieve a 
large range of cardiac output values per animal. C0TPTD was determined before and after 
every fluid challenge. When the C0UFP did not increase as a result of fluid loading, one or 
two further fluid boluses were given. In four animals, dobutamine 10 microgram/kg/ 
min was additionally administered to further increase cardiac output.
Statistical analysis
Comparison between the two flow measurement techniques was performed using 
correlation statistics (Pearson correlation) after confirming normal frequency 
distribution of the data. Correlation between the two measurement techniques was 
calculated with absolute values but also with changes in CO. In addition, the method 
described by Bland and Altman was used (18). Hereby the difference between the two 
methods (bias) was calculated by subtracting the value of COUFp from COTPTD. The bias 
was plotted against the mean CO ([COUFp + COTPTD] /2). The limits of agreement (LOA) 
were calculated by multiplying the standard deviation (SD) of the bias with 1.96. The 
95% confidence interval (95%-CI) of the bias was determined by first calculating the 
standard error (Vs2/n). Subsequently, the appropriate point of the t distribution with n
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-1 degrees of freedom was determined. The t value was then multiplied by the standard 
error. The 95%-CI of the LOA were calculated in the same manner, except for the 
calculation of the standard error. This was determined by V3s2/n. (18). The percentage 
error between CCL^ and C0IIt,n measurements was used to perform the Bland-Altman
TPTD UFP r
analysis for percentage errors. The percentage bias was calculated by dividing the mean 
bias by mean cardiac output x 100%. The percentage error was calculated by 100% x 
(1.96 x SD of the bias)/mean cardiac output (19).
Differences between consecutive lung water measurements were calculated using the 
paired Student’s t-test.
Calculations and data management were performed using Excel for windows (Office 
2003, Microsoft, Seattle, USA). Statistical calculations were performed with MedCalc 
(MedCalc Software, Mariakerke, Belgium).
»  RESULTS
One animal (no. 9) died during the surgical procedure before measurements could be 
undertaken. Death was related to intractable hemodynamic shock as a result of a large 
aorta- pulmonary shunt. Table 1 shows the characteristics of the remaining 11 animals. 
A total of 78 simultaneous CO measurements were suitable for analysis. The coefficient 
of variation (as percentage of mean) for the various COTpTD measurements was 6.9% 
(95%-CI 6.2 to 7.7%; p < 0.001). Figure 1 shows the correlation between COTpTD and 
COUFp. The correlation coefficient was 0.97 (95%-CI 0.94 to 0.98; p < 0.0001).
Figure 2 shows the Bland-Altman plot of the absolute values of COTPTD and COUFF The 
mean bias was 0.19 L/min and limits of agreement were -0.04 and 0.43 L/min. The 
percentage bias was 12.0% with limits of agreement (percentage error) of ±14.7%. 
There were no significant correlations between mean arterial pressure, heart rate, 
bodyweight, and the bias between COTpTD and COUFp.
Table 2 shows the comparison between cardiac output measured with UFP and TPTD 
(n = 78). The mean cardiac output, mean bias, and limits of agreement of the first one 
to three TPTD measurements and all four TPTD injections were compared to the UFP 
method. To study the ability of TPTD for monitoring small changes in CO during volume 
loading, percentage changes in COTpTD and COUFp were calculated during this procedure.
A total of 58 CO changes were identified. Figure 3 shows the correlation of the relative 
changes between the two methods. The correlation coefficient was 0.97 (95%-CI 0.95 
to 0.98; p < 0.0001). The overall sensitivity for COTPTD to reflect changes in COUFp was 
85% and the specificity 83%. When only changes in COTPTD of >5% were analyzed, 
these numbers improved to 92% and 8 6 %. Both numbers improved further to 100% 
when only changes in COTpTD >10% were analyzed. The correlation between changes 
in SVI and changes in GEDVI or central venous pressure is depicted in Figure 4. The 
course of EVLWI during the experiment from baseline to the hypovolemic phase and 
the consecutive fluid resuscitation and deliberate fluid overload is shown in Figure 5. 
During volume loading, the correlation coefficient between changes in EVLWI and SVI 
was -0.21 (95%-CI -0.45 to -0.05; p = 0.11). The correlation coefficient between changes 
in EVLWI and changes in GEDVI was 0.40 (95%-CI 0.16 to 0.60; p = 0.002). The bias 
between CO,,,^ and COIIt,n as a function of EVLWI is shown in Figure 6 .
TPTD UFP °
164
Table 1. Characteristics of animal subjects (n = 11). The table shows weight, total fluids received 
during volume resuscitation, number of thermodilution cardiac output measurements, mean 
measured cardiac output with ultrasound flow probe, mean arterial blood pressure, mean heart 
rate, mean GEDVI and mean EVLWI per animal.
Lamb Weight Total fluids C0TpTD
C 0 UFP
MAP HR GEDVI EVLWI
(kg] (mL/kg) (n) (L/min) (mmHg) (bpm) (mL/m2] (mL/kg]
1 5.0 100 9
2 4.2 160 8
3 6.5 140 6
4 7.7 20 1
5 6.0 120 8
6 5.8 120 8
7 9.2 120 5
8 9.4 120 8
10 12.5 40 5
11 5.7 160 12
12 4.7 120 8
1.4 42 194 430 36.1
(0.9-2.3) (35-49] (183-206) (360-590) (25.0-49.7)
1.1 48 146 411 25.3
(0.4-1.6) (33-56) (117-171) (314-471) (22.1-36.1)
1.3 46 147 365 24.4
(0.8-1.5] (36-53) (141-153) (241-452) (18.3-33.0)
1.0 43 181 298 25
1.6 70 168 369 23.4
(0.8-2.0] (49-79) (157-180 (254-459) (18.0-28.1)
1.7 85 162 402 20.8
(0.5-3.1) (60-101) (125-240) (263-442) (18.9-22.6)
1.3 60 135 426 24.2
(0.6-1.6) (39 - 89) (115-143) (315-491) (18.7-29.7)
1.8 62 156 482 31.6
(1.0-2.5] (46-81) (148-167) (346-581) (27.8-35.4)
1.4 58 161 284 15.9
(0.8-1.9] (28-82) (143-196) (236-347) (12.9-19.5)
1.6 44 169 416 30.7
(0.8-2.5] (35-58) (129-268) (327-480) (23.4-35.7)
1.8 41 179 388 40.3
(1.0-2.3] (32-50) (147-201) (284-540) (21.3-63.4)
Data are expressed as mean (range). C 0 TplD: transpulmonarv thermodilution cardiac output measurement; C 0 UFp: 
cardiac output measured with ultrasoundflow probe around the pulmonary artery; EVLWI: extravascular lung wa­
ter index; GEDVI; global end-diastolic volume index; HR; heart rate; MAP: mean arterial pressure
Fiqure 1. Correlation between C0^n and C0„u„
TP TD  UFP
C O UFp (l/m in)
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(COjptd + COUFP) / 2 (l/min)
Figure 2. Bland Altman plot of C0TpTD and C0UFp (n = 78). Straight lines represent bias and limits of 
agreement. Dotted lines represent 95% confidence intervals. The mean bias is 0.19 l/min and limits 
of agreement are between -0.04 and 0.43 l/min.
Table 2. The transpulmonary thermodilution cardiac output based upon the mean of the first, first 
two, first three or all four thermodilution injections compared to the cardiac output measured with 
the ultrasound flow probe around the pulmonary artery. The table shows absolute bias, relative bias, 
absolute limits of agreement and relative limits of agreement.
CO
TPTD
1 Injection
CO
TPTD
2 Injections
CO
TPTD
3 Injections
CO
TPTD
4 Injections
Mean bias [L/min) 0.25 0.23 0 .21 0.19
Mean bias [%) 16.7 15.3 14.2 13.5
LOA ± [L/min) 0.40 0.30 0.24 0.24
LOA ± [o/o) 25.6 2 0 .8 18.3 18.1
C0TPTB: cardiac output measured with transpulmonary thermodilution; LOA: limits of agreement
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Figure 3. Scatter plot of relative changes between cardiac output measured with transpulmonary 
thermodilution (COTPTDj and cardiac output measured with pulmonary flow probe (COUFP) in 58 
paired measurements during volume loading. Correlation coefficient is 0.97 (95% Cl 0.95 to 0.98; p 
< 0.0001]. The solid line reflects the regression line.
A  C V P  (m m H g ) A  G E D V I  (m l/m2)
Figure 4. Scatter plot of the relation between changes in central venous pressure (CVP) and stroke 
volume index (SVI) on the left and SVI and global end-diastolic volume index (GEDVI) on the right 
during fluid resuscitation (n = 57). Correlation coefficient between ACVP and ASVI is 0.03 (95% Cl 
-0.23 to 0.29; p=0.80). Correlation coefficient between AGEDVI and ASVI is0.59 (95% Cl 0.39 to 0.74; 
p<0,0001).
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Figure 5. Course of extravascular lung water index (EVLWl) during the experiment 
(n = 78). EVLWl measurements are presented as means; error bars reflect standard deviation. 
*Signiflcantfrom baseline, ** significant from cardiac output (CO) maximized.
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Figure 6. Scatterplot between extravascular lung water index (EVLWl) and the bias between COUFP 
and COTPTD. (n = 78). Correlation coefficient is 0.006 (95% Cl -0.23 to 0.22; p=0.96).
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» DISCUSSION
Our experiment shows that the TPTD technique adequately measures cardiac output 
in this newborn animal model. During volume loading, TPTD is able to track changes in 
cardiac output with acceptable accuracy. Optimum results were achieved with the mean 
of three bolus injections with ice-cold saline.
Transit time ultrasound flow probes are considered the standard reference method 
for cardiac output measurements in an animal model (10). However, positioning of these 
probes is of great importance. Resting coronary blood flow is around 5% of the total 
cardiac output (20) but may increase when heart rate increases (21). Therefore, only 
positioning the flow probe only around the main pulmonary artery reflects true cardiac 
output in contrast to positioning around the ascending aorta. By using this standard 
reference method, we were able, for the first time, to determine the accuracy of TPTD 
in small animals.The accuracy of the TPTD in the present study (11%) agrees with the 
results of others in larger animals and children (7, 8 , 22, 23) and is well within the 
acceptable limits of 30% as described by Critchley and Critchley (19). A clinical study 
that included small children showed comparable accuracy but a smaller bias (6 ). In 
this study, the Fick method was used as the standard reference technique, which might 
overestimate true CO in cases of pulmonary disease (24). In general, thermodilution 
cardiac output measurement overestimates true CO. This is caused by loss of indicator 
due to injectate warming by the environment. Because of the longer indicator route, 
the transpulmonary technique is more sensitive to this phenomenon compared to 
thermodilution using the pulmonary artery catheter (22, 25). The loss of indicator 
could be enhanced by larger amounts of pulmonary edema. Most of the indicator 
dispersal occurs during transit through the pulmonary capillary bed, and alveolar gas 
space surrounding these structures provides an effective thermal insulation. Thermal 
loss in the lung is therefore <1% (26). However, in severe pulmonary edema it could be 
anticipated that thermal loss could increase, leading to overestimation of the cardiac 
output. In the present study, up to EVLWI values of 60 mL/kg, the amount of lung 
water had no influence on the bias between COUFp and COTPTD. To our knowledge, this 
has not been demonstrated before. A large amount of blood loss within the thoracic 
cavity, however, has been shown to cause overestimation of COTPTD (27). The coefficient 
of variation for the TPTD measurements in the present study was 6.9% and is in 
agreement with other studies in children and adults (6 -8 , 28). This variation may be 
explained by the averaging process and by variations in amount of injectate and speed 
of the injection. Also, thermodilution is less accurate in pulsatile flow conditions (29). 
The variation with the TPTD technique could worsen in clinical situations compared to 
a controlled laboratory setting. This might be caused by additional variations in speed 
of injection, small variations in volume, and patient related factors, such as movements 
or hemodynamic and respiratory alterations. Improving the signal to noise ratio by 
increasing the volume of the injectate will only lead to a small improvement and could 
artificially increase CO (30). Increasing the number of injections will only lead to a 
small increase in accuracy but may increase the workload of the nursing staff and could 
cause fluid overloading in small children. Because fluid overloading is a serious risk, 
particularly in small children, the smallest number of thermodilution measurements 
is desirable. Our results show a small decline in accuracy when fewer measurements
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are done (Table 2). The central venous line was always flushed with ice-cold saline 
just before a series of measurements, which prevented the first bolus from being less 
cold than the following ones. Therefore, the difference between the mean of two and 
three injections was probably very small. However, we advise that the mean of three 
measurements be taken as this is standard clinical practice and is also recommended 
for the use of PAC (30). When fluid overload is a serious problem, the mean of two 
measurements can be used but accuracy and reproducibility will be less. This is also the 
first study that compares changes in COTPTD and COUFp during volume loading. We feel 
that the capability of tracking changes in cardiac output determines the clinical value 
of the technique (31). The high correlation coefficient and acceptable specificity and 
sensitivity prove that COTPTD is capable of guiding volume loading when maximization 
of cardiac output is desired. Because of the variation of the TPTD technique, very small 
changes in cardiac output of <5% are more difficult to determine.
There was no significant correlation between changes in CVP and changes in SVI 
(Figure 4). Apparently, changes in CVP do not reflect changes in preload, which has 
been demonstrated before in animals (32, 33), adults (34-36), and children (5, 15). 
Also, the moderate correlation between changes in GEDVI and changes in SVI is in 
agreement with other studies (32-35). EVLWI increased during the experiment (Figure 
5). The initial increase of mean EVLW during hypovolemia probably related to the 
separate experiment in which a large aortic-pulmonary shunt was made. This caused a 
temporary increase in pulmonary blood flow with possibly a concomitant increase in 
lung water that became apparent after discontinuation of this separate experiment. An 
increase in lung water as a result of shock has not been described by others (32, 37). 
During volume resuscitation guided by CO, the EVLWI did not increase; however, during 
deliberate fluid overloading there was a small but significant increase. This has also 
been found in other studies (38,39). However, changes were small and variation among 
subjects was large (Table 1). EVLW measurement in animals appear to be different from 
humans (40). In this study, values of EVLWI were much higher than those considered 
normal in adult patients (< 8  mL/kg).
Our animal model is comparable with the critically ill pediatric population regarding 
weight, blood pressure, and cardiac output. Cumulative fluid loading was also comparable 
when related to children with severe septic shock. The maximally increased heart rate 
and probably low hemoglobin level in our animal model were less physiologically 
similar to children and also infrequent in clinical practice, but we consider this of 
minor influence on the overall bias between COUFp and COTPTD. Although TPTD appears 
to be a useful technique to measure cardiac output in children, it still requires central 
venous catheters and several injections of saline and will only intermittently provide a 
CO value. Also, in several congenital cardiac defects, predominately with left-to-right 
shunt, TPTD does not provide an accurate measurement. A faster, preferably beat-to- 
beat technique like arterial wave analysis seems therefore more attractive, although 
performance in congenital cardiac defects remains to be determined (41-43). Further 
research in adapting the algorithm to the pediatric population seems necessary (44).
»  CONCLUSIONS
The transpulmonary thermodilution technique is a reliable method of measuring
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cardiac output in small newborn animals. It is also capable of tracking changes in 
cardiac output, thereby making goal-directed hemodynamic therapy in small children 
possible. During a process of volume resuscitation global end-diastolic volume reflects 
changes in cardiac stroke volume more reliable compared with central venous pressure.
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CHAPTER 9
SUMMARY, CONCLUSIONS 
AND FUTURE PERSPECTIVES
SUMMARY
In general the adequacy of the neonatal circulation is judged by clinical assessment 
of indirect markers of systemic blood flow, like blood pressure, urine output, heart rate, 
lactate concentration et cetera. This clinical estimation of the hemodynamic status is 
unreliable in critically ill children and adults, irrespective of the level of experience of 
the clinician (1,2). No equivalent studies, comparing objective measurement and clinical 
estimation of systemic blood flow, have been performed in the neonatal population.
In chapter 2 we review the literature discussing the predictive value of clinical 
indicators of circulatory failure in newborn infants with focus on the most frequently used 
variables, namely blood pressure, heart rate, urine output, capillary refill time, serum 
lactate concentration, central-peripheral temperature difference, acid-base balance, 
central venous oxygen saturation and skin color. We conclude that these individual 
indicators are rather subjective and have a limited predictive value. The predictive 
value of clinical parameters can be slightly increased when used in combination or 
with trend monitoring. Hemodynamic management that is solely based on clinical 
judgment implies the risk of both under- and overtreatment and consequently potential 
iatrogenic injury. Despite these concerns, clinical assessment is still the most frequently 
used method to monitor neonatal hemodynamics. This is explained by complexity of 
objective measurement of cardiac output in the newborn infant.
Objective cardiac output measurement could be beneficial for the critically ill neonate 
and potentially reduce morbidity and mortality. Low cardiac output is associated with 
an increased mortality in children (3) and any delay in diagnosis of pediatric-neonatal 
shock increases mortality (4). Low systemic blood flow in preterm infants is associated 
with increased risk of periventricular/intraventricular hemorrhage (5-8), oliguria with 
subsequent hyperkalemia (9), compromised EEG activity (10), mortality and impaired 
neurodevelopment (11,12). It seems therefore plausible to prevent the risks associated 
with low systemic blood flow by monitoring cardiac output in critically ill neonates. 
Although many methods of cardiac output monitoring are available, the feasibility 
in newborns is limited due to technical and size restraints, potential toxicity of used 
indicators, difficulties in vascular access and the high prevalence of shunts (transitional 
circulation, congenital heart defects). An overview is presented in chapter 3 discussing 
available methods of cardiac output measurement with their basic principles of applied 
technology. Special attention has been given to the feasibility in critically ill newborns 
and the respective advantages and limitations of each technique. Transpulmonary 
indicator dilution, arterial pulse contour analysis and thoracic electrical impedance 
could all be optimal diagnostic tools for the assessment of neonatal hemodynamics. 
Transthoracic (functional) echocardiographic evaluation of potential ductal and/or 
atrial shunts remains however essential for a correct interpretation of obtained cardiac 
output values, irrespective of the used methodology.
In search for a technique of cardiac output monitoring that can be applied in 
critically ill newborns we validated three different methods in an experimental juvenile 
animal model. The studied technologies are the modified carbon dioxide Fick method 
(section II), transpulmonary ultrasound dilution (section III) and transpulmonary 
thermodilution (section IV).
In chapter 4 the modified carbon dioxide Fick (mC02F) method is validated in a lamb
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model for the assessment of cardiac output. The major advantage of the mC02F method 
is that no additional equipment is needed. It requires gas analysis of both arterial 
and central venous blood as well as of expiratory air by in-line capnography. mC02F- 
derived cardiac output is compared with invasively measured pulmonary blood flow 
with ultrasonic transit time flow probes which may be considered the gold standard 
reference method in an experimental animal model (13). We choose to place the flow 
probe around the main pulmonary artery instead of the ascending aorta, because with 
the former placement the coronary blood flow is not excluded and the measured blood 
flow will reflect true systemic blood flow. The ductus arteriosus was ligated to exclude 
any influence of a ductal shunt on the measurements. Cardiac output was manipulated 
during the experiment by creating hemorrhagic hypotension. When a steady state 
was reached, defined as a stable pulmonary carbon dioxide exchange during at least 6 
minutes, mC02F-derived cardiac output was measured. We conclude that measurement 
of cardiac output with the mC02F method is reliable and easily applicable in ventilated 
newborn lambs. As in neonates the tip of a central venous catheter is generally 
positioned in the transition zone between the right atrium and the inferior vena cava 
or superior vena cava, we analyzed the influence of the site of central venous blood 
sampling on the accuracy and precision of the mC02F method. For clinical use, the site of 
central venous blood sampling (right atrium, inferior vena cava or superior vena cava) 
is of minor importance.
In newborns admitted to a neonatal intensive care unit the incidence of a patent ductus 
arteriosus varies between 20 and 60 percent. A prerequisite is that the monitoring 
technique is also reliable in the presence of a (ductal) shunt. The hypothesis that the 
mC02F method is applicable even in the presence of a significant left-to-right shunt is 
tested in a lamb model in chapter 5. An artificial ductus arteriosus was constructed by 
insertion of a Gore-Tex1 shunt between the left pulmonary artery and the descending 
aorta. This aortopulmonary shunt was intermittently opened and closed, while during 
the experiment the cardiac output was manipulated by the creation of hemorrhagic 
hypotension. The agreement between the mC02F method and invasively measured blood 
flow was assessed with an ultrasonic transit time probe around the main pulmonary 
artery. No statistical significant difference was found between measurements with an 
open or closed shunt, which means that cardiac output measurement with the mC02F 
method is reliable in ventilated lambs in the presence of a significant left-to-right shunt. 
One should realize that mC02F-derived cardiac output can represent both pulmonary 
and/or systemic blood flow, which depends on the site of arterial and central venous 
blood sampling in relation to the position of a possible shunt. Regardless of the used 
method of cardiac output measurement it is therefore of the utmost importance to be 
informed about potential intra- and extra-cardiac shunts in order to correctly interpret 
the obtained value of cardiac output.
In chapter 6 we assess the agreement between ultrasound dilution cardiac output and 
measurement of main pulmonary blood flow in a piglet model. Central venous injection 
of isotonic saline at body temperature will decrease ultrasound velocity, which is used 
to obtain an indicator dilution curve in arterial blood. Cardiac output is calculated 
with use of the Stewart-Hamilton principle. Moreover, the difference in accuracy was 
evaluated for an injection volume of 0.5 mL/kg versus 1.0 mL/kg of isotonic saline. 
Cardiac output was manipulated by creating hemorrhagic hypotension. Our conclusion 
is that transpulmonary ultrasound dilution cardiac output measurement is reliable
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in piglets with the use of a small volume of a nontoxic indicator (isotonic saline). An 
injection volume of 0.5 mL/kg is as accurate as a volume of 1.0 mL/kg. Averaging 
multiple estimations of ultrasound dilution cardiac output will not affect accuracy, and 
precision is only slightly increased. We advise the use of 0.5 mL/kg of isotonic saline 
as indicator to prevent fluid overload. Two injections should suffice, and only if these 
estimations differ >1 0 % a third measurement should be performed.
For transpulmonary ultrasound dilution cardiac output measurement a volume- 
primed extracorporeal tubing loop is inserted in between an indwelling arterial and 
central venous catheter. During cardiac output measurement blood circulates through 
this extracorporeal loop, which is controlled by a peristaltic pump with an adjustable 
flow between 6 and 12 mL/min. Although the priming volume of the extracorporeal 
circuit is limited to 0.9 to 2.4 mL we speculated that starting and stopping the pump 
might cause relevant hemodynamic changes. In order to obtain a reliable dilution curve 
it is advised to inject the indicator (isotonic saline) in a volume of 0.5 to 1.0 mL/kg in 
the venous limb of the extracorporeal loop as fast as possible. We hypothesized that a 
fast injection of isotonic saline in a volume of 0.5 - 1.0 mL/kg through a central venous 
catheter might influence the cardiac performance with subsequent changes in cerebral 
blood flow. In chapter 7 we evaluate the safety of the ultrasound dilution technology in 
a piglet model with the focus on systemic and cerebral hemodynamics and oxygenation. 
Near infrared spectrophotometry and left carotid blood flow measurement with a 
transit time flow probe were used to analyze the effects on cerebral oxygenation and 
circulation. Moreover, the changes in heart rate, blood pressure and main pulmonary 
blood flow in response to fast injections of indicator and pump actions were studied. 
The study demonstrates that the initiation and/or stopping of blood flow through 
the extracorporeal loop with the pump does not cause relevant changes in systemic 
and cerebral hemodynamic and oxygenation in juvenile piglets. Injection of isotonic 
saline, performed as fast as possible, causes a transient increase in blood flow in the 
main pulmonary artery and left carotid artery, that is statistically significant more 
pronounced with an injection volume of 1.0 mL/kg in comparison to 0.5 mL/kg. After 
injection of isotonic saline a transient increase in the cerebral concentration of oxy- and 
deoxyhemoglobin occurs, followed immediately by a decline. This biphasic response 
was more pronounced after an injection volume of 1.0 mL/kg compared to a volume of
0.5 mL/kg of isotonic saline. The observed changes in parameters reflecting cerebral 
and systemic circulation and oxygenation during ultrasound dilution cardiac output 
measurements are within physiologic ranges in this juvenile piglet model. To minimize 
hemodynamic changes we advise to use an injection volume of 0.5 mL/kg of isotonic 
saline. An interesting finding in this study is that with the ultrasound dilution technology 
one does not measure the actual cardiac output, but the cardiac output that is possibly 
transiently influenced by the injection of the indicator volume. It is speculated that this 
is not unique for the UDCO method, but that it might also be extrapolated to all methods 
of cardiac output measurement that requires an injection of a indicator, even in a low 
volume of 0.5 mL/kg.
Chapter 8 describes the validation study of transpulmonary thermodilution cardiac 
output measurement in a lamb model in which it is compared to ultrasound transit 
time pulmonary blood flow measurement. The central venous injection of a known 
quantity of ice-cold saline will cause changes in blood temperature that is detected 
by a thermistor-tipped catheter positioned in the femoral artery. Measurements were
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started in a phase of hypovolemic shock after which the animals are resuscitated using 
fluid boluses. We conclude that transpulmonary thermodilution adequately measures 
cardiac output in this lamb model and is able to track changes in cardiac output during 
volume loading with acceptable accuracy.
»  CONCLUSIONS AND FUTURE 
PERSPECTIVES
Clinical estimation of systemic blood flow cannot be used to guide hemodynamic 
management in critically ill newborn infants. Despite the availability of many different 
technologies, cardiac output monitoring remains very challenging in the neonate. At 
present no clinical gold standard exists for neonatal cardiac output measurement that 
can be used reliable to guide hemodynamic management. In this thesis we report the 
validation studies in an experimental animal model of three different technologies of 
cardiac output monitoring that are potentially feasible in newborn infants, i.e. modified 
carbon dioxide Fick principle, transpulmonary ultrasound dilution and transpulmonary 
thermodilution.
The major limitation of the mC02F method is the necessity to intermittently sample 
arterial and central venous blood that will subsequently lead to an unacceptable 
blood loss, especially in the low birth weight infants. It would be interesting to explore 
the possibility of in-line measurements of pH, pC02, oxygen saturation, hemoglobin 
concentration and hematocrit through specifically developed intravascular catheters. In 
this way the veno-arterial concentration difference in carbon dioxide can be calculated 
without blood withdrawal. We used the Douglas equation to calculate total carbon 
dioxide concentration in blood (14). This equation is, however, based on measurements 
in adult blood. It is not known whether this algorithm is also applicable to fetal and/ 
or neonatal blood. We plan to assess the agreement between the calculated total 
C02 concentration using the Douglas equation and the measured total carbon C02 in 
umbilical blood samples. For the reference method umbilical blood is acidified to force 
all C02 into the dissolved state that is subsequently measured with a C02 electrode (15, 
16). Precise measurement of total C02 concentration in blood is essential for optimal 
accuracy of the modified carbon dioxide Fick method.
The feasibility of transpulmonary thermodilution in newborns is limited due to the 
preferred position of the arterial catheter in the femoral, brachial or axillary artery. 
The risk of ischemia of the limb secondary to placement of the arterial catheter is 
unacceptably high. Unfortunately there is no thermistor-tipped umbilical artery 
catheter available. Moreover, injection of ice-cold saline may influence cardiac output 
and subsequent cerebral blood flow due to transient bradycardia (17). Preterm infants 
are more at risk for cerebrovascular injury due to an immature systemic and cerebral 
hemodynamic regulatory system (18). This underlines the necessity of safety studies 
prior to clinical application of transpulmonary thermodilution in newborn infants, 
especially the preterm born, provided that thermistor-tipped umbilical artery catheters 
are available.
From the three studied technologies transpulmonary ultrasound dilution looks the 
most promising for application in the neonatal population. It is a reliable method 
with good accuracy and precision in a neonatal range of cardiac output in an animal
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model. Moreover, no clinical relevant changes in cerebral and systemic circulation and 
oxygenation were observed in piglets. In order to be applicable in human newborns it 
is a prerequisite that ultrasound dilution cardiac output measurement is reliable in the 
presence of shunts. It is known that shunting of blood will distort indicator dilution 
curves, which makes cardiac output measurement with an indicator dilution technique 
very challenging. At present, data are analyzed from a study in which we examine the 
influence of a left-to-right shunt on the accuracy of ultrasound dilution cardiac output 
measurement in a juvenile lamb model. It is assumed that none of the injected indicator 
is lost in the pulmonary vasculature during its first pass. Non-homogeneous pulmonary 
perfusion might partially lengthen the transit time of the injected indicator. This loss 
of indicator could cause an overestimation of true cardiac output. A subsequent study 
is prepared to analyze the influence of pulmonary pathology on the accuracy of the 
ultrasound dilution technology to measure cardiac output in an experimental model of 
respiratory distress syndrome (RDS) in newborn lambs.
In the next phase we will start human studies to elucidate the potential consequences 
for systemic and cerebral hemodynamics and oxygenation of ultrasound dilution cardiac 
output measurement in preterm and term newborns. The availability of an objective 
measurement of cardiac output will enable us to study neonatal hemodynamics under 
different physiologic circumstances, such as during and after the transitional phase of 
circulation in the first days of life. Little is known about pharmacodynamics of most 
used drugs in the management of circulatory failure, such as dopamine, dobutamine, 
epinephrine and norepinephrine. Most theories about the working mechanisms of these 
drugs are deduced from studies in adult patients. Objective monitoring of systemic 
blood flow during different treatment strategies could reveal specific effects in critically 
ill newborn infants that might be different from adult patients. Another research 
subject could be the influence of several diseases on cardiac output, for example septic 
shock, persistent pulmonary hypertension, congenital diaphragmatic hernia and patent 
ductus arteriosus. Moreover, hemodynamic effects of different ventilation strategies 
can be studied.
Since low systemic blood flow is associated with increased mortality and 
neuromorbidity it seems plausible to prevent inadverse outcome by monitoring cardiac 
output and the implementation of a goal-directed therapy. However, there is still limited 
evidence to confirm the assumption that cardiac output monitoring is beneficial for the 
patient in reducing mortality and/or morbidity (19). Randomized controlled trials are 
needed to clarify the impact of goal-directed hemodynamic management of neonatal 
circulatory failure on outcome.
In summary, the suggestions for further research are:
1. Development of a clinical risk score for neonatal circulatory failure, including
objective measurement of systemic blood flow
2. Exploration of the possibility to obtain the necessary parameters for cardiac
output measurement with the modified carbon dioxide Fick method 
without withdrawal of central venous and arterial blood, for example via 
in-line measurement
3. Evaluation of the applicability of the Douglas equation for measurement of
total carbon dioxide concentration in fetal and/or neonatal blood
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4. Analysis of the influence of pulmonary pathology with non-homogeneous
perfusion of the lungs on the accuracy of ultrasound dilution cardiac 
output measurement
5. Study of neonatal hemodynamics with ultrasound dilution technology
o under different physiologic circumstances, such as during and after 
the transitional phase of neonatal circulation 
o under different pathologic conditions, such as septic shock, patent 
ductus arteriosus, persistent pulmonary hypertension and congenital 
diaphragmatic hernia
o during different ventilation strategies, for example conventional 
ventilation versus high frequency ventilation
6 . Pharmacodynamic studies of the most used treatment strategies for neonatal
circulatory failure
7. Randomized controlled trial to elucidate the effect of goal-directed
hemodynamic management on outcome of neonatal circulatory failure
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CHAPTER 10
SAMENVATTING 
(SUMMARY IN DUTCH)
SAMENVATTING (SUMMARY IN DUTCH)
Het bewaken van de bloedsomloop bij kritisch zieke pasgeborenen op een intensive 
care vormt één van de essentiële taken van betrokken artsen en verpleegkundigen. Dit 
blijkt echter niet zo eenvoudig te zijn. De bloedsomloop wordt in de praktijk beoordeeld 
op basis van klinisch onderzoek van de pasgeborene. Hierbij worden de bloeddruk, 
de urineproductie, de hartfrequentie en vele andere klinische kenmerken van de 
bloedsomloop beoordeeld en geïnterpreteerd. Echter, men heeft bij volwassenen en 
grotere kinderen wetenschappelijk aangetoond dat deze klinische beoordeling van de 
bloedsomloop onnauwkeurig is, ongeacht de ervaring van de betreffende arts (1,2). Het 
lijkt aannemelijk dat dit eveneens geldt voor de populatie pasgeborenen.
In hoofdstuk 2 wordt een overzicht gegeven van de gepubliceerde medische 
wetenschap aangaande de voorspellende waarde van diverse klinische kenmerken 
op basis waarvan de bloedsomloop wordt beoordeeld, zoals daar zijn bloeddruk, 
hartfrequentie, urineproductie, capillary refill time, serum lactaatconcentratie, 
centraal-perifeer temperatuurverschil, zuur-base evenwicht, centraal veneuze zuurstof- 
verzadiging en kleur van de huid. De conclusie van dit hoofdstuk luidt dat interpretatie 
van de individuele klinische kenmerken van een falende bloedsomloop niet als objectief, 
meer veeleer als subjectief moet worden geduid en dat de voorspellende waarden van 
deze symptomen beperkt zijn. De zeggingskracht van de individuele klinische kenmerken 
kan enigszins worden verbeterd door deze in combinatie met elkaar te interpreteren of 
de variatie in tijd (trend) te evalueren. Dit betekent, dat wanneer het medisch beleid ten 
aanzien van de bloedsomloop uitsluitend wordt gebaseerd op interpretatie van deze 
klinische kenmerken, er een risico bestaat op onderbehandeling of overbehandeling 
met alle mogelijke consequenties van dien. Ondanks de onnauwkeurigheid van de 
klinische inschatting van de hemodynamische status van een pasgeborene is dit in de 
praktijk nog steeds de meest toegepaste methode. Deze contradictie wordt onder meer 
veroorzaakt door de complexiteit van objectieve beoordeling van de bloedsomloop bij 
de pasgeborene.
Verondersteld wordt dat objectieve meting van de bloedsomloop de prognose van 
de patiënt zal verbeteren. Het is bekend, dat wanneer het hart bij kinderen te weinig 
bloed rondpompt, dit geassocieerd is met een hoger overlijdensrisico (3) en dat elke 
vertraging in het onderkennen van een falende bloedsomloop de mortaliteit verhoogt 
(4). Het volume bloed dat het hart per minuut rondpompt wordt hartminuutvolume, 
in het Engels cardiac output, genoemd. Bij te vroeg geboren kinderen is gebleken 
dat een laag hartminuutvolume het risico verhoogd op hersenbloedingen (5-8), te 
lage urineproductie met dientengevolge een te hoog kaliumgehalte in het bloed (9), 
gestoorde elektrische hersenactiviteit (EEG) (10), overlijden en/of een afwijkende 
neurologische ontwikkeling (11, 12). Men veronderstelt dat deze risico’s verlaagd 
kunnen worden, wanneer het hartminuutvolume op een objectieve wijze bij 
pasgeborenen kan worden gemeten en de behandeling daarmee kan worden gestuurd. 
Er zijn verschillende methoden beschikbaar, waarmee het hartminuutvolume gemeten 
kan worden. Echter, de toepasbaarheid van deze methoden blijkt bij pasgeborenen zeer 
beperkt te zijn om verschillende redenen, zoals bijvoorbeeld het gebruik van potentieel 
schadelijke stoffen, het te grote formaat van het materiaal en de moeilijkheden bij het 
inbrengen van speciale katheters. Een overzicht van de beschikbare methoden van
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hartminuutvolumemetingen wordt gepresenteerd in hoofdstuk 3 met een beschrijving 
van de basale principes van de toegepaste technologie. Specifieke aandacht wordt 
besteed aan de toepasbaarheid van de meetmethoden bij pasgeborenen (neonaten) met 
de respectievelijke voor- en nadelen van elke techniek. De meest kansrijke kandidaten 
voor objectieve meting van het neonatale hartminuutvolume lijken de transpulmonale 
indicatorverdunningmethoden, de arteriële polscontour analyse en de thoracale 
elektrische bioimpedantie. Transthoracale (functionele) echocardiografische evaluatie 
van potentieel aanwezige ductale en/of atriale shunts blijft echter onontbeerlijk 
teneinde de verkregen waarden van het hartminuutvolume bij een pasgeborene op een 
juiste wijze te kunnen interpreteren, ongeacht de toegepaste meetmethode.
In de zoektocht naar een methode, waarmee potentieel het hartminuutvolume bij 
een kritisch zieke pasgeborene kan worden gemeten, hebben we drie verschillende 
technieken gevalideerd in een experimenteel diermodel, waarbij nadrukkelijk de 
nauwkeurigheid, de precisie en de veiligheid zijn geëvalueerd. De drie bestudeerde 
methoden zijn: de gemodificeerde kooldioxide Fick methode (Sectie II), de 
transpulmonale ultrageluiddilutie (Sectie III) en de transpulmonale thermodilutie 
(Sectie IV).
In hoofdstuk 4 wordt de validatie van de gemodificeerde kooldioxide Fick (mC02F) 
methode in een lammermodel beschreven. Een groot voordeel van de mC02F methode is 
dat er geen extra meetapparatuur voor nodig is. Voor deze techniek is gasanalyse nodig 
van zowel arterieel als centraal veneus bloed, alsmede van de uitademingslucht met 
behulp van in-line capnografie. Hartminuutvolumemeting met behulp van de mC02F 
methode wordt vergeleken met de invasief gemeten bloedstroom door de longslagader 
door middel van een transit time ultrasonic flow probe, hetgeen in een diermodel als de 
"gouden standaard” referentiemethode wordt beschouwd. Wij geven de voorkeur voor 
plaatsing van de flow probe om de longslagader in plaats van om de grote lichaamslagader, 
aangezien bij deze laatste positie de bloedstroom naar de kransslagaders wordt gemist. 
In deze studie wordt de ductus arteriosus (Botalli) geligeerd, teneinde elke invloed 
van een mogelijke ductale shunt in deze fase van het onderzoek uit te sluiten. Het 
hartminuutvolume van het lam, dat onder algehele narcose verkeerde, wordt beïnvloed 
door het veroorzaken van hemorragische hypotensie (verbloedingshock). Ten tijde 
van een steady state, gedefinieerd als een stabiele pulmonale kooldioxide uitwas 
gedurende minimaal 6 minuten, wordt het hartminuut-volume gemeten met de mC02F 
methode en vergeleken met de simultaan gemeten bloedstroom door de longslagader 
als referentiemethode. Wij concluderen dat meting van het hartminuutvolume met 
behulp van de mC02F methode betrouwbaar en makkelijk toepasbaar is bij pasgeboren 
lammeren. Aangezien de tip van de centraal veneuze katheter bij pasgeborenen over 
het algemeen wordt gepositioneerd in de overgangszone tussen de rechterboezem 
(rechteratrium) enerzijds en de bovenste holle ader (vena cava superior) of onderste 
holle ader (vena cava inferior) anderzijds, is tevens de invloed van de plaats van 
afname van centraal veneus bloed op de accuratesse en precisie van de mC02F methode 
geanalyseerd. Het blijkt, dat voor de klinische toepassing van de mC02F techniek de 
plaats van afname van centraal veneus bloed (rechter atrium, vena cava superior of 
vena cava inferior) van ondergeschikt belang is.
Bij 20 tot 60% van de pasgeborenen, die op een intensive care worden opgenomen, 
kan op enig moment een persisterende open ductus arteriosus (Botalli) worden 
geconstateerd, hetgeen betekent dat er bloed vanuit de aorta kan shunten naar de
longslagader (en/of vice versa). Deze potentiële shunt kan een nadelige invloed hebben 
op de betrouwbaarheid van de techniek, waarmee het hartminuutvolume wordt 
gemeten. Vele methoden van hartminuutvolumemeting zijn dan ook niet toepasbaar 
in de aanwezigheid van een shunt. Gezien de hoge incidentie van een persisterende 
ductus arteriosus dient een methode, dat wordt toegepast om het hartminuutvolume 
te meten bij pasgeborenen, idealiter niet beïnvloed te worden door shunting van 
bloed. In hoofdstuk 5 wordt in een lammermodel de hypothese onderzocht, dat de 
mC02F methode ook toepasbaar is in geval van een significante links-rechts shunt 
(van aorta naar longslagader), zoals het geval is bij een belangrijke persisterende 
open ductus arteriosus. Bij de lammeren is chirurgisch een kunstmatige ductus 
arteriosus geconstrueerd met behulp van een Gore-Tex» shunt tussen de linkertak 
van de longslagader en de aorta. Deze aortopulmonale shunt wordt gedurende het 
experiment intermitterend geopend en gesloten, terwijl het hartminuutvolume van 
het lam wordt beïnvloed door het veroorzaken van hemorragische hypotensie. Het 
gemeten hartminuutvolume met behulp van de mC02F methode wordt vergeleken 
met de simultaan gemeten bloedstroom door de longslagader door middel van een 
transit time ultrasonic flow probe. Uit dit onderzoek blijkt dat de nauwkeurigheid van 
de mC02F methode bij een open of gesloten aortopulmonale shunt vergelijkbaar is. Dit 
betekent dat de mC02F methode, ook in de aanwezigheid van een significante links- 
rechts shunt, betrouwbaar is bij beademde lammeren. Men dient zich wel te realiseren 
dat de absolute waarde van het hartminuutvolume dat wordt verkregen met de mC02F 
methode zowel de pulmonale (kleine) als de systemische (grote) bloedsomloop kan 
representeren. Dit is afhankelijk van de plaats afname van arterieel en centraal veneus 
bloed in relatie tot de positie van de shunt. Ongeacht de toegepaste methode is het van 
essentieel belang dat men geïnformeerd is over potentiële intra- en/of extracardiale 
shunts, teneinde de verkregen waarde van hartminuutvolume correct te interpreteren.
Hoofdstuk 6 beschrijft de validatie van de ultrageluiddilutie (UDCO) methode in 
een biggenmodel, waarbij deze nieuwe methode van hartminuutvolumemeting wordt 
vergeleken met de simultaan gemeten bloedstroom door de longslagader door middel 
van een transit time ultrasonic flow probe. Centraal veneuze injectie van een isotone 
zoutoplossing op lichaamstemperatuur veroorzaakt een afname van ultrageluidsnelheid 
door het bloed, wat gebruikt kan worden om een indicatorverdunningcurve te 
verkrijgen in arterieel bloed. Met gebruik van het Stewart-Hamilton principe kan 
vervolgens het hartminuutvolume worden bepaald. Het te injecteren volume isotone 
zoutoplossing, dat per meting geadviseerd wordt, bedraagt 0,5 tot 1,0 ml/kg. Deze 
studie is tevens gebruikt om de accuratesse van een injectievolume van 0,5 ml/kg te 
vergelijken met een volume van 1,0 ml/kg. Het hartminuutvolume van het lam wordt 
tijdens het experiment beïnvloed door het veroorzaken van hemorragische hypotensie. 
De conclusie van deze studie luidt dat de transpulmonale ultrageluiddilutie methode 
betrouwbaar is bij jonge biggen met gebruik van een klein volume van een niet-toxische 
indicator. Een injectievolume van 0,5 ml/kg blijkt even nauwkeurig als een volume van
1,0 ml/kg. Het middelen van meerdere opeenvolgende metingen geeft geen verbetering 
van de nauwkeurigheid en slechts een kleine toename van precisie. Het advies luidt om 
standaard een injectievolume van 0,5 ml/kg te gebruiken ter preventie van overvulling. 
Over het algemeen voldoen twee opeenvolgende metingen en wordt een derde meting 
uitsluitend geadviseerd, wanneer de uitkomsten van de eerste twee metingen meer dan 
1 0 % van elkaar verschillen.
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Voor de toepassing van de UDCO methode dienen een arteriële en centraal veneuze 
katheter met elkaar verbonden te worden door middel van een extracorporeel 
circuit. Tijdens meting van het hartminuutvolume circuleert gedurende circa 3 tot 5 
minuten bloed door dit circuit, hetgeen gecontroleerd wordt door een peristaltische 
pomp met een flow van 6 tot 12 ml/min. Ondanks het feit dat het priming volume van 
dit extracorporele circuit slechts 0,9 tot 2,4 ml bedraagt, is het voorstelbaar dat het 
starten en stoppen van bloedflow door dit circuit met behulp van de pomp relevante 
veranderingen kan veroorzaken in de bloedsomloop van de patiënt. Voor een optimale 
metingvan het hartminuutvolume metdeUDCO methode wordtgeadviseerd de indicator 
(isotone zoutoplossing) zo snel als mogelijk via het veneuze deel van het extracorporele 
circuit te injecteren in een volume van 0,5-1,0 ml/kg. Het is aannemelijk dat deze snel 
toegediende vloeistofbolus de hartfunctie kan beïnvloeden met dientengevolge een 
verandering in de doorbloeding van de hersenen, hetgeen potentieel schadelijk is. 
Hoofdstuk 7 beschrijft het onderzoek bij biggen naar de veiligheid van toepassing van 
de UDCO methode, waarbij met name de invloed van de metingen op de bloedsomloop 
en zuurstofvoorziening van het lichaam (globaal) en de hersenen (specifiek) wordt 
bestudeerd. Met behulp van near infrared spectrofotometrie (NIRS) en een transit 
time ultrasonic flow probe om de linkerhalsslagader is de invloed van de UDCO 
metingen specifiek op de hersenen geanalyseerd. De consequenties voor de globale 
bloedsomloop naar het lichaam zijn geëvalueerd door analyse van de bloedstroom 
door de longslagader, de hartfrequentie en de bloeddruk rondom de UDCO metingen. 
Zowel het starten als stoppen van bloedstroom door het extracorporele circuit met 
behulp van de pomp veroorzaakt géén relevante veranderingen in de doorbloeding 
en zuurstofvoorziening van het lichaam en/of hersenen. De snelle injectie van isotone 
zoutoplossing veroorzaakt een voorbijgaande toename in bloedstroom door de 
longslagader en de linkerhalsslagader, dat statistisch significant meer uitgesproken is 
na een injectievolume van 1,0 ml/kg in vergelijk met een volume van 0,5 ml/kg. Het 
injecteren van isotone zoutoplossing veroorzaakt een initiële toename in cerebrale 
oxyhemoglobine- en deoxyhemoglobine-concentratie in de hersenen, direct gevolgd 
door een afname van beide concentraties. Deze bifasische respons was eveneens meer 
uitgesproken na gebruik van een injectievolume van 1 ,0  ml/kg in vergelijk met een 
volume van 0,5 ml/kg. Het blijkt dat deze waargenomen veranderingen in parameters, 
die de bloedsomloop en zuurstofvoorziening van de hersenen en/of het gehele lichaam 
weerspiegelen, binnen de normale, fysiologische spreiding vallen. Teneinde de effecten 
van een snelle injectie van indicator te beperken, wordt geadviseerd een volume van 
0,5 ml/kg te hanteren. Een interessante bevinding tijdens deze studie is, dat met de 
UDCO methode niet altijd het actuele hartminuutvolume wordt gemeten, maar het 
hartminuutvolume dat mogelijk kortdurend door het injectievolume is beïnvloed. Het 
is aannemelijk dat dit niet uitsluitend geldt voor de UDCO methode, doch eveneens 
voor alle methoden, die gebruikmaken van injectie van een indicator, zelfs bij een laag 
volume als 0,5 ml/kg.
In hoofdstuk 8 wordt de validatie van een derde meetmethode beschreven, 
te weten de transpulmonale thermodilutie (TPTD). In een lammermodel zijn de 
hartminuutvolumemetingen met behulp van TPTD vergeleken met de simultaan 
gemeten bloedstroom door de longslagader door middel van een transit time 
ultrasonic flow probe. Centraal veneuze injectie van een ijskoude, isotone zoutoplossing 
veroorzaakt een verandering in temperatuur van het bloed, dat door een specifieke
arteriële katheter kan worden gedetecteerd. Op deze wijze kan een indicatorverdunning- 
curve worden verkregen, waarmee met behulp van het Stewart-Hamilton principe het 
hartminuutvolume kan worden bepaald. De metingen zijn verricht bij lammeren, die 
initieel in een hypovolemische shock verkeren en vervolgens zijn geresusciteerd met 
intravasale vulling. De conclusie van deze studie luidt dat het hartminuutvolume bij 
lammeren betrouwbaar kan worden gemeten met de TPTD methode en dat de techniek 
in staat is veranderingen in hartminuutvolume ten tijde van vaatvulling te detecteren.
»  CONCLUSIES
Ondanks het bestaan van verschillende technieken vormt objectieve hartminuut- 
volumemeting bij een pasgeborene nog immer een uitdaging. Vooralsnog bestaat er geen 
klinische gouden standaard voor meting van het hartminuutvolume bij pasgeborene, 
waarop betrouwbaar een beleid kan worden gebaseerd.
Van de drie bestudeerde methoden van hartminuutvolumemeting lijkt de 
transpulmonale ultrageluiddilutie (UDCO] de meest veelbelovende techniek, die 
toegepast zou kunnen worden bij pasgeborenen. Momenteel worden de data 
geanalyseerd van een studie naar de invloed van een belangrijke links-rechts shunt 
op de nauwkeurigheid van de UDCO methode. Vervolgens is de tijd rijp voor klinische 
studies bij kritisch zieke pasgeborenen op de intensive care.
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DANKWOORD
DANKWOORD
Een proefschrift schrijf je niet op een zondagnamiddag en komt eveneens niet tot 
stand zonder de hulp van velen. Allen die op enigerlei wijze betrokken zijn geweest 
bij dit promotieonderzoek wil ik dan ook danken. Een aantal personen wil ik expliciet 
noemen, mij realiserend dat ik daarmee het risico loop iemand te vergeten. Bij voorbaat 
bied ik daarvoor mijn welgemeende excuses aan, maar zoals de Poolse dichter en aforist 
Stanislaw Jerzy Lee zei: "Wie een goed geheugen heeft, kan bepaalde dingen gemakkelijker 
vergeten".
Mijn promotor prof. dr. R. de Groot. Beste Ronald, het moment dat jij betrokken raakte 
bij mijn promotieonderzoek kwam het geheel in een stroomversnelling. Jij was degene 
die zorg droeg voor het creëren van de noodzakelijke omstandigheden om voortgang in 
het onderzoek te houden en tijd te oormerken voor het schrijven van de manuscripten. 
Ik ben je hiervoor zeer dankbaar.
Mijn promotor prof. dr. J.G. van der Hoeven. Beste Hans, je enorme brede kennis 
van zaken hebben een grote indruk op me gemaakt. Je hebt de gave om verschillende 
disciplines op een uiterst soepele wijze te laten samenwerken. Ook tijdens dit onderzoek 
is er een plezierige en vruchtbare samenwerking geweest tussen de afdelingen 
Kinderlntensive Care en Neonatologie. De wijze waarop je leiding gaf aan de kerngroep 
"Kinderhartchirurgie” is voor mij het toonbeeld geworden van constructief, kritisch, 
respectvol en efficiënt leiderschap. Ik hoop van ganser harte dat deze promotie het 
begin is van een intensieve wetenschappelijke samenwerking.
Mijn copromotor dr. K.D. Liem. Beste Djien, Je bent de neonatoloog, waar ik altijd een 
immense bewondering voor heb sinds mijn start als arts-assistent Neonatologie. Je 
klinische vaardigheden zijn onnavolgbaar, alsook je kennis van de neonatale neurologie. 
Jij hebt me wegwijs gemaakt in het veld van de onderzoeker en voorzien van waardevolle 
adviezen. Zonder je inbreng hadden we geen gedegen analyse kunnen verrichten naar 
de consequenties van cardiac output metingen op de cerebrale circulatie en oxygenatie 
met behulp van near infrared spectrofotometrie.
Drs. J.C.W. Hopman, beste Jeroen, ere wie ere toekomt! De bijdrage die jij hebt geleverd 
aan mijn wetenschappelijke vorming, de opzet en uitvoering van de dierexperimentele 
studies, de analyse van de onderzoeksgegevens en de totstandkoming van de 
manuscripten is door niemand te evenaren. Het is een voorrecht om met je te mogen 
samen te werken.
Prof. dr. 0. Daniëls, beste Otto, helaas is onze samenwerking tijdens ditpromotietraject 
van te korte duur geweest. Omstandigheden, zoals dat heet, hebben er toe geleid dat 
ik geen gebruik meer kon maken van jouw grote kennis van de neonatale circulatie. Ik 
ben je dankbaar voor de bijdrage die je in de beginfase van mijn promotieonderzoek 
hebt gehad.
Ik ben de leden van de manuscriptcommissie, prof. dr. M.T.E. Hopman, prof. dr. F. 
Lotgering en prof. dr. D. Tibboel dank verschuldigd voor hun kritische beoordeling van 
het manuscript.
I'm very honored by the willingness of dr. Tibby and professor Weindling to be a 
member of the Doctoral Examination Board at the public defense of my thesis. Dear 
Shane and Michael, I really appreciate your presence on this special day.
Dr. A.F.J. van Heijst, beste Arno. Jij bent degene geweest die mij in contact bracht met
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Nikolai Krivitski, de persoon die de ‘ultrasound dilution cardiac output! methode heeft 
ontwikkeld. Dit heeft uiteindelijk een grote vaart gegeven aan hetpromotietraject. Ik ben 
je daar dankbaar voor. Ik voorzie een toekomst met een succesvolle wetenschappelijke 
samenwerking en kijk uit naar momenten waarop we 'even kunnen sparren’.
Partofthis thesis wouldnot have been possible without the pioneering work of Nikolai 
Krivitski. Dear Nikolai, after a phase of major skepticism on my part you convinced 
me that it must be possible to measure cardiac output safely in newborn infants with 
ultrasound dilution technology. This initiated our scientific cooperation and I sincerely 
hope this will continue in the same inspiring, pleasant and successful way thus far.
Dr. R.B. Tanke, beste Ronald, na het vertrek van Otto Daniels nam je zitting in de 
projectgroep. Op deze wijze werd de kindercardiologische expertise binnen de groep 
behouden, waarvoor ik je erkentelijk ben.
Op het Centraal DierenLaboratorium heb ik met vele vakkundige mensen mogen 
samenwerken, wat ik zeer heb gewaardeerd. Een speciaal woord van dank aan een 
aantal van hen: Alex Hanssen, zonder wiens vaardigheden en expertise de experimenten 
nooit zo voorspoedig zouden zijn verlopen; Theo Arts, de nestor die mij wegwijs heeft 
gemaakt bij het opereren van biggen en lammeren; Jos Evers van de afdeling Fysiologie, 
die altijd weer bereid was om de benodigde voorzieningen te treffen voor een accurate 
bloedgasanalyse op de operatiekamer; prof. dr. Merel Ritskes, voor de plezierige 
samenwerking en het gestelde vertrouwen in mij; dr. ir. Marlies Leenaars en dr. Mathieu 
Sommers, proefdierdeskundigen, voor hun waardevolle adviezen.
Ik prijs me gelukkig dat het mogelijk is gebleken meerdere (multidisciplinaire) 
onderzoeken in één dierexperimentele studie te combineren, opdat we de drie V’s 
(Vervanging, Verfijning en Vermindering) van proefexperimenten optimaal hebben 
benut. Ik wil dan ook een aantal medeonderzoekers bedanken. Drs. J. Lemson, beste 
Joris, we delen onze interesse in de hemodynamiek van kritisch zieke kinderen. Ik 
kijk terug op een zeer plezierige samenwerking op het dierenlaboratorium, waar we 
van vroeg tot laat op elkaar waren aangewezen. De samenwerking wordt gelukkig 
voortgezet en zal naar mijn volle overtuiging zeer succesvol blijken. Ik kijk uit naar 
jouw promotie die aanstaande is. Drs. S.L.A.G. Vrancken en drs. A. Nusmeier, beste 
Sabine en Anneliese, jullie zetten het onderzoek voort. Ik wens jullie evenveel plezier 
toe als ik daarbij ondervind. Dr. M.H.W.A. Wijnen, dr. S.K. Singh en prof. dr. P.H. Schoof, 
beste Mare, Sandeep en Paul, ik vind het moeilijk om toe te geven, maar sommige 
operatieve handelingen vergen de expertise van topchirurgen. Ik ben jullie dankbaar 
voor de flexibiliteit en de grote chirurgische vaardigheid die jullie hebben getoond bij 
het aanleggen van de aortopulmonale shunts. Het bedroeft mij des te meer dat wij niet 
meer in hetzelfde ziekenhuis werkzaam zijn. Dr. ir. C.L. de Korte, drs. M.M. Nillesen, dr. 
L. Kapusta en J.P.T. Rijk, beste Chris, Maartje, Livia en Bob, de samenwerking op het 
dierenlaboratorium, teneinde driedimensionale opnamen van het hart te maken voor 
het berekenen van het hartminuutvolume, vond ik intrigerend en inspirerend. Het is 
een voorrecht met zulke vakkundige collega’s te mogen samenwerken.
Een speciaal woord van dank ben ik verschuldigd aan ing. J.J.M. Menssen. Beste Jan, 
ik heb het getroffen met de samenwerking met een persoon als jij met een grote kennis 
van zaken aangaande data-acquisitie en data-analyse. Je geeft me het gevoel dat ik altijd 
bij je terecht kan met mijn vragen en telkenmale ben ik verwonderd over het tempo 
waarin je de resultaten uit de computer weet te verkrijgen en te presenteren.
I would also like to thank Naveen Thuramalla for all his advise and assistance
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regarding ultrasound dilution cardiac output monitoring.
Ik prijs me gelukkig dat ik bij technische problemen tijdens de verschillende 
onderzoeken een beroep kon doen op twee zeer kundige technici van de Instrumentele 
Dienst, Theo van Rijswijck en Wouter Starren. Theo en Wouter, heel erg bedankt voor 
jullie kundigheid, geduld en flexibiliteit, wanneer ik weer eens langs kwam met een 
nieuw apparaat met een "verkeerde” stekker.
Als beginnend arts-assistent op de afdeling Neonatologie in 1991 kon ik mijn 
voorliefde voor basale anatomie en fysiologie delen met één van mijn toenmalige 
supervisoren, te weten dr. W.B. Geven. Beste Wil, jij hebt aan de wieg gestaan van mijn 
wetenschappelijke carrière. Uit vele onderlinge discussies tijdens een ECMO-congres 
op grote hoogte in Keystone ontsproot - weliswaar onder invloed van enige hypoxie - 
het idee om een methode te ontwikkelen, dan wel te vinden om de hemodynamiek van 
een pasgeborene beter te kunnen monitoren. Ik ben dankbaar dat ik in die essentiële 
fase van mijn wetenschappelijke vorming een zo goede leermeester heb gehad.
Collega neonatologen en fellows in Nijmegen, het is een voorrecht te mogen werken 
met zoveel getalenteerde mensen. Het voelt voor mij heel veilig om in een team als 
het onze te werken, waarbij je ten allen tijden te rade kunt gaan bij een collega. We 
maken roerige tijden mee, maar met de teamgeest en de gedrevenheid van deze groep 
voorzie ik een prachtige toekomst. We zijn in mijn ogen een complementair team 
met een groot synergistisch potentieel. Mijn promotieonderzoek was niet mogelijk 
geweest zonder jullie bereidheid tijdelijk enige klinische taken van mij over te nemen. 
Djien {‘‘magie hands met een niet te evenaren geduld"), Arno [‘‘Mr. ECMO, dat betekent 
Extra Collegiale Momenten van Overleg"), Viola ("waakster over het milieu interne"), 
Katerina ["Mrs. foUow-up"), Sabine ("Vlaamse (hemo)dynamiek"), René ("tussenlanding 
op de Bahama's"), Tim [“simulant, het is echt geen computerspelletje"), Marije [“sorry 
promovenda, kun je dat enzym voor me spellen?'), Maresa [“PRN-virtuoos, maar de server 
lag er echt uiü') en Ronny ["niet gek te krijgen")-, dank jullie wel! Daarnaast wil ik ook 
Berty Hilderink en Femke Croes, beide nu elders werkzaam als neonatoloog, bedanken.
Verpleegkundigen, ‘nurse-practitioners’, medisch maatschappelijk werkenden en 
arts-assistenten van de afdeling Neonatologie wil ik bedanken voor de goede werksfeer. 
Het is bijzonder om deel uit te maken voor zo’n professioneel ingesteld team.
Ik wil de dames van het stafsecretariaat en afdelingsecretariaat danken voor de 
flexibiliteit, deskundigheid en hartelijkheid, die zij altijd ten toon spreiden. Eén 
secretaresse wil ik speciaal bedanken en dat is Corrie van Wolferen. Corrie, jij bent de 
enige echte spil in onze organisatie en voor mij een rots in de branding! Velen kennen 
je grote verdiensten en je onmetelijke loyaliteit, al valt aan de erkenning daarvan mijns 
inziens nog veel te verbeteren. Dank je wel Corrie, het is een voorrecht om met jou te 
mogen werken.
Ik wil Christel Janssen en Jamilla van der Ploeg [Communicatiebron] bedanken voor 
de vormgeving van zowel de omslag als lay-out van dit proefschrift. Christel en Jamilla, 
dank voor jullie creativiteit en kundigheid. Ik zou een ieder jullie bijdrage van harte 
willen aanbevelen!
José van de Wouw heeft een belangrijke bijdrage geleverd aan dit proefschrift. Lieve 
José, in een enorm tempo heb jij de Engelse teksten geredigeerd. Ik ben je daar zeer 
dankbaar voor.
Reinier Raymakers, mijn "supervisor” tijdens mijn onvrijwillige stage op de afdeling 
Hemato-Oncologie, ben ik veel dank verschuldigd. Reinier, je hebt mij geleerd hoe
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belangrijk het is om als patiënt vertrouwen te hebben in je behandelend arts. Ellen en ik 
hadden ons geen betere behandelaar kunnen wensen!
Angela van Altena. Beste Angela, dankzij jou kunnen Ellen en ik met een gerust hart 
naar ons werk Wij weten als geen ander hoe belangrijk het is om een vertrouwd gevoel 
te hebben over de opvang van onze kinderen. Dank je voor je hartelijkheid voor de 
kinderen en de grote flexibiliteit. Je bent een onmisbare schakel in ons systeem.
Ik prijs me zeer gelukkig met mijn paranimfen, Petr Jira en Alexander Bours.
Beste Petr, nooit zal ik je onvoorwaardelijke steun vergeten in moeilijke tijden. Het 
verschijnen van het naambord "Hodgkin & non-Hodgkin” op onze gedeelde werkkamer 
heeft een onuitwisbare herinnering achtergelaten. Weet dat de onvoorwaardelijke 
steun wederzijds is, in goede en slechte tijden.
Beste Alexander, jij was geen verzekeringsagent en Mariëlle geen diëtiste. Het bleek 
uiteindelijk een bijzondere ontmoeting in Toscane met bijzondere mensen. Het is 
opmerkelijk wat de overeenkomsten zijn tussen onze echtgenotes en ons zelf. Ik ben 
erg blij met onze hechte vriendschap. Weet dat je altijd op mij kunt rekenen.
Lieve familie en vrienden, dank voor jullie interesse in mijn onderzoek, maar 
bovenal voor al die momenten tussendoor. Bewust noem ik geen namen, maar voel je 
aangesproken! Jullie vriendschap in alle fasen van ons leven zijn mij zeer dierbaar. Alle 
goede koffie, al dan niet zelfbereide etentjes en gezamenlijke vakanties met alle kinderen 
waren de brandstof voor dit onderzoek. Geloof het of niet, maar het proefschrift is 
afgerond. Partytime!
Lieve mevrouw en mijnheer van der Laan, u heeft een groot aandeel gehad in mijn 
eerste en allerbelangrijkste promotie, namelijk mijn promotie tot uw schoonzoon! Wie 
had kunnen bevroeden dat die lange jongen met afgeknipte spijkerbroek naar de hand 
van uw dochter zou vragen. Ik vind het geweldig dat u zo met ons meeleeft. Ik ben trots 
op zulke schoonouders, die bovendien zulke fantastische grootouders zijn.
Lieve ouders, het is zover! Ik ben jullie zeer dankbaar dat ik in een warm nest ben 
opgegroeid en alle mogelijkheden heb gekregen om mij te ontwikkelen. We hebben met 
z’n allen heel wat meegemaakt en zijn er sterker uitgekomen! De rol van opa en oma 
is jullie daarnaast op het lijf geschreven. Megchelien, dank je voor je onuitputtelijke 
interesse in wat ik doe. Willem, vanaf nu kun je in discussies niet alleen refereren aan 
hetgeen geschreven staat in Vrij Nederland, HP de Tijd of de Groene Amsterdammer, 
maar ook aan het proefschrift van je zoon!
Ellen noemde het altijd "Willems wereldwens”, een gezin met veel kinderen. Dit is 
maar gedeeltelijk juist, want het was namelijk "Ellens en Willems wereldwens” . Ellen 
en ik prijzen ons dan ook zeer gelukkig dat het mogelijk is gebleken ouder te worden 
van vier fantastische kinderen.
Lieve David [muzikaal, cabaretesken theatraal talent met enorme sociale gaven), Berend 
[levensgenieter die meerdere belangrijke stappen tegelijk kan nemen), Eefje [het mooiste 
kleine meisje met een verpletterende spontaniteit en energie) en Daniël [onze vroege vogel 
met een onuitputtelijke interesse in alles om hem heen). Mama en papa zijn ontzettend 
trots op jullie. Werken is belangrijk, maar het allerleukste daarvan is het naar huis gaan 
en jullie weer te zien!
Allerliefste Ellen (aldvdhweo"), ik fluister de woorden, die uit onmetelijke liefde als 
vanzelf naar buiten komen, in je oren. Dat is en blijft altijd iets tussen ons alleen!
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Willem-Pieter de Boode was born on the 13th of January 1966 in Arnhem, the 
Netherlands. After finishing secondary school (Coornhert Scholengemeenschap in 
Haarlem) he started Medical School in Amsterdam (Free University of Amsterdam) in 
1984. The medical degree was obtained in May 1991 (cum laude), after which he worked 
as a resident at the Department of Neonatology of the University Hospital Nijmegen. 
His training in Pediatrics commenced in 1993 at the pediatric departments of the Sint 
Joseph Hospital in Veldhoven (head: Dr. E.J.P. Lommen) and University Hospital Nijmegen 
(head: Prof.dr. R.C.A. Sengers), respectively. In October 1997 he was registered as a 
pediatrician, after which he was employed as fellow at the Department of Neonatology 
of the University Hospital Nijmegen (head: Prof.dr. M. van de Bor). During his fellowship 
a six month involuntary training was followed at the Department of Hemato-Oncology 
of the University Hospital Nijmegen (supervisor: Dr. R. Raymakers). In October 1999 
he finished his fellowship in Neonatology and since then he is a member of staff at the 
Department of Neonatology of the Radboud University Nijmegen Medical Centre.
Willem-Pieter de Boode is more than happily married to Ellen van der Laan. They are 
very lucky to have four magnificent children: David (October 11, 1995), Berend (March
8 , 1999), Eefje (June 11, 2001) and Daniël (June 11, 2001).
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